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Protein-Calorie Malnutrition.:
PCM can occur in up to 5 0 % of
surgical patients1- 2- 3. Its conse
quences are so serious — sep
sis, wound dehiscence, sup
pressed im m unocom petence —
that protein-calorie malnutrition
(P C M ) m ust be anticipated, and
preve n te d ...

before surge ry

and afte r surgery

Many patients face surgery with marginal
reserves that are further depleted by
semi-starvation regimens imposed dur
ing pre-op tests. Low-residue Ensure
meets the criteria for bowel preparation
but unlike clear liquid diets, Ensure
provides complete, balanced nutrition.

Increased metabolic rate and protein
losses may soon lead to PCM, unless a
positive nitrogen balance is quickly
restored. With Ensure, complete nutrition
can begin as soon as gastric motility has
returned. By mouth or by tube, Ensure
supplies adequate levels of protein and
calories, in a low osmolality, low solute
load, lactose-free formulation which is
exceptionally well tolerated. And during
recovery, when energy needs are still
high, Ensure is a delicious way to help
patients get the extra nutrition they need.

BY MOUTH OR BY TUBE

ENSURE*

I ROSS LABORATORIES
Division of Abbott Laboratories, Limited
Montreal, Canada H4P1A5

COMPLETE LIQUID NUTRITION
FOR A POSITIVE
NITROGEN BALANCE

1. Butterworth, C. E., Blackburn, G. L., Nutrition Today,
March/April 1975.
2. Bistrian, B. R. et al„ JAMA 230:6, Nov. 11,1974.
3. Bollet, A. J.. Owen, S„ Am. J. Clin. Nutr. 26. Sept. 1973.
•RD.T.M.
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A Major Advance in Controlling
Upper Gastrointestinal
Bleeding

Tagamet
(cunetidine)

INJECTION

Rapidly Controls
Bleeding
In hemorrhage due to
stress lesions, bleeding stopped
in most patients within 2-6 hours
after treatment with 'Tagamet'
began, and endoscopic reassess
ment at 24 hours showed that
57 out of 61 patients (93.4%) had
stopped bleeding.1
In an additional study with
'Tagamet' it was concluded "that
cimetidine is an effective agent for
controlling bleeding from hemor
rhagic gastritis, even in situations
where other medical and surgical
measures failed".2

Permits Conservative
Surgical Decisions
"The histamine H 2-receptor
antagonist, cimetidine, was used
in 27 patients with erosive gastritis,
and bleeding ceased in 24. There
is a prospect that such agents
will obviate the necessity of total
gastrectomy in the occasional
resistant cases in favour of conser
vative surgery."3

1. Muhe, E., et al: Proceedings of Brussels Symposium on Cimetidine, 1977.
2. Dunn, D.H., et al: Gastroenterology, 1977.
3. MacDonald, A.S., et al: Canadian Journal of Surgery, 1978.

QUILL ON SCALPEL
►►
►
This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.
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The knee is not a simple hinge joint.
Those very niceties of movement, in
addition to flexion and extension, are
its downfall. As long as the mechan
ism is normal, the knee is a beautiful
piece of equipment, for “ . . . when
she was good/She was very, very
good,/But when she was bad she was
horrid” to quote Longfellow.
Grenier and du Tremblay in this
issue (page 186) report on the value
of arthrotomy and arthroscopy and on
their limitations; they emphasize the
importance of clinical examination in
the diagnosis of internal derange
ments of the knee. In the last decade
progress has been made in under
standing the mechanism, the func
tional anatomy and biomechanics of
the knee joint and in refining aids to
exact diagnosis of pathologic condi
tions of the knee such as arthrogra
phy and arthroscopy, but, as noted
by Grenier and du Tremblay, even
these sophisticated aids leave much to
be desired and clinical assessment is
still a most important tool.
All of that is well and good but,
having made a correct analysis, where
do we stand with regard to treat
ment? The meniscal component of the
problem is now quite well understood
and treated. But the ligamentous in
juries, now also well understood, are
not as well handled. The difficulties
become apparent with an understand
ing of the complex mechanism of the
knee joint.
The helical motion of the knee is
imposed on it by the cam-like shape
of the unequal femoral condyles-—
sliding and rotation must take place
but in every position of the knee there
must be stability. Somehow gravity,
that ever-present knee flexor, must be
opposed by an extending mechanism
that is competent. This requires a
stable fulcrum. Inadequacy of the
extending mechanism allows the force
VOLUME 23, NO. 2, MARCH 1980
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of gravity to flex the knee involun stronger and on anchoring them better
tarily; that is, the knee gives way.
in bone; we are told to fix the joint
This inadequacy is caused by mus at the angle of flexion that will guar
cular weakness, abnormalities of os antee that the repaired ligament will
seous configuration (as a result of heal tightly. Then we exhort our
infection, trauma or congenital de patients to work hard at physiotherapy
fect) or ligamentous incompetence to regain motion and power. The only
and may be present in any weight way to do this in our cam-like knees
bearing position of the knee (all de is to stretch out the ligaments we
grees of flexion and rotation and have repaired so snugly, and then we
varus-valgus) and under any condi are back where we started from. Or,
tions (climbing steps, running, moving if the ligaments are so strong that
on uneven ground and playing sports). they cannot be stretched, then cartilage
Stability in paralytic conditions is and bone will be crushed to regain
quite easy to obtain using a long-leg motion, or motion may not be re
brace which keeps the knee extended gained.
passively against the flexor action of
For the professional athlete to re
gravity. This is done at the expense turn to the sports arena after opera
of knee motion. Most frequently, in tion is not necessarily a criterion of
stability is due to ligamentous incom success. They are extremely well mo
petence. Given the cam-like shapes of tivated individuals and are pushed by
the osseous components, the liga their “owners”, and their knees, sup
ments must be complex, each with ported by strong muscles, tape and
many points of attachment and of braces show a good short-term result.
varying length. We should not talk But the 1980s will bring many of
of the anterior and posterior cruciate these knees home to roost.
ligaments and the collateral ligaments
We already have “adjustable liga
as if they were each a single, uniform ments” which restrain the joint in a
structure with clearly defined, inde variable way because they are really
pendent functions, when they actually tendon transfers; as long as the
comprise hundreds of ligaments. In muscle is still functioning in its trans
fact, what we have considered as ferred position, some transfers are
separate structures are really part of theoretically sound, but they are often
a continuum. A force acting for a not strong enough to be fully effec
certain time and of a given amount tive. Perhaps a new era will be ushered
may tear one portion of one structure, in by the computer— first to furnish
but if the force is continued longer an analysis of the total defect and
and is of sufficient amount, it will second, to provide a ligament recon
tear a second and third structure. struction plan, with the exact location
The wonder is that Grenier and du of multiple points of attachment and
Tremblay did not find more “asso the design of the ligament itself, with
ciated lesions”.
the variable lengths of its components;
Having made careful analyses of perhaps the computer will even direct
the problems of our patients, we sur the weaving of the ligament, prefer
geons discard the knowledge we have ably with an absorbable material that
acquired when attempting to repair eventually is replaced by living tissue
torn ligaments. We are taught to put attached to bone by a living bond.
them together tightly: we are work
We have learned a great deal about
ing on making artificial ligaments the structures involved through deTHE CANADIAN JOURNAL OF SURGERY
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tailed examination and research and
about the defects that result from
specific mechanisms, because many
injuries are filmed as they happen in
high school, in university and in
professional sports. Also we now have

excellent radiologic and direct meth
ods for visualizing some of the le
sions, but we must go on from mere
excellence in diagnosis to having more
regard for putting things together in
a physiologic way that will assure nor

mal function—and as yet we don’t
know how.
J.L. Shugar,

md , frcs [c ]

Associate editor

The Healthier Heart
It is understandable, in such a wide
field as general surgery, that we
sometimes forget what we owe to our
sister specialties in terms of surgical
progress. The discovery of the value
of such drugs as dopamine, isopro
terenol, xylocaine, propranolol and
sodium nitroprusside may seem to be
of little moment when replacing a
hip joint, but if the patient is elderly
and has cardiac disease such drugs
may be life-saving. The skilled appli
cation of such drugs together with the
knowledge of how to control fluid
balance, electrolyte shift, oxygen utili
zation, cardiac output or trace metal
depletion may do much to make a
surgical procedure successful. Anes
thetists have made tremendous strides
in furthering the application of these
skills. Indeed anesthesia has almost
become a science rather than an art!
The same is true of cardiology and
surgery.
Cardiac surgery has played an im
portant role in providing the type
of acute clinical emergency that has
justified the use and indeed the trial
of new techniques and new drugs.
Fortunately, such emergency situa
tions, as a result of our increased
knowledge, are now relatively uncom
mon.
In the three decades of heart sur
gery certain landmarks stand out.
In the first decade— 1950 to 1960—
the finding of greatest significance
was that heart surgery, albeit closedheart surgery, could be done at all
with survival and improvement of the
patient’s health!
In the second decade, when cardiac
bypass and open-heart surgery were
introduced, the flood gates opened.
Each month cardiovascular surgical
journals reported new techniques for
dealing with intracardiac and major
vessel problems. There appeared to be
no end to technical ingenuity.
In the past decade, surgery for
coronary artery disease has been de
veloped and coronary artery bypass
grafting has become the commonest
of all cardiac operations.
108

But in the mid-1970s, a strange
and rather long-delayed disquiet be
gan to develop in the field of cardiac
surgery. Many of the older surgeons
began to think that the long-term re
sults of open-heart surgery were disap
pointing and that this resulted not
from technical faults or the imper
fections of our tools but from the
permanent, though initially not dis
cernible, damage inflicted on the myo
cardium, especially during long and
complex cardiac procedures.
We had spent too much time on
perfecting our technical skills in cor
recting cardiac deformity or disease
and too little time in perfecting meth
ods of protecting the myocardium
while we were busy with our hands.
With increasing intensity, discus
sion and research, “myocardial pro
tection” has become the “watch-word”
in present-day cardiac surgery.
The inclusion in this issue of the
journal (pages 111 to 126 and 132 to
153) of selected papers presented at
the 32nd annual meeting of the
Canadian Cardiovascular Society in
Quebec City bears this out, as three
of the papers so selected deal with
possible methods of further increasing
myocardial protection.
In terms of body chemistry, the
danger of an imbalance of sodium,
calcium, potassium, chloride, urea,
etc., has long been known. In recent
years, the possible danger of changes
in cations and trace metals such as
magnesium, in particular, and zinc or
copper have received increasing at
tention. The report by Meltzer and as
sociates (page 113) indicates that there
appears to be a substantial depletion
of myocardial magnesium levels when
the cardioplegic solution does not
contain sufficient magnesium. The
authors make no comment on the
possible clinical importance of such
changes but in practice it is known
that magnesium will sometimes abol
ish cardiac arrythmias particularly
ventricular premature beats, when
other drugs have failed.
Addetia and Callaghan (page 146)

VOLUME 23, NO. 2, M A R C H 1980
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present an interesting new concept in
furthering myocardial protection. Un
til now, one of the fundamental con
cepts of myocardial protection has
been to reduce the energy demands
of the myocardium, if possible to
zero, during cardiac arrest. The myo
cardium is still “alive” during cardio
plegia and with the ascending aorta
cross-clamped still requires energy
although at a much reduced level.
The authors suggest that more
attention should be paid to building
up energy stores, small though the
demand may be, to provide energy
during cardioplegia and for better
restoration of normal function at
the end of cardioplegia. In one
group of dogs, cardioplegia with hypo
thermia at 20 °C and no aortic crossclamping was continued for 4 hours.
At autopsy, minimal hemorrhage was
seen in the endocardium and the ul
trastructure was completely preserved.
Akyurekli, Taichman and Keon
(page 122) outline the value of intra-aortic balloon counterpulsation in
relation to systolic unloading, in other
words, the value of reducing after
load or, more simply, the work of the
left ventricle, which results in im
proved coronary artery perfusion.
This is another ancillary aid to myo
cardial protection as is the use
of such drugs as sodium nitroprusside.
The value of intra-aortic balloon
pumping both pre- and postoperatively
and in acute coronary ischemia has
been proven clinically beyond doubt.
Much has yet to be learned about
how to make the sick heart a healthier
heart, whether on a medical or sur
gical regimen, but the present wide
spread and avid research being fo
cused on myocardial protection will
surely go a long way to providing the
answer.

J ames A. K ey, m b , ch b , frcs [c1
Department of surgery,
Toronto General Hospital,
Toronto, Ont.
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CANADIAN CARDIOVASCULAR SOCIETY PAPERS

Direct Revascularization of the Septal Artery
P. B e d a r d , m d , f r c s [c ], W.J. K eo n , m d , f r c s [c ],
M. BRA1S, MD, FRCSfc] AND W. GOLDSTEIN, MD, FRCS[C]

Between July 1, 1976 and May 1,
1979, 21 patients underwent coronary
artery grafting of the first septal
artery. Blood flow in the septal
bypass averaged 60.2 m l/m in and the
diameter of the distal anastomoses
averaged 2.1 mm. Among the 20
survivors, 13 were subjected to
angiography at an average of 7 months
after the operation (from 2 weeks
to 2 years). The bypass graft to
the first septal artery was patent
in 84% of the patients (11 of 13)
and 90% of the grafts were open
(57 of 63).
The authors believe that if a
patient has an important stenosis in
the first septal artery, direct
revascularization may be carried out.
However, because of technical
difficulties during dissection and
anastomosis it is wise to select an
artery at least 2 mm in diameter
which supplies a large area.

Over the past 10 years coronary artery
bypass grafting has been performed
with increasing frequency. It has been
realized that an increase in the total
myocardial blood flow is necessary to
relieve coronary insufficiency. There
fore grafting to branches of the right,
left anterior descending (LAD) and
circumflex coronary arteries is being
carried out more frequently, specially
if these arteries are 1.5 mm or more
in diameter.
The calibre of the first septal artery
(Si) of the LAD coronary artery may
at times be large enough to warrant
revascularization if it is stenosed.1 Its
direct revascularization by bypass

Entre fe 1" juillet 1976 et le 1" mai

From the University of Ottawa
Cardiac Unit, Ottawa Civic Hospital,
Ottawa, Out.
Presented at the 32nd annual meeting
of the Canadian Cardiovascular
Society, Quebec, PQ, Oct. 19, 1979
Supported by Ontario Heart
Foundation grant 5-6
Accepted for publication Nov. 13, 1979
Reprint requests to: Dr. P. Bedard,
Division of cardiothoracic surgery,
Ottawa Civic Hospital, 1053 Carling
Ave., Ottawa, Ont. K 1 Y 4E9
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1979, 21 patients ont subi un pontage
coronarien de la premiere artere
septale. Le debit sanguin dans la
derivation septale fut, en moyenne,
de 60.2 m l/m in et le diametre moyen
de I'anastomose distale fut de 2.1 mm.
Parmi les 20 survivants, 13 furent
soumis a une angiographie 7 mois en
moyenne (de 2 semaines a 2 ans)
apres I'intervention. Le greffon de la
premiere septale etait libre chez 84%
des patients (11 sur 13) et 90% des
greffons etaient ouverts (57 sur 63).
Les auteurs croient qu'une revascu
larisation directe peut etre pratiquee
si le patient presente une importante
stenose de la premiere artere septale.
Toutefois, a cause de difficultes
techniques durant la dissection et
I'anastomose, il est preferable de
choisir une artere d'au moins 2 mm
de diametre qui irrigue une large
region.

/

grafting may at times be difficult be
cause of its situation in the anterior
portion of the interventricular septum,
under the LAD artery.
Patients and Methods

From July 1, 1976 to May 1, 1979,
1510 patients underwent coronary ar
tery bypass grafting at the University
of Ottawa Cardiac Unit. Of these, 21
patients received grafts to Si. There
were 18 men and 3 women; their ages
ranged from 31 to 62 years (mean
51.9 years). On average, 4.4 grafts
were placed per patient (range 3 to 6).
Additional procedures included seven
endarterectomies to the right coronary
artery and three plications or resec
tions of a left ventricular aneurysm.
Intra-aortic balloon pump assistance
(IABPA) was used in two patients.
One patient had a tear in the anterior
portion of the right ventricular septum
(IABPA was used prophylactically in
this patient). The average pump time
was 99 minutes (range 50 to 241 min
utes) and the average duration of
cardiac anoxia was 47.6 minutes
(range 38 to 67 minutes). The dia
meter of the distal Si anastomosis
was measured in 12 patients and aver
aged 2.1 mm (range 1.5 to 2.5 mm).
In 20 patients, the blood flow in the
graft to Si was measured and varied
from 13 to 135 ml/min (mean 60.2
ml/min).
Results

One patient died during the opera-
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tion because he could not be weaned
from cardiopulmonary bypass. At the
time of writing, 17 of the 20 survivors
were asymptomatic, 1 was in class II
(New York Heart Association classi
fication) and 2 were in class III. Of
the two in class III, one had angina
and the other had congestive heart
failure.
Perioperative myocardial infarction
as diagnosed by the appearance of
new Q waves on the electrocardiogram
did not occur. However, in one patient
a complete left bundle branch block
developed. In one patient a left bundle
branch block that was present preoperatively disappeared after opera
tion.
Thirteen of the 20 survivors under
went coronary angiography 2 weeks
to 2 years postoperatively (mean 7
months) (Fig. 1). Of the 63 bypass
grafts, 57 (90%) were patent whereas
of 13 grafts to Si, 11 (84%) were
patent.

septum. Because of the LAD vein,
dissection of Si is carried out on the
right ventricular side of the LAD
artery. The relationship of Si to the
first diagonal artery should be as
sessed on the angiogram so that the
origin of the first diagonal artery is
used as a marker. The origin of Si
is then localized as cardiopulmonary
bypass is instituted, but before cardiac
anoxia is induced. Usually bypass
grafting to Si is carried out as the
last anastomosis. Retraction sutures
are positioned around the LAD artery
proximal and distal to the origin of
Si to facilitate exposure. Careful dis
section of the first centimetre of Si
is carried out, care being taken to
protect the right ventricular wall as
the Si tends to come closer to the
right ventricular endocardium.4
The most feared complication of

bypass grafting of Si is a rupture of
the right ventricular wall. We had this
problem in one patient and it was
with the greatest difficulty that we
repaired the tear, with the loss of the
graft to Si as indicated on the posto
perative angiogram. Leakage at the
anastomotic site may present a prob
lem as it may be difficult to apply
sutures on the distal anastomosis after
cardiac anoxia or cardiopulmonary
bypass has been terminated. In dissect
ing Si care should be taken to protect
branches of the LAD artery or vein.
Revascularization of Si may be
obtained in various ways. Often, one
can obtain indirect revascularization
by grafting the LAD artery or first
diagonal artery (Fig. 2, a and b). How
ever, if there is a stenosis at the
origin of Si or diffuse obstruction of
the LAD artery, revascularization may

Discussion
The anatomy of the septal arteries
has been reviewed by Stoney and
associates.1 They reported a large Si
in 30 of 100 arteriograms studied.
However, in their study, in the study
by Auer2 and in our own, the rate of
grafting of Si is much lower, being
less than 2% of all patients being
operated upon for coronary artery by
pass grafting.
The first septal artery originates
from the proximal third of the LAD
artery. Its branches are usually pa
rallel and seldom at a right angle; this
allows easy identification on angio
graphy. Its importance is related to
the fact that it may supply up to
15% of the blood to the myocar
dium3 and is a source of collateral
circulation to the posterior descend
ing coronary artery.1
The exposure of Si involves dissec
tion in the anterior interventricular

20 survivors.

12

F IG . 2— Schematic view of left an terior descending (LAD) coronary artery,
with its two first branches: first diagonal (D,) and first septal (S,) arteries. Indirect
revascularization of S, may be obtained by bypass grafting of LAD (a), D, (b) or
LAD endarterectom y (c). Direct bypass grafting of S, may be carried out in (c) or (d).
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be obtained only with direct bypass
Coronary artery bypass grafting of
grafting of Si (Fig. 2d) or by perform Si may provide an important source
ing an endarterectomy of the LAD of blood supply to the myocardium
artery (Fig. 2c).5
particularly if there is diffuse coronary
artery disease in the three major coro
Conclusions
nary arteries or if a second or third
The first septal artery may at times operation for myocardial revascular
be large enough to warrant revascular ization is needed.
ization if it is stenosed. However,
because of technical difficulties en
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1.
S
toney WS, Vernon RP, A lford
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Myocardial Cations and Trace Metals in Cardioplegia:
a Clinical Study
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C a tio n s and tra c e m e ta ls p la y
im p o rta n t ro le s in th e p a th o p h y s io lo g y
o f m yo card iu m , and u n d e rsta n d in g
th e ir c h a n g e s d u rin g c a rd io p le g ia
m ay be im p o rta n t in fu rth e r re fin in g
th e te ch n iq u e o f m y o c a rd ia l p ro te c tio n .
S e ria l m y o c a rd ia l, b lo o d and u rine
s a m p le s w e re tak e n fro m 12 p a tie n ts
u n d erg o in g c a rd ia c o p e ra tio n u n d er
c o ld c a rd io p le g ia . The c o n c e n 
tra tio n s o f c a lc iu m , m a g n e siu m ,
z in c and c o p p e r w e re m e a su re d
w ith an a to m ic a b so rp tio n s p e c tro 
m eter. M y o c a rd ia l m a g n e s iu m le v e ls
w e re fo und to be s ig n ific a n tly
(P < 0.05) d e p le te d w h e n th e
“ c a r d io p le g ic ” s o lu tio n c o n ta in e d
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0.69 m m o l/ l o f m a g n e siu m , b u t
t h is c o u ld be p re v e n te d by
in c re a s in g the m a g n e s iu m c o n c e n tra 
tio n o f the in fu s a te to 2.2 m m o l/ l.
W ith c a lc iu m -fre e in fu s a te , th e
m y o c a rd ia l c a lc iu m c o n c e n tra tio n
d e c re a s e d , but z in c an d c o p p e r
v a lu e s d id not c h a n g e s ig n ific a n tly .
T here w e re d e c re a s e d se ru m
c o n c e n tra tio n s o f t h e s e c a tio n s an d
tra ce m e ta ls d u rin g th e h e m o d ilu tio n
c a rd io p u lm o n a ry b y p a s s but th e ir
24-hour e x c re tio n s in u rin e w e re
w ith in n orm a l range. A lth o u g h th e
c lin ic a l im p o rta n ce o f su ch c h a n g e s
re m a in s to be e lu c id a te d , the
in fo rm a tio n m ay be v a lu a b le in
d e s ig n in g fu tu re c a r d io p le g ic s o lu tio n s
w ith o p tim a l c o m p o s itio n s .
L e s c a tio n s e t le s o lig o -e le m e n ts
jo u e n t un ro le im p o rta n t da n s la
p a th o p h y sio lo g ie du m yo ca rd e ; la
c o n n a is s a n c e de le u rs m o d ific a tio n s
d u ra n t la c a r d io p le g ie p e u t e tre
im p o rta n te s i Ton v e u t a ffin e r
d a vantag e c e tte te c h n iq u e de p r o te c tio n
du m yo ca rd e . D e s p re le v e m e n ts
s e r ie s du m y o c a rd e , du sa ng e t de
I'urine o n t e te fa it s c h e z 12 p a tie n ts
qui o n t su b i une o p e ra tio n c a rd ia q u e
s o u s c a rd io p le g ie p a r le fro id . L e s
c o n c e n tra tio n s d e c a lc iu m , de
m a g n e siu m , de z in c e t de c u iv r e o n t

e te m e s u re e s au s p e c t r o m e t r e
d 'a b s o rp tio n a to m iq u e . O n a r e tro u v e
une d e p le tio n s ig n ific a t iv e (P < 0.05)
d e s ta u x m y o c a r d iq u e s d e m a g n e s iu m
quand la s o lu tio n d e c a r d io p le g ie
c o n te n a it 0.69 m m o l/ l d e m a g n e s iu m ,
m a is c e c i p u t e tre p re v e n u en
a u g m e n ta n t la c o n c e n tra tio n d e
m a g n e s iu m d a n s le liq u id e d e p e r fu s io n
a 2.2 m m o l/ l. A v e c un liq u id e d e
p e rfu s io n e x e m p t d e c a lc iu m , la
c o n c e n tra tio n m y o c a rd iq u e en c a lc iu m
a d im in u e , m a is c e lle s e n z in c e t
en le c u iv r e n 'o n t p a s c h a n g e
s ig n ific a tiv e m e n t. O n a e n r e g is t r e u n e
d im in u tio n d e s c o n c e n t r a t io n s d e c e s
c a tio n s e t o lig o - e le m e n ts d u ra n t
I'h e m o d ilu tio n d e la c ir c u la t io n e xtra c o rp o r e lle , m a is le u r s e x c r e t io n s
u rin a ir e s d e 24 h e u re s d e m e u r e re n t
a I 'in te rie u r d e s lim it e s n o rm a le s .
B ien que I'im p o rta n c e c lin iq u e d e c e s
c h a n g e m e n ts n 'a it p a s e n c o r e e te
e lu c id e e c e t t e in fo rm a tio n p e u t e tre
d 'in te r e t p o u r la m ise -a u -p o in t fu tu re
de s o lu tio n s d e c a r d io p le g ie p o s s e d a n t
une c o m p o s itio n o p tim a le .

Cations such as calcium and magne
sium are known to be important in
the normal functioning of the myocar
dium. Abnormalities of these and
other trace elements have been im
plicated in myocardial ischemia and
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other cardiovascular disease states.1*6
In recent years, cold cardioplegia has
become increasingly popular as a
method for protecting the myocardium
during cardiac surgery, but the com
position of an ideal “cardioplegic”
solution remains unsettled. Many ex
perimental studies have been under
taken to determine the most desirable
composition of the cardioplegic infusate in regard to the cation portion
and the results have varied widely.7’8
Furthermore, such data obtained from
normal animal hearts, often in in vitro
preparations, may not always be ap
plicable to humans. In this report we
present our findings with respect to
changes in calcium, magnesium, zinc
and copper concentrations, both in
the myocardium and in the body fluids
of patients undergoing cardiac oper
ations using cold cardioplegia for myo
cardial protection.
Patients and Methods

Twelve patients who underwent
either aortocoronary bypass grafting
or valve replacement were studied.
Cardiopulmonary bypass with moder
ate hypothermia (30°C) was em
ployed, using Ringer’s lactate as the
priming solution. Immediately after
aortic cross-clamping, the cold (4°
to 8°C) cardioplegic solution was in
fused rapidly either into the aortic
root or directly into the coronary
ostia. The composition of the cardio
plegic solution used in seven patients
who made up group 1 is shown in
Table I. In the remaining five patients
who made up group 2, extra magne
sium was added to the same solution
so that it contained a higher concen
tration (2.2 vs 0.69 mmol/1) of the
element. The intramyocardial temper
ature was monitored with a needle
thermistor probe and maintained,
with additional surface cooling, at less
than 25 °C throughout the aortic
cross-clamping period (average 66
minutes). Upon removal of the aortic
cross-clamp and rewarming of the
heart, there was rapid return of
spontaneous rhythm. Full-thickness

photometry but for copper, 2 ml of
urine was dry ashed in a muffle fur
nace and analysed by flameless spec
trophotometry.11

left ventricular myocardial biopsy
specimens were obtained with a biopsy
needle: (a) immediately after the
aortic cross-clamp was applied and
before infusion of the cardioplegic
solution, (b) just before the aortic
cross-clamp was removed and (c) 10
minutes after myocardial reperfusion.
All tissue samples were wet ashed,
weighed and diluted using different
proportions of nitric acid depending
on the elements being analysed. All
analyses were performed by flameless
atomic absorption spectrophotometry.9
Blood samples were collected during
operation, at the same time as the
myocardial biopsies were obtained,
and then daily after the operation.
The serum was diluted with water for
zinc and copper analyses. Plastic sam
ple tubes and doubly distilled water
were used to prevent contamination.
For magnesium and calcium diluted
samples were prepared using a 1000
ppm lanthanum solution. All four
elements were quantitatively analysed
by flame atomic absorption spectro
photometry.10 Twenty-four hour urine
collections were obtained for the first
2 postoperative days. Urinary mag
nesium, calcium and zinc were meas
ured by flame absorption spectro

Results

In group 1 the concentrations of
both magnesium and calcium ions ap
peared to decrease in the myocardium
at the end of the cardioplegic period
(Table II) but, because of sample size
and variations (Fig. 1), only the mag
nesium depletion was statistically
significant (P < 0.05, paired Student’s
/-test). The concentrations of both
ions returned to normal after 10
minutes of reperfusion. In contrast,
zinc and copper did not show
significant change. Table II also shows
the trace metal levels in myocardial
tissue in group 2 patients who
received more magnesium in the
cardioplegic infusate. In this group the
myocardial magnesium depletion dur
ing cardioplegia was prevented (Fig.
2) (P > 0.10). Zinc and copper levels
again showed no significant change.
Table III shows the blood levels of
cations measured in groups 1 and 2,
respectively. There was a slight de
crease in magnesium and calcium
levels during cardiopulmonary bypass

Table II— Myocardial Tissue Levels*
Elem ent, (xg/gf
Group
1 (n - 7)
Before cardioplegia
End of cardioplegia
Reperfusion, 10 min
2 (n = 5)
Before cardioplegia
End of cardioplegia
Reperfusion, 10 min

Mg

Ca

Zn

Cu

62.75 ± 18.18
51.54 ± 20.17
53.85 ± 16.53

153.07 ± 39.38
121.09 ± 43.78
130.31 ± 37.22

3.75 ± 0.58
3.95 ± 0.74
3.70 ± 0.57

3.07 ± 0.67
3.02 ± 0.61
2.88 ± 0.49

75.16 ± 9.73
62.06 ± 11.76
63.78 ± 11.25

174.92 ± 44.14
161.77 ± 40.69
168.00 ± 52.73

4.10 ± 0.68
3.81 ± 0.51
3.85 ± 0.58

2.83 ± 0.26
2.96 ± 0.10
2.85 ± 0.11

‘ Date expressed as mean ± standard deviation.
fW et weight.

Table I— Composition of the
“ Cardioplegic Solution”
N orm osol® , m l*
1000
Potassium chloride, mmol
20
Sodium bicarbonate, mmol
25
Lidocaine, g
0.5
Dextrose, g
17
pH: 7.4
osm olarity: 383 mOsm/l
*C ontains 0.69 m m ol/l of Mg2+, 7 m m ol/l
of K+ and no Ca2+, Cu2+ or Zn2+.
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FIG. 1— Myocardial tissue values for magnesium in group i patients. Decrease
at end of cardioplegia is significant (P <0.05, paired Student’s /-test).
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and there was a considerable variation
in the zinc and copper values. The
higher concentration of magnesium in
the cardioplegic solution administered
to group 2 patients did not produce
higher serum magnesium levels either
during or after the operation.
In the 24-hour urine values for
groups 1 and 2 (Table IV) the in
crement of magnesium in the cardio
plegic solution did not appear to in
crease the magnesium output from the

urine and there was no significant dif
ference in the data obtained from
these two groups.
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while the tissue copper value de
creased and zinc remained un
changed. These and other epidemiol
ogic studies12 have implicated trace
Discussion
metals in the pathogenesis of ischemic
The cardiac magnesium level de myocardial disease. In cold cardio
creases substantially in people dying plegia, myocardial hypothermia plays
suddenly from ischemic heart disease, a central role and we have found
although the precise pathophysiology that direct monitoring of the intrais not clear.3"5 Anderson and asso myocardial temperature adds a meas
ciates2 described such depletion, to ure of safety during cardiac surgery.13
gether with an increase in calcium However, various experimental studies
have shown that the tolerance of the
myocardial cells to ischemia can be
further increased or decreased depend
250
ing on the content of the cardioplegic
solution.14 The optimal ionic composi
tion of such a solution remains con
200
troversial. Infusates whose composi
/ug/9
tion is like that of intracellular fluid
.............
have been used by some surgeons,
**150
although the majority have used extracellular-like solutions. Kirsch, Rodewald and Kalmar15 believe that no
in n
calcium should exist in the solution.
i
i'o min
Indeed calcium antagonists, such as
|
Aortic
nifedipine16 and verapamil,17have been
Reperfusion
1
C ro sssaid to protect the myocardium from
Clam p
ischemic injury. Bretschneider and as
FIG. 2—Myocardial tissue values for magnesium in group 2 patients. In sociates,7 whose solution was low in
creased magnesium concentration in “cardioplegic” solution prevented depletion
sodium (12 mmol/1), stated that re
of myocardial magnesium (P > 0.1).
moval of extracellular sodium causes
an increased influx of calcium ions
into the cell. Consequently, cellular
T a b le III — S e r u m L e v e ls *
energy turnover is increased, unless
the extracellular calcium concentra
E le m e n t
tion is reduced simultaneously. The
G ro u p
C a , m e q /l
M g, m e q /l
Z n , [ ig / d l
C u , [x g /d l
degree of reduction should be calcul
ated by the quotient Nae/C ac2. Thus
1 ( n = 7)
P r e o p e r a t iv e
a decrease of the extracellular sodium
5 .20 ± 0.34
1 .6 6 ± 0.23
2 6 8 .09 ± 186.57
111.66 ± 2 1.3 7
E n d o f c a r d io p le g ia
4 .65 ± 0.56
1 .38 ± 0.22
1 4 1 .0 7 ± 67.54
49.87 ± 2 0.8 2
(Nae) concentration to 1/10 of the
R e p e r f u s io n , 10 m in
4 .7 0 ± 0.71
1 .32 ± 0 . 3 2
3 4 4 .7 6 ± 3 27.89
56.00 ± 3 0.3 5
normal
requires compensating reduc
P o s t o p e r a t iv e
tion of the extracellular calcium (Ca„)
day 1
5.14 ± 0.21
1 .45 ± 0 .06
1 6 3 .6 6 ± 1 00.90
88.34 ± 1 0.6 2
day 7
5.51 ± 0.77
1 .51 ± 0.29
2 3 0 .00 ± 109.64
109.74 ± 18.17
concentration to 1/100 of the normal.
2 (n = 5)
Jynge, Med and Hearse,8 however,
P r e o p e r a t iv e
5.40 ± 0.49
1 .7 6 ± 0.05
1 9 9 .60 ± 58.42
129.48 ± 1 11.23
pointed out that low extracellular cal
E n d o f c a r d io p le g ia
5 .32 ± 0.50
1 .0 6 ± 0.05
1 94.30 ± 75.87
71.78 ±
16.57
cium compounded by the ischemiaR e p e r f u s io n , 10 m in
5.57 ± 0.58
1.11 ± 0.09
3 15 .20 ± 2 7 1 .9 8
76.66 ± 17.30
P o s t o p e r a t iv e
induced loss of membrane control,
day 1
5 .94 ± 0.73
1 .2 7 ± 0.15
2 2 2 .3 6 ± 9 3.0 6
157.56 ± 88.41
would
ultimately lead to the loss of
day 7
6 .09 ± 0.68
1 .6 6 ± 0 . 1 1
2 3 2 .4 0 ± 62.39
93.08 ± 1 1.7 7
intracellular calcium into the extra
’" D a ta e x p r e s s e d a s m e a n ± s t a n d a r d d e v ia t io n .
cellular space. This process predis
poses the cells to a calcium paradox
and further reperfusion injury. Their
“St. Thomas’ Hospital solution” thus
contains 1.2 mmol/1 of calcium
T a b le I V — L e v e ls in 2 4 - H o u r U r i n e S a m p le s *
chloride. Our data indicated that myo
cardial calcium concentration de
E le m e n t
creased
during cardioplegia. Our solu
G ro u p
C a , m eq/2 4 h
M g , m e q /2 4 h
Z n , [j.g/24 h
C u , [ ig / 2 4 h
tion, like many others, is calcium1 (n = 7)
free. Because of the considerations
P o s t o p e r a t iv e
described above, we have not so far
day 1
4 .2 8 ± 1.31
7 .0 0 ± 1.24
3 5 2 .8 6 ± 6 0.4 7
3 0 .5 5 ± 1 5 .0 6
added calcium to our clinical inday 2
4 .6 2 ± 1.04
6 .3 6 ± 0.21
3 06 .71 ± 8 1.8 7
2 7 .2 0 ± 1 4 .1 6
2 ( n = 5)
fusate. However, 1 g of calcium
P o s t o p e r a t iv e
chloride
is often given intravenously
day 1
4 .9 0 ± 0.72
6 .0 0 ± 1.08
3 7 8 .8 0 ± 177.31
3 4 .8 0 ± 5.81
later, usually before the termination
day 2
4 .19 ± 0.29
5 .35 ± 0.74
2 89 .40 ± 79.48
2 7 .0 0 ± 5 .05
of the cardiopulmonary bypass, when
‘ D a t a e x p r e s s e d a s m e a n ± s t a n d a r d d e v ia t io n .
the heart reassumes its hemodynamic
load.18
/
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On the basis of their experimental
studies, Hearse, Steward and Braimbridge19 stressed the importance of
magnesium ions in the cardioplegic
solution, and Buckburg18 has discussed
the role of magnesium in various
experimental conditions. The results
from our group 1 myocardial samples
indicate that tissue magnesium con
centration decreased during cardio
plegia. Assuming that the maintenance
of precardioplegic tissue values is
desirable, we decided to supplement
the infusate with magnesium in group
2 patients. We found that 2.2 mmol/1
of magnesium, slightly higher than
Bretschneider’s solution (2 mmol/1)
but much lower than the 15 mmol/1
suggested by Hearse, Steward and
Braimbridge,19 prevented the depletion
of tissue magnesium during cardio
plegia. Whether the tissue magnesium
is intracellular or not cannot be deter
mined from this study. It is interest
ing that zinc and copper values in
the myocardium did not change in
contrast to magnesium and calcium
values.
We have previously observed that
the serum concentrations of zinc and
magnesium decreased during cardio
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pulmonary bypass.20 We suspected
that hemodilution was a factor and
such changes were again noted in the
present study. The serum levels of
zinc recorded in our series are higher
than the previously published normal
values of 100 to 120 m g/dl (15.3 to
18.36 /zmol/1). However, it should be
noted that our control level for zinc
in healthy subjects was 254.9 ± 75.6
(SD) jag/dl (38.86 ± 11.57 /zmol/l)
which did not differ significantly
from that in our patients.
The clinical importance of changes
in these cations and trace metals re
quires further elucidation. However,
their physiological and biochemical
importance in the normal functioning
of myocardium is well recognized.
Calcium is an important regulator of
contraction and relaxation of the myo
fibrils. Magnesium is involved in
many metabolic pathways, especially
those of oxidation and energy trans
fer, and is an essential cofactor in
over 95 metabolic reactions.21 Hypo
magnesemia was found to be asso
ciated with an increased frequency of
postoperative cardiac
arrhythmias
following open-heart surgery.22 Zinc
and copper are also important ca
talysts for many enzymes and have
been implicated in some studies of the
pathophysiology of ischemic heart
disease, although their actual role in
myocardial protection remains to be
explored. Improved knowledge of the
changes in the myocardial cations and
trace metals may thus aid us in
further refining our technique of myo
cardial protection during cardiac
surgery.
We appreciate the cooperation and
assistance in this study of Dr. Peter E.
Blundell and Mr. Roger Samson, CP.
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Clinicopathological Correlations in Patients Who
Received an Isolated Model 104 Beall Mitral Valve

L eonard Schwartz , md , frcp [c ],* H ugh E. Scully , m d , frcs [c ],*
M alcolm D. Silver, md , FRCp[c],t Jeri A zum a and E. D ouglas W igle , m d , facp ,

Following reports of accelerated
wear in the model 104 Beall
prosthetic valve, the authors initiated
a recall and prospective follow-up
study of patients who received Beall
valves. In the 3 years of the follow
up program, 12 patients who had
an isolated Beall mitral valve
implanted have had elective replace
ment of the prosthesis. Cinefluoroscopy was the most accurate
preoperative method of predicting
the degree of pathologic wear.
The serum lactic dehydrogenase
value was the next most helpful
measurement. Change in functional
class, mitral regurgitation murmur,
hemodynamic status, echocardio
graphy and the duration of the valve
in situ were not sensitive indicators.
Suite a des rapports signalant
I'usure acceleree de la prothese
valvulaire Beall modele 104, les
auteurs ont entrepris un rappel et
une etude prospective de surveillance
de patients qui avaient recu des
valvules Beall. Au cours des 3 annees
du programme de surveillance,
12 patients porteurs d'un appareil
valvulaire mitral par prothese ont
subi le changement non urgent
de la prothese. La cinefluoroscopie
s'est averee la methode pre-operatoire
la plus exacte pour prevoir le
degre d'usure pathologique. La con
centration serique de deshydrogenase
From the * cardiovascular unit,
t department o f pathology and $divi
sion o f cardiology, Toronto General
Hospital, Toronto, Ont.
Presented at the 32nd annual meeting
o f the Canadian Cardiovascular
Society, Quebec, PQ, Oct. 18, 1979

The model 103 Beall heart valve
prosthesis was introduced in 1967.1
It was a low profile valve consisting
o f a disc made o f extruded Teflon,
metal struts coated with Teflon and
a cloth-covered metal sewing ring.
The base was covered with Dacron
velour preventing any metal-to-metal
interface. The design and material
were thought to have low thrombogenicity and this was the primary
reason for introduction o f the valve.
It soon became apparent that the disc
did not wear well and in 1969 its
composition was changed to a denser
compression-moulded Teflon (model
104, Fig. l).a From 1969 to 1973
this prosthetic valve was used fre
quently, particularly in the mitral p o 
sition. By 1977, our pathology depart
ment had examined 12 Beall valves
which showed moderate to severe
wear;5 7 valves were recovered at
autopsy and in four patients, death
was directly related to failure o f the
valve. This finding initiated a recall
o f all patients who had had Beall
valves inserted at the Toronto G en 
eral Hospital, and a periodic fo llo w 
up o f these patients continues.
This paper reports on the com posi
tion and results o f this follow-up study
and what we have learned from it.

prosthetic valve an abnormality was
attributable, so, although these patients
are part o f our follow -up program,
they will not be considered in this
report. The potential study population,
therefore, consisted o f 71 patients who
had an isolated Beall mitral valve
inserted between 1969 and 1973. Six
teen o f these patients died within 3
months o f the operation and 17 others
had either died or had the valve re
placed by the time the follow -up study
began. One patient was lost to fo llow 
up. Therefore, 37 surviving patients
(8 men, 29 wom en) were available
for the follow -up study which was
conducted over a 3-year period from
Jan. 1, 1977 to Jan. 1, 1980. The
mean age o f these 37 patients was
52 years (range 26 to 64 years).
M ethods

Patients were admitted overnight.
Details o f the functional classification
(New Y ork Heart Association), symp
toms and physical examination were
recorded using questionnaires and
computer forms previously described.4
In particular, a variable murmur was
sought. Such a murmur, which is quite
loud and is pansystolic for one beat
and absent the next, indicates sticking
or wedging o f the disc.

Patients

In 97 patients 101 Beall valves
(model 104) were inserted; 26 o f
these patients had either an additional
Starr-Edwards valve inserted in an
other position or more than one Beall
valve implanted. In patients who
received more than one prosthetic
valve we could not determine to which
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lactique fut la deuxieme mesure
la plus utile. La changement de
classe fonctionnelle, un souffle
de regurgitation mitrale, I'etat
hemodynamique, I'echocardiographie
et la duree de la valvule in situ
ne se sont pas reveles des
indicateurs sensibles.
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FIG. 1— Model 104 Beall valve.
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suspicion of coronary artery disease
or other valve involvement.

In 1977, Clark and associates5 re
ported a new method of cinefluoroscopy for assessing the status of the
Beall valve. This method involves
orientation of the patient so that one
of the four struts is superimposed
on another. This so called threelegged view permits an accurate meas
urement of the disc (which is radio
paque) and cage diameter. The disc:
cage ratio by manufacturer’s specifi
cations is 0.955. As the valve wears,
the disc size diminishes and the ratio
decreases. Following Clark’s report
we added cinefluoroscopy with meas
urement of disc:cage ratio to our
protocol. This procedure was therefore
attempted in all patients except those
who had their Beall valve replaced
between January and August 1977.
Unfortunately, even with the most
modern equipment (Siemens C-arm)
it is not always possible to orient the
valve to the three-legged position and
this accounts for the absence of this
information in some of our patients.
Cardiac catheterization was not per
formed on all patients since it soon
became apparent that it was neither
a sensitive nor a specific method of
assessing valve wear. Catheterization
was performed only in the following
circumstances: (a) to investigate symp
toms such as dyspnea whose cause
could not be explained by other means
or (b) to determine the status of the
coronary arteries or other valves, or
both, in patients with clinical evidence
of moderate to severe wear.
Three patients had a Beall valve re
placed without preoperative cardiac
catheterization. These patients had ob
vious severe wear detected by noninvasive measurements and no clinical

Results

Patients with Valve Failure
Twelve patients have had their
Beall valves removed and replaced
with another prosthesis since the initia
tion of the follow-up. All removed
valves were examined by one of us
(MS), who had no knowledge of the
results of the noninvasive preoperative
studies, and were graded as showing
mild, moderate or severe wear ac
cording to the criteria of Silver and
Wilson.3 Briefly these criteria are as
follows: In “mild wear” the disc edge
is notched and there is thinning of the
Teflon coat on the struts but no
exposed metal. In “moderate wear”
disc notching is more pronounced and
bare metal is exposed on the struts;
the cloth seat may be frayed but is not
torn. In “severe wear” the cloth seat
is worn through exposing underlying
metal and the disc edge is bevelled
and greatly reduced in size. Table 1
summarizes the data obtained on these
patients from their last follow-up as
sessment before the valve was re
moved. The hemodynamic data ob
tained in 10 of the 12 patients are
also shown. The patients are categor
ized according to the degree of wear
of the removed valve as graded by the
pathologist. In 10 cases surgery was
recommended
because significant
valve wear was indicated by nonin
vasive studies. Nine of the removed
valves demonstrated moderate or se
vere wear while in one patient (VM)
the valve showed only mild wear. This

was the only time an error was made
in the clinical prediction. In two cases
operation was recommended for other
reasons; one patient (LF) had debilitat
ing angina and required aortocoronary
bypass grafting. The preoperative in
vestigation suggested mild wear and
this was confirmed upon removal of
the valve. This case illustrates an
other facet of prosthetic valve dys
function. The patient had a pansystolic
apical murmur and moderate mitral
regurgitation angiographically. At
operation it was found that normal
disc closing was prevented by residual
papillary muscle. In a second patient
(PX) severe aortic regurgitation had
developed since her first operation
with resultant functional deterioration
and this was the primary indication
for reoperation. Mild Beall valve wear
was predicted preoperatively and this
was confirmed at operation and later
on pathological examination.
Patients without Valve Failure
Of 25 patients whose Beall valve
was not removed during the follow-up
study period, 24 are alive; 11 of them
are now living outside Ontario and
are being seen at other centres. The
remaining 13 form an interesting
group of patients (Table II). Generally
they have only mild or even no wear
in spite of the long time the valve has
been in situ. They are all in stable
condition with essentially no change
in functional class or other abnormal
findings over many months.
The patient who died during the
follow-up period with her original
Beall valve still in place died suddenly
apparently of a stroke. Her condition

Table I— Patient Data and Relationship between Prosthetic Wear of Removed Valve and Preoperative Clinical
and Hemodynamic Measurements

Patient

Degree of
wear*

Time
in situ,
mo

NYH Af
class

LF
VM
PX
VM
JG
ND
GM
JB
JM
FM
JS
PD

Mild
Mild
Mild
Moderate
Moderate
Severe
Severe
Severe
Severe
Severe
Severe
Severe

66
94
102
67
107
73
82
84
102
102
103
105

III
III
III
III
III
III
lib
lib
lib
1la
III
lib

NYHA
class
changef

l/2
a

Mitral
insufficiency
murmur,
Hemoglobin,
grade
g/dl

1
0

+ (2/6)
+(2/6)
None
+ (3/6)
+ (2/6)
+ (2/6)
None

a
VA

+ d /6 )
+ (2/6)

2

u
0

0
1
l'/2

+ d /6 )
+ (1/6)
+ d/6)

9.2
11.1
13.0
12.0
12.6
13.6
11.1
10.6
12.7
12.0
11.0
12.4

LDH,
iu

/ is

525
574
710
1770
294
1799
1074
1020
792
1725
1140
800

Disc:cage
ratio

Cl
l/m in m 2

Mitral
diastolic
gradient,
mm Hg

0.951
0.947
0.922
ND
0.897
ND
0.830
0.877
0.862
0.879
ND
0.884

2.9
2.4
3.7
2.5
4.1
1.7
2.4
ND
ND
3.2
3.8
ND

7
5
12
0
0
7
16
ND
ND
7
8
ND

M itral
regurgitation
on angiogram
Moderate
Moderate
None
Severe
T rivial
Moderate
Moderate
ND
ND
Severe
Mild
ND

fA s assessed by pathologist.
*New York Heart Association functional class.
fFrom previous follow-up (6-mo interval).
§Normal range 50 to 190 IU/1.
U = unknown, ND = not done, LDH = lactic dehydrogenase, Cl = cardiac index.
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was last assessed 3 months before
she died. Then she was asymptomatic,
had no murmur, was in sinus rhythm
and had a serum lactic dehydro
genase (LD H ) value o f 593 IU/1.
We could not obtain a discxage ratio.
Her prothrombin time was satisfactory
2 days before she died. Unfortun
ately, no autopsy was carried out but
the available data and sequence of
event s do not suggest that death was
due to failure o f the Beall valve.
Determination of Valve Wear

E>

V v

q
A »

4
-u

The clinical measurement that best
correlated with the degree o f wear on
direct inspection was the discxage
ratio obtained preoperatively by cinefluoroscopy. In all cases in which
there was severe wear o f the valve
the ratio was less than 0.884; in the
three cases o f mild wear the ratio was
greater than 0.922. In the valve which
had moderate wear the ratio was in
termediate at 0.897. This shows ex
cellent agreement with Clark’s ranges
o f discxage ratios5 (i.e., minimal wear
0.955 to 0.925, moderate wear 0.920
to 0.880 and severe wear 0.875 to

0.835). Clark and associates based
their estimates o f wear on correlation
with hemolytic indices not with his
tologic data. We further validated this
method by measuring the discxage
ratio directly after the valve had been
removed. Table III compares the cinefluoroscopic and direct measurements
for those in whom both ratios were
determined. Included are one patient
(AS) with a tricuspid Beall valve and
one patient (RS) who had her Beall
valve inserted in the Hospital for S'ick
Children in Toronto and therefore,
was not part of our follow-up popula
tion.
The serum L D H level as an indicator
o f mechanical hemolysis was also a
good predictor o f the degree of wear.
A ll but one patient with moderate or
severe wear had values greater than
792 IU/1 but the highest value in the
three patients with mild wear was
710 IU/1. However, in contrast to
the discxage ratio, the L D H value
did not distinguish between moderate
and severe wear. The other clinical
finding that was quite specific for
severe wear was a variable mitral
regurgitation murmur. It was heard

Table II—Data on 13 Patients Whose Beall Valve Was Still in Place at the End of the
Follow-Up Period

Patient

Time in
situ, mo

NYHA
class

Mitral
insufficiency
murmur, grade

Hemoglobin
g/dl

LDH,
IU/1

Discxage
ratio

MP
AD
CM
FS
BP
HC
MF
GP
SH
RR
CS
SP
DB

74
79
80
83
90
92
97
98
102
103
105
106
116

lib
IV
1
1la
lib
lib
lla
lla
1
lib
lla
III
lla

+ (2/6)
None
None
None
None
None
+ (2/6)
+ d /6 )
None
None
+ d /6 )
None
+ (2/6)

10.8
12.0
12.0
10.7
13.1
12.7
12.0
18.2
13.0
11.2
11.9
12.8
14.1

846
290
ND
715
236
460
520
325
063
ND
621
645
344

0.911
0.972
ND
0.937
0.942
ND
0.922
0.925
0.905
ND
ND
0.920
0.943

Mean

94

12.6

460

0.930

(carbenicillin)
CONTRAINDICATIONS: C a rb e n ic illin
should not be used in patients with a
history of p e n icillin or cephalosporin
allergy. Carbenicillin is hydrolyzed by
staphylococcal beta-lactamase and is,
therefore, contraindicated in infections
caused by beta-lactam ase-producing
s ta p h y lo c o c c i. PRECAUTIO NS: The
same as fo r p e n ic illin G. R e sista n t
organism s have arisen d u rin g tre a t
ment. Adequate dosage should there
fore be m aintained and interm ittent sen
s itiv ity te s ts ca rrie d out. One g o f
PYOPEN contains 6.5 mEq o f sodium
ion. Therefore, large doses of the drug
should be administered with caution to
patients with congestive heart failure,
severe h yp e rte n sio n , o r edema.
ADVERSE REACTIONS: Sim ilar to those
re p o rte d w ith p e n ic illin G. A ls o
reported: pain and rashes at site o f i.m.
injection; th ro m b o ph le b itis after pro
longed i.v. a d m in is tra tio n ; p ru ritu s ;
eosinophilia; nausea; occasional rise in
SGOT and alkaline phosphatase levels;
anicteric hepatitis; one case of an unex
plained drop in hem oglobin level; one
case of seizure in a hem iplegic patient
on high doses and one case or increased
m uscle weakness in a p a tie n t w ith
myasthenia gravis have been reported.
Prolonged b le e d in g tim e has been
reported in 22 o f a series o f 30 patients
receiving between 500 and 750 m g/kg
daily of PYOPEN during 14 days (giving
blood levels o f 200-400 ^g /m l). Aggrega
tion of platelets by adenosine d ip h o s
phate was decreased in all 30 patients.
The defect appeared w ithin 12 hours
after starting therapy and to o k from 3 to
7 days to disappear after d iscontinuing
the drug. Two women receiving 30 g of
PYOPEN daily developed hypokalem ia
a fte r 7 a n d 9 d a y s r e s p e c tiv e ly .
Potassium levels were 2 and 1.5 m E q/l.
Oral p o tassium ch lo rid e rapidly co r
rected the electrolyte disorder.
DOS AG E : R e la t iv e ly h ig h d o s e s o f
carbenicillin are required in the treat
ment o f severe Pseudom onas in fe c 
tions. ADULTS—Severe and overwhelm 
ing in fe ctio n s (septicem ia, extensive
burns and wounds, pneumonia, men
ingitis, peritonitis): 12 to 30 g daily in 
tra ve n o u sly o r by in fu s io n w ith or
w ithout 1 g o f probenecid orally 3 tim es
daily. In moderately severe infections:
ig every 4 h o u rs fo r 5 to 10 days.
C H IL D R E N — Dosage, a c c o rd in g to
w e ig h t, age and severity o f infec
t io n , m a y v a ry fr o m 1 0 0 -3 0 0 m g /
k g /b o d y w eig h t.A V A ILA B IL IT Y : Vials
containing: 1 g or 5 g carbenicillin.
Complete p rescribing inform ation and
references available on request.
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Table III —Comparison of Disc:Cage Ratio Measured by Cinefluoroscopy and Directly
Discxage ratio

Y V
>
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Patient

By cinefluoroscopy

By direct
examination

Wear of
removed valve

LF
VM
AS*
JG
FM
JB
JM
RS

0.951
0.947
0.921
0.897
0.879
0.877
0.862
0.861

0.943
0.934
0.933
0.907
0.889
0.880
0.833
0.888

Mild
Mild
Moderate
Moderate
Severe
Severe
Severe
Severe

Ayerst

AYERST LABORATORIES
D ivision o f A y e rs t, M c K e n n a & H a rris o n L im ite d
M o n tre a l, Canada
M ade in C a nada by a rra n g e m e n t w ith
B E E C H A M , INC.
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*This patient had a Beall tricuspid valve.
*R e g ’d
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in two cases in the follow-up popula
tion and in two others; all four valves,
upon removal, showed severe wear.
However, it was often absent when
severe wear was present and therefore
is not a sensitive indicator.
Other factors surprisingly were not
helpful. Mitral regurgitation could be
mild in severe wear and moderate (as
described above) in mild wear. Mitral
diastolic gradients similarly showed no
pattern. A functional deterioration
was absent in three of nine instances
of moderate wear and when present
the deterioration was often quite sub
tle. Echocardiography, which was not
part of the routine protocol, was per
formed on three patients with severe
wear just before reoperation and
showed normal prosthetic valve func
tion !
When all patients who received
Beall mitral valves are considered, the
reduction in the diameter of the disc
on cinefluoroscopy correlated with the
length of time the valve was in situ
(r s= 0.73). However, many factors
other than the time of the valve in situ
must determine the degree of wear
since one of our patients had severe
wear at 73 months and another had
only mild wear at 102 months after
placement. Also, in the 13 patients in
our series who have their original
Beall valve in situ, the mean duration
of implantation is 94 months and, on
the basis of clinical assessment, these
patients have mild or no wear.
Discussion
This study demonstrates the value
of organized recall and follow-up
when a problem is encountered with
a particular prosthetic valve. Before
we initiated our follow-up of patients
who had undergone Beall valve place
ment, there were four deaths directly
attributable to Beall valve failure but
since then only one patient has died
unexpectedly and even in this case,
death could not be definitely attributed
to valve wear. In 11 of 12 patients
in whom replacement of the Beall
valve was performed during the fol
low-up period, the degree of wear was
accurately predicted preoperatively
and the surgery was elective. This ex
perience is similar to that of our pace
maker program in which follow-up
procedures have been refined to the
point where emergency battery pack
replacement is rare.
The limitations of many of the cur
rent methods used to assess the con
dition of patients with prosthetic valves
have also been shown. Functional
120

status, prosthetic sounds and hemody
namic measurements may remain
unaltered in spite of severe wear of
the valve. Hemolytic indices at either
end of the spectrum have some predic
tive power. A serum LDH level
greater than 1500 IU/1 almost always
indicates severe wear and a value of
less than 500 IU/1 is considered reas
suring. However, the intermediate
values do not indicate any specific
degree of wear. This lack of specifi
city is associated with many other
methods of assessment. In the case
of LDH estimation the degree of
mechanical hemolysis may be altered
by other factors such as red blood
cell fragility and the velocity of flow
across the valve. Vigorous exercising,
for example, causes elevation of the
LDH value in patients with a prosthe
tic valve, and LDH values may in
crease for reasons other than hemol
ysis.
Clearly there is a need for tech
niques that directly measure valve
structure. Fortunately, in the case
of the Beall valve, cinefluoroscopy
represents such a technique. The disc,
probably more by good fortune than
design, is radiopaque and its diameter
can be determined. Also, the maxi
mum cage diameter can be measured
by superimposing two of the four
struts. This yields a ratio that permits
a valid comparison between patients
and between serial studies on the same
patient. This ratio has been extremely
reliable in our follow-up study, to the
point where a ratio of less than 0.88
as an isolated abnormality constitutes
an indication for replacement of the
Beall valve. Unfortunately, this ratio
cannot be measured in all patients.
Valve manufacturers are now recog
nizing the importance of cinefluorscopy in valve follow-up and many
new valves have radiopaque poppets.
We are exploring other more direct
methods of assessing prosthetic valve
function. One of these, computerized
acoustical analysis, records the heart
and prosthetic sounds on tape, filters
out the heart sounds and then char
acterizes the prosthetic sounds in
terms of frequency bands, intensity
and decay time. This method has been
used on some of the patients who have
Beall valves and more recently on
patients with Bjork-Shiley valves, but
the results are too preliminary to re
port.
With the plethora of new prosthetic
valves on the market, follow-up studies
and improved assessment techniques
are needed. The ideal prosthetic valve
has yet to be designed. Often, apparent
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improvements in design or material
create problems that are not antici
pated. The Beall valve was introduced
as a prosthetic device with low thrombogenicity and this has proven to be
the case but unfortunately it is not
durable. Our experience with the
model 104 Beall valve has taught us
that, although valve failure clinically
appears to be sudden, it is often
gradual and can be detected, before
symptoms appear, by regular follow
up examinations. Also it has emphas
ized that duration of the valve in situ
is only one of many variables deter
mining the degree of valve wear. In
our series, moderate wear occurred in
one case as early as 2 years3 after im
plantation, but in other cases even 9
years after implantation valve wear
may be only mild. It is never too early
to begin a follow-up study but, on the
other hand, if accelerated wear is dem
onstrated with a particular prosthesis,
it is not correct to choose arbitrarily
a cut-off time beyond which the valve
is routinely replaced. The mean dura
tion in situ of the valve in our re
maining 13 Beall valve patients is al
most 8 years and only mild wear is
present. Our current policy when we
introduce any new prosthetic valve is
to follow-up a sample population from
the date of implantation. In addition
to routine clinical assessment, our pro
tocol includes measurement of hemol
ytic indices, cinefluoroscopy and
acoustical analysis. We hope to ac
cumulate a data library for each new
valve and to diagnose valve wear be
fore failure becomes clinically mani
fest. It is hoped this will prevent the
sudden deaths that occurred in our
early experience with Beall valves.
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Effectiveness of Intra-aortic Balloon Counterpulsation
on Systolic Unloading
Y. A kyurekli,

md, frcs [c],

The therapeutic benefit of intra-aortic
balloon pumping (IABP) is believed
to result from the combined action
of reducing myocardial demand
(systolic unloading) while improving
myocardial supply (diastolic
augmentation). However, the relative
importance of these aspects has
not been fully understood.
Accordingly, the systolic unloading
responses to IABP were studied
in 13 dogs on total coronary bypass.
By perfusing the coronary circulation
from an extracorporeal source at a
controlled pressure the authors were
able to analyse the systolic unloading
responses without diastolic augmenta
tion directly altering coronary flow.
The results suggest that IABP is
effective only in reducing myocar
dial demand at normotensive
levels; IABP during hypotensive
states did not assist the failing heart
mechanically by systolic unloading.
Therefore the therapeutic action
of IABP must result from increases
in coronary blood flow by diastolic
augmentation.
On croit que les gains therapeutiques
de la contre-pulsion diastolique
par ballonnet intra-aortique
(CPBIA) resultent de Taction combinee d'une reduction de la demande
myocardique (delestage systolique)
et de (’amelioration de I'apport
myocardique (augmentation diastoli
que). Toutefois, I’importance relative
de ces aspects n'a pas ete completem ent elucidee. En consequence,
le delestage systolique en reponse
a la CPBIA a ete etudie chez
13 chiens sous pontage coronarien

G.C.

T aichman,

ph d and

W.J.

complet. En perfusant la circulation
coronarienne a partir d'une source
extracorporelle a pression controlee,
nous avons ete capables d’analyser
la reponse de delestage systolique
sans que I’augmentation diastolique
ne modifie directement le debit
coronarien. Les resultats indiquent
que la CPBIA n’est efficace qu'a
reduire la demande myocardique a des
niveaux de tension normale; la
CPBIA durant les etats hypotensifs
ne soulagea pas mecaniquement le
coeur defaillant par delestage
systolique. L’action therapeutique de
la CPBIA doit done resulter d'une
augmentation du debit sanguin
coronarien par augmentation dia
stolique.

Intra-aortic balloon pumping (IABP)
for the treatment of cardiogenic shock
was introduced in 1962 by Moulopoulos, Topaz and Kolff1 and po
pularized in 1968 by Kantrowitz and
associates.2 Since then, the indications
for its use have been extended to
include a wide variety of clinical situa
tions requiring temporary circulatory
support.3,4
In spite of the overwhelming clini
cal evidence of the beneficial effects
of IABP, the underlying mechanisms
have not been clearly resolved.5,6 In
theory, the beneficial effects of coun
terpulsation are achieved by the active
synchronous displacement of aortic
blood during the cardiac cycle which
reduces left ventricular work (systolic
unloading) and increases coronary
flow (diastolic augmentation). Al
though both features would assist the
failing heart, the presence and re
lative effects of either aspect during
IABP have not been appreciated. The
purpose of this study was to determine
the systolic unloading effects of IABP
independent of diastolic augmentation.
This was accomplished by counterpulsating dogs while their coronary
arteries were perfused from an extra
corporeal source.

K eon,

md , frcs [c ]

in weight from 22 to 31 kg. Each
animal was premedicated with atro
pine (0.4 mg, intramuscularly) and
anesthetized with an intravenous in
jection of sodium thiopental (20 mg/
kg). The trachea was intubated and
positive-pressure ventilation (Harvard
Apparatus Corp., Millis, Mass.) initi
ated. Throughout the remainder of the
experiment, a surgical plane of anes
thesia was maintained with a mixture
of 30% nitrous oxide and 70% oxy
gen plus 0.25% to 0.75% halothane.
As a precautionary measure against
ventricular arrhythmias, lidocaine hy
drochloride was administered intraven
ously as a priming bolus (70 mg)
followed by a continuous infusion (2
mg/min).
The surgical procedure for total
coronary bypass has been reported
previously.7,8 The heart was exposed
through the left fifth intercostal space.
The three main coronary vessels were
cannulated close to their aortic origins
and perfused with arterialized blood
at a controlled pressure while the
remainder of the systemic circula
tion was left intact. The right atrial
pressure was maintained within a lim
ited range (7 to 11 cm HsO) by means
of a pressure-regulated system. The
extracorporeal circuit was primed with
a mixture of heparinized citrated
whole blood from donor dogs and
lactated Ringer’s solution in a 1:1
ratio. During coronary bypass, venous
blood was collected from the femoral
veins and passed through a bubble
oxygenator (W. Harvey Research
Corp., Santa Ana, Calif.). The pH,
oxygen pressure and carbon dioxide
pressure of the oxygenated blood
ranged from 7.36 to 7.42, 91 to 146
mm Hg and 32 to 46 mm Hg, re
spectively. The blood was then heated
(35° to 38 °C) and pumped to a per
fusion reservoir which subsequently
drained into the three coronary per
fusion catheters. The driving pressure
of the system was regulated by adjust
ing the height of the perfusion reser
voir above the heart.
Of the 13 animals studied, 3 were
counterpulsated with a 12-ml capacity
single-segment intra-aortic balloon
while in the remaining 10 a 20-ml
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triple-segment balloon was inserted. for Medicine, White Plains, NY).
The balloon (AVCO-Roche, Cran- Right and left mean atrial pressures
bury, NJ) was passed into the left fe were measured by direct cannulation
moral artery and positioned just distal and water manometry. All pressures
to the origin of the left subclavian ar were referenced to the level of the
tery. It was inflated by a helium-driven right atrium. Flow through the pul
pumping system (AVCO IABP-7, AV- monary artery (cardiac output) was
CO-Roche) triggered by the R-wave measured periodically by a thermodi
of the electrocardiogram and synchro lution technique using a Swan-Ganz
nized to inflate at the closing of the catheter (model 93-118-7F, Edwards
aortic valve and to vent to atmos Laboratory, Santa Ana, Calif.) in con
pheric pressure immediately before junction with an Edwards computer
the left ventricular ejection. The tim (model 9510). Cardiac work was cal
ing and duration of balloon inflation culated as the product of cardiac out
were adjusted to produce maximum put and mean ventricular ejection
augmentation of diastolic aortic pres pressure. Coronary flows were meas
sure measured proximal to the bal ured by three electromagnetic flow
loon.
probes (Biotronex Laboratory, Inc.,
During the experiments heart rate Silver Spring, Md.) which were placed
was computed from the electrocardio in series with the perfusion cannulas.
graphic signal (lead II). Central aortic Relative myocardial blood flow was
(systolic, diastolic and mean), left derived by adding the flows from all
ventricular (systolic and diastolic) and three coronary vessels together and
mean pulmonary artery pressures were normalizing the value per 100 g of
measured from fluid-filled catheters ventricular weight.
in conjunction with Statham P23Db
Myocardial oxygen data were ob
transducers (Statham Instruments, Ox tained by measuring the uptake across
nard, Calif.) and Electronics for Med the coronary circulation; arterial (ex
icine SGM-2 amplifiers (Electronics tracorporeal) and coronary sinus blood

samples were drawn anaerobically and
analysed for their oxygen content with
an oxygen analyser (Lexington Instru
ments, Waltham, Mass.). These data
in combination with myocardial flow
values were used to compute myocar
dial oxygen extraction and consump
tion according to formulas outlined
previously.7
At the end of the operation, the
animal was stabilized for at least 60
minutes at a coronary perfusion pres
sure of 120 mm Hg. During this
period the plateau of the FrankStarling curve was estimated by ad
justing the venous pressure until the
arterial pressure and cardiac output
were at their maximum levels. Once
this was achieved, no further adjust
ments were made in the height of
the venous reservoir.
At the end of the stabilization peri
od, the effects of IABP without direct
augmentation of coronary flow were
studied at various coronary perfusion
pressures. The perfusion pressure was
reduced from 120 mm Hg to a lower
level (80, 70, 60, or 50 mm Hg) for
20 minutes. During the first 10 min-

Table I—A Summary of the Hemodynamic and Metabolic Values (mean ± SEM) Measured before (Con) and after Intra-aortic Balloon
Pumping (IABP) at Four Reduced Coronary Perfusion Pressures*
Coronary perfusion pressure, mm Hg
120
(n = 13)

80
(ni = 8)

Con

Con

IABP

123
±4
Cardiac index, ml/min • kg
90.8
±11.3
Right atrial pressure, cm H20
8.8
±0.6
Left atrial pressure, cm H20
15.6
±1.0
Pulmonary mean pressure, mm Hg
20.0
±0.7
Left ventricular diastolic pressure, mm Hg
15.6
±1.4
Left ventricular systolic pressure, mm Hg
123.2
±5.8
Aortic systolic pressure, mm Hg
123.6
±6.1
Aortic mean pressure, mm Hg
106.6
±4.3
Aortic diastolic pressure, mm Hg
92.9
±3.4
Myocardial blood flow, ml/min • 100 g
85.5
±4.8
Left anterior descending-septal artery,
46.5
% of coronary flow
±1.2
Circumflex artery, % of coronary flow
36.5
±1.2
Right coronary artery, % of coronary flow
16.9
±1.1
Myocardial oxygen extraction, %
61.5
±2.4
Myocardial oxygen consumption, ml/min • 100 g
8.35
±0.43

122
±6
65.3
±13.2
7.6
±0.8
13.1
±1.0
18.1
±1.2
13.9
±1.2
105.3
±5.6
107.0
±7.0
90.8
±4.7
83.0
±3.7
59.4
±2.3
48.9
±1.8
37.0
±1.8
14.0
±1.0
67.5
±3.2
6.25
±0.40

125
±7
70.0
±19.3
7.4
±0.8
12.9
±0.6
17.6
±1.0
11.9
±1.1
99.0
±6.4
102.4
±7.1
96.0
±6.0
107.3
±7.6
54.9
±1.6
50.0
±2.9
37.8
±2.4
12.0
±0.5
67.6
±3.4
5.91
±0.37

Heart rate, beats/min

t
t
t
t
t
t

70i
(ni = 8)
Con

IABP

115
121
±6
±6
63.0
57.3
±12.4
±11.7
10.3
9.9
±0.7
±0.8
18.5
20.8
±1.6
±2.5
20.4
22.7
±1.0
±1.3
16.9
17.0
±2.1
±2.0
101.4
104.0
±4.0
±3.2
106.3
107.1
±4.6
±4.1
87.4 t 97.0
±4.2
±3.7
75.1 t 108.7
±4.2
±5.0
56.1
53.5
±4.0
±2.9
46.8
46.3
±1.3
±1.5
36.0
35.6
±1.0
±1.2
17.3
18.1
±0.9
±1.3
73.0
73.0
±2.3
±1.4
6.40
6.13
±0.27
±0.30

60
(n = 9)
Con

IABP

129
133
±4
±5
37.0
36.2
±3.0
±3.3
7.8
7.9
±0.9
±0.8
16.9
18.1
±2.1
±3.0
19.5
21.8
±1.7
±2.4
16.8
16.6
±2.0
±2.7
80.0
77.0
±3.4
±3.6
79.1
77.1
±3.8
±4.4
66.8
73.4
±3.8
±4.0
59.5 f 81.0
±3.0
±4.9
38.7
40.4
±1.5
±1.3
49.8
48.6
±1.9
±2.4
38.0
36.7
±2.1
±3.0
12.8
14.8
±1.4
±2.1
78.7
80.3
±2.0
±2.1
5.06
5.32
±0.26
±0.16

50
(n = 6)
Con

IABP

131
131
±6
±3
25.7
24.6
±3.4
±2.9
9.1
9.3
±0.8
±0.7
19.7
18.8
±1.9
±2.1
19.2
19.5
±2.2
±1.6
19.7
16.5
±2.4
±2.7
63.0
63.3
±3.9
±4.2
62.7
61.5
±5.5
±4.1
52.8
57.3
±4.8
±4.5
45.7 f 64.8
±4.9
±5.2
36.2
37.0
±2.4
±2.7
44.8
43.5
±3.6
±3.8
35.5
35.3
±3.7
±3.7
19.5
21.2
±4.3
±5.2
84.7
82.5
±1.9
±2.1
4.83
4.83
±0.41
±0.41

•Values in the first column were measured after stabilization at a coronary perfusion pressure of 120 mm Hg
(Significant changes, P < 0.05.
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utes of coronary hypotension, the intra-aortic balloon remained inactive;
counterpulsation was instituted during
the final 10 minutes. Data were col
lected before and after IABP. The
coronary perfusion pressure was then
returned to 120 mm Hg for 20 min
utes of recovery followed by addi
tional hypotensive episodes at dif
ferent perfusion pressures. All four
hypotensive pressures were attempted
in each dog; however, if control levels
(measured at 120 mm Hg) could not
be re-established after 20 minutes of
recovery, the experiment was discon
tinued. Hemodynamic and metabolic
responses between control and counterpulsated states at each hypotensive
level were statistically evaluated by
means of the paired Student’s f-test;
differences were considered signi
ficant at P < 0.05.
Results

In our experiment, 13 animal pre
parations required 82 ± 18 minutes
(mean ± SEM) to stabilize at a coro
nary perfusion pressure of 120 mm
Hg. At the end of this period, vari
ous hemodynamic and oxygen meas120 r

O’-

80
70
60
50
Coronary Fterfusion Pressure - mm He

FIG . 1— Left ventricular (black bar)
and aortic (white bar) intravascular pres
sures (systolic and diastolic) as function
o f four coronary perfusion pressures.

urements were noted (Table I). When
the perfusion pressure was temporarily
reduced, coronary flow decreased and
left ventricular power failure ensued
(Table I, Fig. 1). Although the lower
limits of normotensive pressures were
measured at perfusion pressures of 80
and 70 mm Hg, further reductions to
60 and 50 mm Hg produced progres
sive degrees of systemic hypotension
(Table I, Fig. 1). Severe reduction in
coronary flow led to an increase in
myocardial oxygen extraction; how
ever, this increase was insufficient to
maintain the oxygen consumption
which subsequently dropped as the per
fusion pressure was reduced (Table I).
Although the total myocardial blood
flow became severely reduced as the
perfusion pressure was diminished, the
flow distribution to the three main
coronary vessels did not change signi
ficantly (Table I). When the average
flows in the left anterior descendingseptal, circumflex and right coronary
arteries were measured at the four
reduced perfusion pressures, the pro
portions (47%, 37% and 16%, re
spectively) relative to the total flow
did not differ significantly from those
at a driving pressure of 120 mm Hg.
When IABP was attempted in
these animals on total coronary
bypass no unusual problems were en
countered. The central aortic pulse
pressure clearly monitored the oper
ation of the balloon. Diastolic pres
sures were significantly augmented
(P < 0.05) by 28 ± 4% , 46 ± 5%,
36 ± 5% and 46 ± 11% above the
unassisted levels at coronary perfusion
pressures of 80, 70, 60 and 50 mm
Hg, respectively (Table I, Fig. 2).
Likewise, mean aortic pressure also
increased during periods of IABP but
to a lesser degree (Table I). Evidence
of systolic unloading with IABP was
seen only at a coronary perfusion
pressure of 80 mm Hg. At this pres
sure, IABP significantly (P < 0.05)

reduced systolic pressures in both the
left ventricle and aorta by 6 =t 2%
(Fig. 2) and 4 ± 2% (Fig. 3) re
spectively and left ventricular enddiastolic pressure by 14 ± 5% (Fig.
3); however, the cardiac index re
mained unchanged. When estimates
of the combined action of left ventri
cular pressure and flow were calcu
lated, cardiac work was significantly
(P < 0.05) reduced by 12 ± 3%
(Fig. 3) after 10 minutes of IABP. Al
all lower perfusion pressures (70, 60
and 50 mm Hg), the application of
IABP did not alleviate depressed car
diac performance (Table I, Figs. 2 and
3). The uptake and consumption of
oxygen were not significantly altered
by the application of IABP to hypo
tensive animals on total coronary by
pass. At all perfusion pressures, myo
cardial oxygen extraction and con
sumption were unaffected by IABP
(Fig. 4). Similarly, the distribution of
myocardial flow to the three main
coronary arteries was not significantly
altered by counterpulsation (Table I).

FIG . 2— Relative changes (%) in heart
rate (white) and aortic systolic (black)
and diastolic (dotted) pressures with
intra-aortic balloon pumping (IABP)
at four different coronary perfusion
pressures. Asterisks above or below bars
indicate significant alterations (P <
0.05).

The therapeutic action of arterial
counterpulsation as applied by IABP
is generally believed to result from the
combined effects of increasing coro
nary supply while reducing myocardial
demand.3,4
Coronary supply occurs primarily
during cardiac diastole, when the coro
nary vasculature autoregulates the
flow depending on the myocardial de
mand.9,10 During ischemia the coro
nary vessels dilate so that coronary
flow becomes primarily pressure de
pendent.10 One of the main effects of
IABP is to elevate the diastolic pres
sure in the aorta and the coronary
arterial bed, thus increasing the blood
flow to the ischemic myocardium,
hence the term diastolic augmenta
tion.

124

TO
60
50
Perfusion Pressure - mm Hg

FIG. 3—Relative changes (%) in left
ventricular end-diastolic (shaded) and
systolic (black) pressures, cardiac index
(white) and left ventricular work (dotted)
with IABP at four different coronary
perfusion pressures. Asterisks above bars
indicate significant alterations (P <
0.05).
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FIG. 4— Relative changes (%) in co
ronary flow (shaded) and myocardial
oxygen availability (black), extraction
(white), and consumption (dotted) with
IABP at four different coronary perfu
sion pressures. Asterisk above bar in
dicates significant change (P < 0.05).
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Increases in coronary blood flow
ranging from 7% to 50% with IABP
have been demonstrated in a number
of experiments,11"13 although other
authors14 have been unable to demon
strate any significant change. In the
experiments described by Powell and
associates,5 IABP in hypotensive ani
mals augmented coronary flow while
the same procedure performed on normotensive animals did not significantly
alter the flow; this was subsequently
confirmed by Weber and Janicki.15
Others16"19 have shown that coronary
sinus flow is increased by 5 % to
100%. Gill and associates,20 using ra
dioactive microspheres, found that
IABP in hypotensive animals increased
subendocardial and transmural blood
flow within the ischemic areas while
Shaw, Taylor and Pitt21 using a similar
technique found no increase in col
lateral blood flow to ischemic areas.
As well as increasing coronary per
fusion pressure, IABP is said to be
capable of reducing left ventricular
work.22,23 Balloon deflation just before
ventricular ejection produces an ap
preciable negative intra-aortic pressure
effect which should improve the emp
tying of the left ventricle (systolic un
loading). Some17 have obtained in
creases in cardiac output of 15% to
50% by this method, although
others18,24 have been unable to de
monstrate an unloading response. As
a means of reducing myocardial de
mand, numerous studies2,15,19,23 have
shown that IABP can decrease left
ventricular systolic pressure by 4% to
20%, but others6,24 have been unable
to demonstrate this response. Urschel
and colleagues25 and Weber, Janicki
and Walker26 calculated the change
in mean ejection impedance and re
ported a 10% to 21% reduction with
IABP while Mueller and associates27
demonstrated a 46% reduction in left
ventricular ejection resistance. In addi
tion to the reduction in left ventri
cular afterload, Weber and Janicki15
presented evidence demonstrating that
IABP can reduce left ventricular enddiastolic pressure (preload) as well,
thus reducing ventricular volume and
intramural compression. Although
balloon counterpulsation is dependent
upon a number of physical factors
such as balloon volume, placement,
and the timing and duration of infla
tion and deflation,26 optimal conditions
have not always assured the combined
therapeutic effects of systolic unload
ing and diastolic augmentation.3"6,24
Part of the problem may be that IABP
affects two interrelated systems (coro
nary supply and coronary demand)
VOLUME 23, NO. 2, MARCH 1980
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which cannot be separately investiga
ted. Powell and his associates5 at
tempted such independent studies by
counterpulsating experimental animals
on right heart bypass while perfusing
a coronary vessel at a constant rate.
Although the results and conclusions
were similar to those of the present
study, only one part of the entire
coronary circulation was perfused
from an extracorporeal source and
thus collateral supply could not be
excluded.
In our animal preparation, the en
tire coronary circulation was isolated
from the aortic supply and perfused
from an extracorporeal source at
known perfusion pressures.7,8 Under
these conditions, IABP might produce
both systolic unloading and diastolic
augmentation; however, direct altera
tions of coronary flow were excluded
from the increases in aortic diastolic
pressure with IABP. Previous studies
in the development of this experimen
tal model have shown that normotensive systemic hemodynamic meas
urements could be estimated at
normal coronary perfusion pressures.
As the perfusion pressure was re
duced, acute cardiac failure developed
which remained relatively stable for
extended periods.6,7 When IABP was
applied to this animal preparation at
different levels of left ventricular per
formance, systolic unloading was only
evident at normotensive states (coro
nary perfusion pressure of 80 mm
Hg), as shown by a reduction in left
ventricular systolic and diastolic pres
sures and by a decrease in left ventri
cular work. Since augmented aortic
diastolic pressure could not directly
influence coronary perfusion the meas
ured decrease in flow (Table I, Fig.
4) appears to be an autoregulatory
response, since myocardial demand
has decreased.9
During acute coronary insufficiency
and subsequent left ventricular failure,
IABP was not accompanied either by
systolic unloading or by indirect
changes in coronary flow and oxygen
consumption. These results indicate
that balloon unloading responses may
be intimately related to the functional
status of the circulatory system before
IABP.5,6 For example, an increase in
aortic compliance at lower aortic pres
sures reduces the accompanying
changes in aortic volume.28 Also,
Tyberg’s group6 have shown that a
lower arterial pressure causes the aor
tic wall to move with the balloon so
that changes in balloon volume do not
accompany changes in aortic blood
volume. Finally, reductions in ventri

cular loading with IABP during severe
hypotensive episodes may be secondary
to increases in coronary flow which ac
company increases in aortic diastolic
pressure.5,6■u,12 Previous experiments
with this coronary bypass model have
clearly shown that coronary flow and
myocardial function are closely related
over a wide range of perfusion pressures.7’8 In normotensive states with a
coronary perfusion pressure of 80 mm
Hg, balloon deflation effectively un
loaded the left ventricle which in turn
caused coronary flow to decrease.
This autoregulatory response, which
had been previously inferred,5,6,11,12,29
could not be measured directly with
out isolated coronary perfusion as out
lined in our current study.
Under normotensive conditions,
IABP can effectively reduce myocar
dial demand by systolic unloading. In
contrast, IABP in hypotensive states
is unable to reduce myocardial de
mand. Thus, the main therapeutic
action of IABP to the compromised
heart is achieved by increasing coro
nary flow through augmentation of
the aortic diastolic pressure rather
than by systolic unloading.
We thank Mr. K. Sheldrick and Mrs.
V. Temple for their technical assistance
and Mrs. E. Masson for her help in
preparing the manuscript.
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Aortocoronary Bypass in Patients with
Severe Left Ventricular Dysfunction
D avid E. J ohnstone, md, frcp [c ],* A llan G. A delman , md, frcp [c ],* M ichael W eingert ,
V ictor F. H uckell, md, facc, frcp [c]* and B ernard S. G oldman, md , facs, FRcs[c]f
The results of aortocoronary bypass
grafting in 29 patients with severe
left ventricular dysfunction (ejection
fraction less than 35%) were studied.
All patients had severe angina
pectoris; 17 patients has class IV heart
function and 12 had class III function
according to the New York Heart
Association classification. Intra-aortic
balloon pump support was instituted
preoperatively in all patients. Three
patients died in the perioperative
period. Survivors were followed up
for a mean period of 20 months;
there were three late deaths.
Sixteen patients were clinically im
proved; 8 had class I and 8 class
II heart function at follow-up. Fourteen
patients underwent cardiac catheter
ization postoperatively at a mean
time of 19 months. Although 22
(79%) of the 28 grafts were patent,
there was no significant improvement
in resting left ventricular dysfunction
as assessed by ejection fraction, left
ventricular volume or left
ventricular end-diastolic pressure.
Furthermore, graft patency could not
be correlated with improvement in
segmental wall motion. There was a
10% operative and an 11.5% late
mortality and no measurable improve
ment in resting left ventricular func
tion in this study but the majority
(73%) of the surviving patients ex
perienced definite clinical improve
ment.

de poitrine; d’apres la classification
de la New York Heart Association,
17 patients avaient une fonction
cardiaque de classe IV et 12 avaient
une fonction de classe III. Un
soutien par contre-pulsion diastolique
par ballonnet intra-aortique fut
institue avant I’operation chez tous
les patients. Trois patients moururent durant la periode peri-operatoire.
Les survivants firent I’objet d'une
surveillance de post-cure pendant
une periode moyenne de 20 mois;
il y eut trois morts tardives. Seize
patients furent ameliores sur le plan
clinique; 8 presentaient une fonction
de classe I et 8 une fonction de
classe II a I’examen de contrdle.
Quatorze patients subirent un catheterisme cardiaque, 19 mois en
moyenne, apres ('operation. Bien
que 22 (79%) des 28 greffons
fussent fonctionnels, il n'y eut aucune
amelioration significative de I'insuffisance ventriculaire gauche au
repos evaluee par la fraction
d'ejection, du volume ventriculaire
gauche ou de la pression telediastolique ventriculaire gauche. De
plus, I’ouverture des greffons ne
put etre relie a une amelioration
du mouvement de la paroi segmentaire. On a enregistre une mortalite
operatoire de 10% et une mortalite
retardee de 11.5%, mais il n'y eut
aucune amelioration mesurable de
la fonction ventriculaire gauche au
repos dans cette etude bien que la
majorite (73%) des survivants aient
joui d’une nette amelioration
clinique.

md ,

operated upon with intra-aortic bal
loon pump support and to determine
if direct revascularization improved
their resting left ventricular function.

Patients and Methods
At the Toronto General Hospital
from Feb. 1, 1974 to Nov. 1, 1975,
29 consecutive patients (26 men, 3
women) with intractable angina and
severe left ventricular dysfunction
underwent aortocoronary bypass op
eration. An intra-aortic balloon pump
was inserted preoperatively in each
case. According to the New York
Heart Association (NYHA) classifica
tion of angina pectoris, 12 of the 29
were in class III and 17 in class IV.8
The average age of the patients was
48.6 years. The mean duration of
their anginal symptoms was 4 years
(range 5 to 120 months). Twentyeight patients had evidence of a previ
ous transmural myocardial infarction
as documented by pathologic Q waves
on the resting electrocardiogram; 9
were inferior, 11 were anterior and
8 were combined inferior and anterior
infarctions. Eleven patients had dysp
nea on exertion and mild orthopnea
but none had clinically overt con
gestive heart failure at the time of
operation. Three had sustained a
previous cardiac arrest and 15 were
taking propranolol preoperatively.
Left heart catheterization was per
formed
by Judkin’s technique.9 Aortic
On a etudie les resultats du pontage
and
left
ventricular pressures were
aorto-coronarien chez 29 patients
measured
before angiography. Select
ayant une grave insuffisance ventriive
coronary
and bypass angiograms
culaire gauche (avec une fraction
were
recorded
on 35-mm cine film at
d'ejection de moins de 35%).
Patients
with
severe
left
ventricular
30
frames/s
using
Renografin-76® as
Tous les patients souffraient d'angine
dysfunction and intractable angina the contrast medium. Multiple views
present a therapeutic dilemma to both were obtained using the Siemens carFrom the *department of medicine
the
cardiologist and the cardiovascular dioscope-U (Siemens Corp., Iselin,
and t division of cardiovascular surgery, surgeon.
Experience with both med NJ) as previously reported from our
University of Toronto, Toronto, Ont.
ical
and
therapy has been laboratory.1011 Coronary arteriograms
Presented at the 31st annual meeting of poor,1"6 butsurgical
in a recent report7 there were reviewed by two independent
the Canadian Cardiovascular Society,
was a considerable reduction in the observers. Significant coronary artery
Vancouver, BC, October 1978
number of perioperative deaths when disease was defined as 70% or
Supported by a grant from the
intra-aortic balloon pump support greater narrowing of a coronary ar
Ontario Heart Foundation
Accepted for publication Nov. 20, 1979 was instituted before the operation. tery. Left ventriculography was per
The purpose of our study was to formed in the right anterior oblique
Reprint requests to: Dr. David E.
analyse the results of aortocoronary projection. Single-plane left ventricular
Johnstone, Department of medicine,
Victoria General Hospital, Halifax, NS bypass grafting in patients with severe end-diastolic and end-systolic volumes
B2H 2Y9
left ventricular dysfunction who were were calculated by a computerized
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modification of Simpson’s rule.12 Cal
culations were based on the first
available cardiac cycle after the left
ventricle was fully opacified. Seg
mental wall motion was assessed by
measuring the shortening of six chords
(three anterior and three inferior),
obtained by trisecting the long axis
of the left ventricle at end-diastole
and end-systole and superimposing
these to correct for rotation.
Twenty-five patients had triple
vessel disease. The remaining four
had double-vessel disease. The dis
eased arteries were the left anterior
descending artery in all 29 patients,
the right coronary artery in 28 and
the left circumflex artery in 25 pa
tients. The type of operation per
formed is shown in Fig. 1. Ten patients
received one aortocoronary graft, 11
had two grafts placed and 8 received
three aortocoronary grafts. The left
anterior descending coronary artery
was bypassed in 9 of the 10 patients
who received one graft, in 9 of the 11
patients who received two grafts and
in all 8 patients who had three grafts
placed (Fig. 1). Six patients had con
comitant aneurysm resection.
An intra-aortic balloon (AVCO intra-aortic balloon pump model IABP7; AVCO-Roche, Cranbury, NJ) was
inserted under local anesthesia on the
day of operation in all but two pa
tients. Balloon pumping was used
through most of the operation to
produce pulsatile flow. Saphenous
vein aortocoronary bypass was per
formed with moderate total body hy
pothermia. Ventricular fibrillation was
induced electrically and a left ventri
cular apical vent was inserted in all
cases. Balloon pumping was stopped
during aortic cross-clamping when the
distal anastomosis was carried out un
der anoxic arrest. The average time
of anoxic arrest was 21.7 minutes
(range 12 to 50 minutes). The patient
was subsequently defibrillated and the
proximal anastomosis was then per
formed. An average of two grafts were
placed per patient. Balloon pump as
sistance was continued postoperatively
until the patient’s hemodynamic state
was stable. On average the intra
aortic balloon was removed 5 days
postoperatively and the patient dis
charged 21 days after operation. Sur
viving patients were followed up clin
ically for a mean period of 20 months
(range 8 to 24 months). One patient
was lost to follow-up.
Postoperative myocardial infarction
was diagnosed by the presence of new
persistent Q waves on the electrocar
diogram. Operative death was con
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sidered as that occurring within 1
month of operation. Functional class,
employment record, physical exam
ination, chest roentgenograms and
resting electrocardiograms were com
pared to the preoperative data. In
addition, 14 survivors consented to
heart catheterization at a mean time
of 19 months (range 6 to 24 months)
after operation. Patients in class I or
II (NYHA) postoperatively were con
sidered to be improved. They were
compared with those who failed to
improve or who deteriorated with
respect to preoperative and postoper
ative left ventricular function (left
ventricular ejection fraction, volume,
diastolic pressure and segmental wall
motion). Ejection fractions and endsystolic and end-diastolic volumes in
these 29 patients were also compared
with those of 31 patients with normal
hemodynamic measurements and no
coronary artery disease. Statistical
analysis of the pre- and postoperative
data was carried out by the paired
Student’s r-test.

Results

In three patients persistent new Q
waves were seen on the postoperative
electrocardiograms giving a perioper
ative infarction rate of 10%. Of the
29 patients, 3 (10%) died in the peri
operative period. Of these, two could
not be weaned from bypass and a
third patient had cardiogenic shock in
the immediate postoperative period.
Two additional patients died 3 months
postoperatively. Both deaths were sud
den and occurred at home. Autopsies
were not performed. Another patient
died with refractory congestive heart
failure 2 years after operation. He had
been clinically improved for 16
months. The late mortality at a mean
follow-up of 20 months was 11.5%.
The clinical and angiographic profiles
of the six patients who died were in
distinguishable from those of the sur
vivors. Five of the six had class IV
function preoperatively.
At clinical follow-up there was de
finite improvement in 16 patients
(Fig. 2). Three patients in class III
For analysis of segmental wall mo and five patients in class IV preoper
tion, the three anterior and three atively improved to class I postoperat
inferior chords were considered re ively; three patients in class III and
presentative of the wall motion in the five in class IV improved to class II
distribution of the left anterior des postoperatively. Six patients did not
cending and right coronary arteries improve appreciably or deteriorated.
respectively. A change of 20% post Thus, 16 (73%) of the 22 surviving
operatively in the extent of shortening patients were notably improved; 12 of
was considered notable. Postoperat these were fully employed. Of the 14
ively, it was possible to measure the patients who underwent postoperative
change in segmental wall shortening left heart catheterization at a mean
in 57 segments supplied by 19 of the of 19 months, the mean heart rate
28 grafts. Excluded from analysis and aortic pressures were 80
were one diagonal and five circumflex beats/min and 79 mm Hg respectively
artery grafts because the myocardial and not appreciably different from
segments supplied by these grafts were the preoperative values. The mean
not represented on the single-plane left ventricular end-diastolic pressure
right anterior oblique ventriculograms. was 20 mm Hg preoperatively com
Three grafts from one patient who pared with 15 mm Hg postoperatively
had multiple ventricular premature (Fig. 3). This change was not statisti
beats indicated by the preoperative cally significant. Pre- and postoperat
left ventriculogram were also ex ive left ventricular volumes and ejec
tion fractions are shown in Figs. 4
cluded.

F IG . I — H istogram showing type of
operation perform ed. M ajority of pa
tients had left anterior descending (LAD)
aortocoronary bypass grafts placed.
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F IG . 2— Changes in functional class
(NYHA classification) following aorto
coronary bypass grafting. One patient
was lost to follow-up.
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and 5; the mean preoperative enddiastolic volume was 193 ml com
pared with 235 ml postoperatively and
the mean preoperative end-systolic
volume was 134 ml compared with
159 ml postoperatively. Although
these volumes are markedly abnormal
the pre- to postoperative changes
were not significant.
The mean preoperative ejection
fraction was 22% and did not change
appreciably. Postoperatively it was
23% (Fig. 5). One patient’s ejection
fraction improved from 17% to 43%.
This patient had had many episodes
of recurrent angina before catheteriza
tion and it is possible that transient
ischemia was present preoperatively
but not postoperatively, resulting in
the improved ejection fraction. When
the left ventricular end-diastolic pres
sure, left ventricular volumes and
ejection fractions of the subgroup of
improved patients were analysed se
parately, there was still no significant
hemodynamic or angiographic im
provement postoperatively.
Selective bypass angiography re
vealed that 22 of the 28 grafts were
patent (79%). In the clinically im-

FIG. 3— Preoperative
(Preop) and
postoperative (Postop) left ventricular
end-diastolic pressures (LVEDP) in 13
patients. Circles represent patients who
were clinically improved, squares re
present those who deteriorated. Each
line represents one patient. A indicates
mean ± one standard error of mean.
Change in LVEDP was not significant.

proved group, one patient had a single
graft inserted, two had two grafts
inserted and six received three grafts.
In this group, only three grafts were
occluded; all nine improved patients
had at least one patent graft and the
majority had more than one. In the
group that did not improve, five re
ceived only one graft and three of the
five grafts became occluded.
The results of selective coronary
arteriography, bypass graft angiogra
phy and analysis of segmental wall
motion are summarized in Table I.
In 18 of the patent grafts and 6 of

FIG. 4— Pre- and postoperative left
ventricular diastolic (a) and systolic (b)
volumes in 13 patients (1 patient who
had ventricular premature beats on ven
triculogram is excluded). Format is same
as Fig. 3. Normal diastolic volume is 125
—
5 ml, normal systolic volume is 31
± 2 ml.

the occluded grafts a proximal coro
nary artery lesion progressed to oc
clusion. In four instances, both the
native vessel and the graft were patent.
Patency of the graft or native vessel
could not be correlated with improve
ment in segmental wall motion.
D iscu ssion

Patients with intractable angina
pectoris and severe left ventricular
dysfunction are difficult to manage.
It is often impossible to relieve an
gina with the antianginal regimen of
/3-blockade and nitrates and in several
studies survival has been poor.1'3 In
a series of 590 patients treated medi
cally at the Cleveland Clinic, the 5year mortality in those with diffuse
coronary artery disease and dilated,
poorly contracting left ventricles was
69% compared with 25% in patients
with normal left ventricular function.
Early experience with aortocoronary
bypass grafting in patients with severe
left ventricular dysfunction was equal
ly poor.4"7 Spencer and associates5 re
ported a 1-year mortality of 37%
after aortocoronary bypass in these
patients and only 20% of the sur
vivors had substantial clinical im
provement. Although the majority of
patients experienced relief of their

FIG. 5— Pre- and postoperative ejec
tion fractions in 13 patients. Format is
same as Fig. 3.

Table I— Findings on Selective Coronary Arteriography and Bypass Graft Angiography and Percentage Change in Segmental Wall Shortening

Finding

Total no. grafts
in patients restudied

No. grafts whose
corresponding wall
motion was measured

No. of segments
analysed

Improved

D eteriorated

No change

Graft and native coronary artery patent
Graft patent but native coronary
artery occluded
Graft and native coronary artery occluded

4

2

6

3

2

1

18
6

11
6

33
18

14
11

14
6

5
i

Total

28

19

57

28

22

7
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angina after operation, their clinical
course was characterized by pro
gressive heart failure leading to death.
Recently, Feola and associates7 re
ported their results of aortocoronary
bypass in patients with ejection frac
tions less than 30% operated on with
intra-aortic balloon pump support.
From 1973 to 1974 their operative
mortality without intra-aortic balloon
support was 34.7% but in a later
series of patients operated on with
balloon support the mortality was
only 8% . They believed that the re
duction in operative mortality was
genuine and could not be explained
by evolution of surgical techniques
alone.
To date, no one to our knowledge
has fully randomized these patients
into surgically and medically treated
groups in an attempt to determine if
one form of therapy is superior.
Steele and colleagues6 have followed
up 97 patients with ejection fractions
of less than 25% for 30 months. Fifty
patients underwent aortocoronary by
pass and 47 were treated medically.
Of the medically treated patients only
23% were alive at 30 months com
pared with 66% of the surgically
treated patients. Equally important
was the fact that 79% of patients in
the surgical group were clinically im
proved compared with only 21% of
patients in the medical group. Intra
aortic balloon support was used in 12
(24%) patients and their operative
mortality was only 9%.
In our previously reported exper
ience with intra-aortic balloon support
in 150 patients,13 poor left ventricular
function was one of our prime indi
cations for preoperative balloon sup
port, as it was in the present series
of patients. Recent therapeutic ad
vances which have resulted in better
control of afterload and preload, and
more effective myocardial protection
as well as evolving surgical exper
ience may have obviated the need for
intra-aortic balloon assistance in
some of these patients.
Aortocoronary
bypass
grafting
failed to improve left ventricular func
tion in the patients in this study, a
finding consistent with a number of
previous reports.14"1’ Early enthusiasm
about improved postoperative left
ventricular function followed a report
by Chatterjee and associates19 in 1972.
Their study, however, has been critic
ized because left ventricular function
was assessed within 2 weeks of opera
tion and the results obtained may have
been secondary to postoperative adre
nergic hyperactivity,20 fever, anemia
and the stress of surgery. In fact, no
130

improvement of left ventricular func
tion has been reported following aor
tocoronary bypass in patients who
were totally revascularized, who had
all grafts patent and who had no
evidence of perioperative infarction.15
Failure of patent grafts to produce
improvement of segmental wall motion
has previously been reported.14"18
Steele and associates17 found that 71 %
of the segments supplied by an oc
cluded graft showed decreased motion
although with a patent graft, 91% of
the corresponding ventricular seg
ments showed no change. The status
of the patent vessel did not appear to
alter segmental wall motion. In our
series, patent grafts did not consistently
improve segmental wall motion even
when it was severely depressed preoperatively. Moreover, wall motion
occasionally improved when grafts
were occluded.
An important question in view of
these results is why these patients
were improved clinically. They had
more patent grafts than the unim
proved group of patients and it is
tempting to postulate that myocar
dial revascularization resulted in cli
nical relief of angina pectoris. Alter
natively, appreciable improvement
has been documented in a series of
patients with no grafts patent at fol
low-up.21 Possible explanations for this
have been the placebo effect of sur
gery or perioperative infarction of
the ischemic area. Our perioperative
infarction rate was 10%. This figure
may underestimate the true infarction
rate because the majority of patients
had Q waves on their electrocardio
grams preoperatively and some perio
perative infarctions may have gone
undetected. Regardless of the mech
anism of improvement, the majority
of patients were clinically better fol
lowing bypass operation and many of
them were fully employed 20 months
later.
One limitation of any postoperative
study is that the group restudied may
not represent the whole. The more
symptomatic patients tend to agree
to restudy while the relatively less
symptomatic often refuse. Of the 23
patients surviving 1 month, 8 refused
recatheterization and 1 patient was
lost to follow-up. Three of these eight
patients were functional class I and
four were functional class II at follow
up, compared with five of the patients
who underwent recatheterization who
were functional class III or IV. It
will be important to restudy more
patients with severe left ventricular
function postoperatively to determine
if our results are representative.
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Another important question may be
answered by forthcoming quantitative
postoperative studies on exercise and
left ventricular function since our
clinical appraisal of improvement is
based on how well a patient tolerates
exercise. Further, resting ventriculo
graphy in the right anterior oblique
position best delineates motion of the
inferior and anterior walls and im
portant quantitative and qualitative
details concerning the remaining ven
tricle may not be appreciated. How
ever, the results of segmental wall
analysis14 with biplane ventriculo
grams following bypass surgery have
been similar to those reported here.
The unstable nature of the medical
problem did not permit all patients to
stop taking propranolol before preo
perative heart catheterization. This
was done routinely at least 36 hours
before the postoperative catheteriza
tion. If this biased the study, it
would have done so in a positive way
since left ventricular function should,
if anything, be better without the
negative inotropic effect of propra
nolol. Recently, it has been shown
that left ventricular ejection fraction,
as determined by serial nuclear angio
graphy, does not change when propra
nolol is given22 or withdrawn.23
In summary, there was an appreci
able early (10%) and late (11.5%)
mortality following aortocoronary by
pass grafting carried out with intra
aortic balloon support in the 29 pa
tients with severe left ventricular
dysfunction in this series. The major
ity (73%), of surviving patients with
one or more patent grafts were clini
cally improved despite the fact that
there was no measurable improvement
in resting left ventricular function.
Advances in surgical technology
coupled with valuable experience in
perioperative care may influence the
overall outcome of this severe form
of coronary artery disease.
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Early Clinical Experience with the Carpentier-Edwards
Porcine Heterograft Cardiac Valve
W.R. E ric Jam ieson , m d , frcs [ c ], M ich ael T. Janusz , m d ,
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L aw ren ce H. B u r r , md , fr c s [ c ] and P eter A l l e n , m d , facs , frcs [ c ]

Porcine heterograft cardiac valves
preserved in glutaraldehyde were
first implanted to reduce the risk of
thromboembolism. The CarpentierEdwards bioprosthesis, introduced in
1975, has had limited clinical
evaluation. This report provides
follow-up information on 463 patients
who received Carpentier-Edwards
valves at the University of British
Columbia between September 1975
and March 1979; 213 received an
aortic valve prosthesis, 201 a mitral
valve prosthesis, 4 had a tricuspid valve
replaced and 45 received multiple
valves. The total duration of
follow-up is 608 patient-years with
a maximum of 3.25 years. Actuarial
survival was 89.4% at 30 months
for aortic valve replacement
(A V R ), 80% at 30 months for mitral
valve replacement (M V R ) and
76.6% at 18 months for multiple
replacements (M R ). The operative
mortality was 5 % for AVR, 10%
for MVR and 9 % for MR. The late
mortality expressed linearly as a
percentage per patient-year was 1.0%
for AVR , 5.6% for MVR and
9.6% for MR. The linear morbidity
rates were delineated for thrombo
embolism (AVR, 1.36 episodes/100
patient-years, MVR 1.98 and MR
4.82) and for infective endocarditis
(AVR 1.36, MVR 0.79 and MR 1.61).
Long-term anticoaguiation was
maintained in 10% of patients who
had AVR and 6 0 % of those who
had MVR and MR (usually for
chronic atrial fibrillation). The actuarial
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probability of freedom from em
bolization is 96.5% at 36 months for
AVR and 9 5 % for MVR and MR.
There were no cases of valve
dysfunction (thrombosis, perforation
or calcification). The CarpentierEdwards prosthesis provides satisfac
tory early clinical results but must
receive long-term evaluation.
Les heterogreffes de valvules
cardiaques porcines conservees dans
le glutaraldehyde ont ete initialement implantees afin de reduire
le risque de thromboemboiie. La
bioprothese Carpentier-Edwards
introduite en 1975, a fait I'objet
d'une evaluation clinique limitee. Ce
rapport rassemble les observations
post-therapeutiques chez 463 patients
qui regurent des valvules CarpentierEdwards a I'Universite de Colombie
Britannique entre septembre 1975 et
et mars 1977; 213 regurent une
prothese aortique, 201 une prothese
mitrale, 4 le remplacement d'une
valvule tricuspide et 45 regurent
plusieurs valvules. La duree totale
de la surveillance de post-cure
correspond a 608 patients-annees
avec un maximum de 3.25 annees.
La survie actuarielle a ete de 89.4%
a 30 mois pour un remplacement
de valvulel aortique (R VA),
de 80% a 30 mois pour une
remplacement de valvule mitrale
(R VM ), et de 76.6% a 18 mois pour
des remplacements multiples (R M ).
La mortaiite operatoire a ete de
5 % pour les RVA, de 10% pour les
RVM et de 9 % pour les RM.
La mortaiite retardee exprimee lineairement comme un pourcentage
par patient-annee a ete de 1.0%
pour les RVA, de 5.6% pour les
RVM et de 9.6% pour les RM. Les
taux iineaires de morbidity ont
ete determines pour les thromboembolies (R VA 1.36 crises 100
patients-annees, RVM 1.98 et RM
4.82) et les endocardites infectieuses (R V A 1.36, RVM 0.79 et
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RM 1.61). Les anticoagulants au long
cours ont ete maintenus chez 10%
des patients qui avaient eu un
RVA et chez 60% de ceux qui
avaient eu un RVM ou RM (habituellement, pour fibrillation auriculaire chronique). La probability
actuarielle de demeurer exempt
d’embolie a ete de 96.5% a 36 mois
pour les RVA et de 95% pour les
RVM et les RM. II n'y a eu aucun
cas de dysfonctionnement valvulaire
(par thrombose, perforation ou calci
fication). Les valvules prosthetiques
Carpentier-Edwards donnent des
resultats cliniques immediats satisfaisants mais doivent faire I'objet
d'une evaluation au long cours.

The porcine heterograft valve, glutaraldehyde-preserved, has increased in
popularity over the past 8 years as
a cardiac valve substitute. All pros
thetic valves are judged by their func
tional performance and the frequency
o f clinical complications. The Han
cock porcine heterograft valve has
been extensively evaluated with res
pect to the patient’s functional per
formance, hemodynamic status, valve
durability, the rate of endocarditis and
thromboembolism and complications
of anticoagulation.1"6 Since 1975 the
Carpentier-Edwards porcine valve has
been in clinical use, but document
ation o f clinical performance and
hemodynamic assessment has been
limited.7"11
The Hancock porcine valve has been
shown to give excellent functional
performance, a low rate o f throm
boembolism and to be resistant to en
docarditis.1,2,5,12 The identified prob
lems with the Hancock valve have
been high pressure gradients with the
small aortic prosthesis and structural
changes with collagen degeneration
and calcification at various stages of
implantation, especially over pro
longed periods.13"17
The Carpentier-Edwards valve has

not been observed for as long as the
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Hancock valve and must also receive
exhaustive evaluation for there are
differences in construction, tissue se
lection and mounting, and in tissue
fixation and preservation. The Carpentier-Edwards valve is mounted on
a thin-walled flexible metal stent
which is constructed to permit a
favourable annulus to internal dia
meter ratio.
Surgeons at the Vancouver General
Hospital and St. Paul’s Hospital first
used the glutaraldehyde-preserved por
cine valve in late 1974 and since late
1975 the Carpentier-Edwards prosthe
sis has been implanted primarily. The
porcine heterograft cardiac valve was
used in an attempt to reduce the
morbidity and mortality from throm
boembolism and anticoagulation. This
paper will evaluate our early ex
perience with the Carpentier-Edwards
valve and review the literature on the
Hancock and the Carpentier-Edwards
prostheses.
Patients and Methods

All patients who received Carpen
tier-Edwards porcine bioprostheses at
both hospitals were included in the
evaluation. Between Dec. 1, 1975 and
Mar. 31, 1979, 508 Carpentier-Ed
wards heterograft valves were placed
in 463 patients. There were 253 males
(age range 11 to 81 years, mean 54.5
years) and 210 females (age range
8 to 80 years, mean 54.4 years).
Aortic valves were replaced in 213
patients (161 males and 52 females),
and mitral valves in 201 patients (76
males and 125 females). Multiple
valve replacements were performed
in 45 patients (14 males and 31
females).
Preoperative Status
All the patients were categorized
according to the New York Heart
Association (NYHA) functional clas
sification (Fig. 1). At the time of
operation the majority of the patients
had class III or IV function (54%
class III and 17% class IV). Of the
remainder, 28.4% had class II func
tion and 0.6% class I. The patients
in class II were primarily those with
aortic stenosis.
Ninety-seven patients (21%) had
undergone cardiac surgery previously
—valve replacement in 48 (aortic 19,
mitral 29) and valve commissurotomy
in 42 (closed mitral 35, open aortic
2, mitral 4 and tricuspid 1) and cor
rection of a congenital defect in 7.
Other cardiac procedures were per
formed concomitantly with the valve
replacement in 113 patients (24%).
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Concomitant aortocoronary bypass
was performed in 70 patients (15%).
Of the remainder, 12 patients had
resection of an ascending aortic
aneurysm, 9 had a commissurotomy
and 14 had an anuloplasty of
another valve. One patient had left
ventricular myomectomy for idio
pathic hypertrophic subaortic stenosis
and one had repair of a ventricular
septal defect.
Operative Technique
The operative technique for aortic
valve replacement (AVR) and mitral
valve replacement (MVR) changed
during the observation period with
the introduction, during the latter
half of 1976, of hypothermic chem
ical cardioplegia for intraoperative
myocardial preservation.
A nticoagulation
We previously discussed the hypo
thesis that thromboembolism was a
complication of the cardiac disease
and not necessarily a complication of
the heterograft prosthesis.7,18 To re
duce the risk of thromboembolism,
anticoagulation is mandatory when
factors that contribute towards vas
cular stasis are present. Use of anti
coagulants is at the discretion of the
attending cardiologist. One of three
alternatives is followed at each of
the four major hospitals in Vancou
ver: (a) anticoagulants are given all
patients with mitral valve prostheses
who are in chronic atrial fibrillation
until such time as they are hemodynamically stable in sinus rhythm,
(b) anticoagulants are administered
to all patients with aortic or mitral
prostheses for 3 months and are con
tinued in those with MVR in chronic
atrial fibrillation until they are hemodynamically stable and free of atrial
arrhythmias, or (c) anticoagulants are
given to all patients with MVR in
definitely. All of these avenues meet
our recommendation for long-term
anticoagulation in patients with MVR
who remain in chronic atrial fibril
lation. At the recent clinical eval
uation, 10% of those with AVR and
60% with MVR and multiple re
placement (MR) were receiving long
term anticoagulant therapy.
Follow-Up
The current clinical evaluation was
obtained by direct contact with pa
tients or attending physicians, in
cluding family physicians, internists,
cardiologists or surgeons. The average
follow-up of surviving patients was
16.9 months (range 6 to 39 months).
The cumulative follow-up for all
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patients was 608 patient-years (AVR
293.2 patient-years, MVR 252.4 pa
tient-years and MR 62.3 patientyears), The patient evaluation was
98% complete. Four patients who
reside abroad and two who live out
side British Columbia could not be
reached. Three patients were lost to
follow-up.
Valve Dysfunction
This was diagnosed if one of the
following criteria was evident: (a)
thrombosis of a prosthesis, (b) nonperiprosthetic new regurgitant mur
mur indicating leaflet disruption or
(c) hemodynamically confirmed sub
stantial stenosis, such as is seen in
calcification of valve leaflets. In
fective endocarditis was not consi
dered to be a primary cause of valve
dysfunction.
Thromboembolism
Thromboembolic events included all
documented peripheral arterial emboli
and all new neurologic defects
whether transient or permanent that
occurred after the intraoperative pe
riod. Neurologic events that occurred
intraoperatively were not consi
dered as thromboembolic episodes
and were categorized separately. The
linear morbidity and mortality rates
and actuarial freeedom from thrombo
embolism were calculated on late
thromboembolic episodes.
Statistical Analysis
Patient survival and the rate of
thromboembolism are expressed by
actuarial analysis. The late mortality
and cases of thromboembolism, valve
dysfunction, periprosthetic leak and
infective endocarditis are expressed
as linear occurrence rates.

FIG. 1— New York Heart Association
(NYHA) classification of patients preoperatively.
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Results
T a b le 1— O p e r a tiv e a n d E a r ly * D e a th s

Early M ortality and Com plications
V a lv e r e p la c e m e n t
o p e ra tio n
N o . o f d e a th s

%

A o r tic (n = 213)
M it r a l (n = 201)
T r ic u s p id (n = 4 )
M u lt ip le (n = 4 5 )

11
21
1
4

5
10
25
9

T o t a l ( n = 463)

37

8

The overall hospital (30-day) mort
ality for the 463 patients in the se
ries was 8.0% (37 patients) (Table I).
Of the patients who had had pre
vious cardiac operations (Table II),
10 of 48 (21%) who had undergone
previous valve replacement died and
4 of 42 patients (10%) who had a

* < 3 0 d.

T a b le I I - - In f lu e n c e o f P re v io u s S u rg e ry o n M o r ta lity
O p e r a tiv e sta tu s
P r e v io u s o p e ra tio n
V a lv e r e p la c e m e n t
V a lv e c o m m is s u ro to m y
C o n g e n ita l d e fe c t
N o p r e v io u s s u rg e ry

N o . o f p a tie n ts

N o. o f d e a th s

%

48
42
7
366

10
4
1
22

21
10
14
6

previous valve commissurotomy died.
Of the 366 patients who had not
undergone surgery previously 22 (6%)
died.
Of the 37 operative and early
postoperative deaths, 23 (62%) were
attributed to low-output states. Of
the remainder, the main causes of
death were technical errors (five pa
tients), hemorrhage (four patients),
congestive heart failure and arrhyth
mias (two patients) and infective en
docarditis (one patient).
There were 71 serious but not fatal
operative complications.
Cerebro
vascular accidents occurred in 15
patients, 11 intraoperatively and 4
postoperatively; heart block occurred
in 13 patients requiring insertion of a
permanent cardiac pacemaker. There
were six instances of sternal dehis
cence, two of periprosthetic leak, two
of renal failure and one of left ven
tricular outlet obstruction by a strut
of a mitral prosthesis for which early
reoperation was required.
L ate M ortality and Com plications

FIG. 2—Actuarial survival in 463 patients. Numbers 241, 108 and 12 refer to
patients available for evaluation at 12, 24 and 36 months.

FIG. 3—Actuarial survival by NYHA class of patients who had aortic valve
replacement.
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There were 25 late (more than
30 days) deaths (5.4%). The late
mortality was 4.1% per patientyear, overall. The late mortality
for AVR was 1.0% per patientyear, for MVR 5.6% per patientyear and for MR 9.6% per patientyear. Patient survival was 84% at
30 months, including operative deaths
(Fig. 2). Survival rate for patients
with AVR was 89.4% at 30 months,
for MVR 80% at 30 months and for
MR 76.6% at 18 months. The most
common causes of late death were
congestive heart failure (seven pa
tients) and acute myocardial infarc
tion (six patients). Other causes in
cluded infective endocarditis (three
patients), cerebrovascular accident
(three patents) and periprosthetic leak
(two patients).
The postoperative NYHA func
tional classification in the surviving
patients showed substantial improve
ment in the majority of them
(Fig. 1). Ninety-three per cent of the
patients were in either class I or II
postoperatively; only 7% were in
class III or IV. Figs. 3 and 4 show
the actuarial survival for each pre
operative functional class for both
AVR and MVR.
The serious late complications were
infective endocarditis, periprosthetic
leak and systemic emboli. There were
no cases of valve dysfunction (i.e.,
thrombosis, disruption of a prosthesis,
perforation or calcification).
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Thromboembolism
There were 16 thromboembolic
episodes (Table III). Four occurred
during the early postoperative pe
riod (less than 2 weeks postoperatively) and 12 during the late post
operative period. Of the four early
events, two followed AVR and two
MVR. None of these patients died.
All patients were in chronic atrial
fibrillation except for one who had
AVR. Anticoagulation had been
started in only one patient, but
therapeutic range had not been attain
ed at the time of the cerebrovascular
accident. Of the 12 late episodes,
2 occurred between 2 weeks and 2
months after operation, while the
other 10 were distributed throughout
the remainder of the observation
period.
Of the 12 late thromboembolic
events, 3 were fatal cerebrovascular
accidents. Only 4 of the 12 episodes
occurred in patients with AVR. In
each case, the episode resulted in
transient visual defects only, with
no permanent deficit. Five episodes
followed MVR, and three followed
MR; one affected the peripheral ner
vous system and seven the central
nervous system. These episodes usu
ally produced a serious deficit, most
commonly a hemiparesis. Three epi
sodes resulted in death and one
left a permanent deficit. All but one
of these eight patients were in chronic
atrial fibrillation and only three were
receiving anticoagulants at the time
of embolism.
The linear rate of thromboembo
lism is detailed in Table IV. The
rate of embolic events following
AVR was 1.36 per 100 patient-years.
Anticoagulant therapy was used in
only 10% of patients who had AVR.
Thromboembolism occurred in MVR
and MR at a rate of 2.54 per 100
patient-years (MVR 1.98, MR 4.82),
while 60% of the patients remained
on long-term anticoagulation. The
linear occurrence rate for deaths re
lated to thromboembolism was 1.19
per 100 patient-years for MVR. with
no deaths occurring in patients with
AVR or MR.
Actuarially determined rates of
thromboembolism are shown in Fig.
5. The freedom from embolization
was higher for patients with AVR
than those with MVR (97.0% at 36
months for AVR, 95% at 36 months
for MVR and MR).
Infective Endocarditis
This complication occurred in seven
patients; in four following AVR, 2
V O L U M E 23, NO. 2, M A R C H 1980

following MVR and 1 following MR
(on the mitral prosthesis). Of these
patients two underwent reoperation
and one died. Of the five patients
who did not undergo reoperation two
patients died.
The linear rate of infective endo
carditis following AVR was 1.36 per
100 patient-years; following MVR
0.79 and following MR 1.61 per 100
patient-years (Table IV). The linear
occurrence rate for deaths due to in
fective endocarditis was 0.34 per 100
patient-years for AVR, 0.79 for MVR
and 0 for MR (Table IV).
Valve
There
function
stage of

Dysfunction
were no cases of valve dys
in the series at this early
the follow-up.

Periprosthetic Leaks
There were seven periprosthetic
leaks, three in patients with AVR,
two with MVR and two in the mitral
prosthesis of patients with MR. Of
the seven patients in whom peri
prosthetic leaks developed in the late
postoperative period, six required re
operation and two died. One patient
did not require reoperation.
The linear occurrence rate for peri
prosthetic leak was 1.02 per 100
patient-vears for AVR, 0.79 for MVR
and 3.21 for MR. The mortality re
lated to periprosthetic leak was 0 per
100 patient-years for AVR, 0.4 for
MVR and 1.61 for MR.
Discussion
In 1969 the use of biologic tissue
as a cardiac valve substitute was
firmly established when tissue pre
servation with glutaraldehyde was
initiated.19 The Flancock prosthesis
100
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FIG. 4—Actuarial survival by NYHA
class of patients who had mitral valve
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FIG. 5— Acturial
thromboembolism.
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Table I II— Tim e Interval between Operation and Thromboembolism
Type of valve replacem ent, no. of patients
Tim e interval
< 2 wk
2 w k - 3 mo
3 - 6 mo
6 - 1 2 mo
> 1 2 mo

Aortic

M itral

M ultiple

Total

2
0
2
0
2

2
2
1
2
0

0
0
0
2
1

4
2
3
4
3

Table IV — Linear M o rtality and M orbidity R ates*
Type of valve replacem ent
M ortality and morbidity
Operative m ortality, %
Late m ortality, %
Thromboembolism
Overall
Fatal
Infective endocarditis
Overall
Fatal
Periprosthetic leaks
Overall
Fatal

Aortic

M itral

M u ltip le

5.0

10.0
5.6

9.0
9.6

1.0
1.36
0.34

1.98
1.19

4.82
0

1.36
0.34

0.79
0.79

1.61
0

1.02
0

0.79
0.40

3.21
1.61

’ Expressed as per cent per patient-year or episodes per 100 patient-years.
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was introduced in 1971 but the
Carpentier-Edwards porcine valve was
not applied clinically until 1975. The
Hancock valve has received extensive
clinical and hemodynamic evaluation.
Since there are differences in tissue
selection, fixation and preservation,
and prosthesis construction between
these two glutaraldehyde-preserved
valves, the Carpentier-Edwards pros
thesis also requires extensive eval
uation.
The porcine heterograft cardiac
valve was first used in an attempt to
reduce or eliminate the risks of
thromboembolism. From the early
experience with the Hancock porcine
valve it was recognized that occur
rence of thromboembolism was re
duced.3,6,20'26 During the early years
of its use patients who had a Hancock
valve implanted did not receive anti
coagulant therapy.6,18,20'23,2729 Several
reports21’23,30,31 noted a low rate of
thromboembolism with this prosthesis
in the mitral position. However, our
early experience with the Hancock
prosthesis revealed that factors such
as chronic atrial fibrillation caused
vascular stasis in the left atrium and
such factors were designated as being
thrombogenic.7’18'32 These have been
recognized as important factors con
tributing to thromboembolism, and
the indications for anticoagulant
therapy were thus delineated.4,7,29,30,33 38
It is our experience and that of
others1,7'18,22,34,35 that chronic atrial
fibrillation is the major contributing
factor to thromboembolism. Anti
coagulation is indicated primarily for
MVR and can virtually be eliminated
in AVR.5,7,33 The risk of thrombo
embolism and the role of anticoa
gulants are essentially the same for
the Carpentier-Edwards prosthesis as
for the Hancock prosthesis.
Most thromboembolic episodes oc
cur during the initial 3 months after
valve implantation.1,4,5,24,37 The manu
facturers of the Carpentier-Edwards
valve recommend anticoagulant the
rapy for the first 2 months after
valve replacement until endothelialization of the cloth surfaces and
sutures has taken place and for
indefinite periods when atrial ar
rhythmias, a dilated left atrium and
calcification of the atrial wall are
present or when the patient has had
an atrial thrombus previously. We
have no data to support the use of
anticoagulants in the early post
operative period in patients who have
sinus rhythm. Our experience with
the Hancock valve7 and with the
Carpentier-Edwards prosthesis indi
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cates that thromboembolic episodes
occurred throughout the observation
period, usually when the documented
contributing factors were present.
The freedom from embolic episodes
with the Carpentier-Edwards valve is
essentially the same as with the Han
cock prosthesis.1'5,6
The actuarial survival with the
Carpentier-Edwards valve, taking into
account deaths from all causes in
cluding thromboembolism, valve dys
function and infective endocarditis,
compares favourably with that of the
Hancock valve.1,5,20,27,30,33 The fre
quency of infective endocarditis com
pares favourably with that of me
chanical prostheses.1,3,12 The Hancock
valve is resistant to early postoperative
bacteremias, is easier to sterilize than
mechanical prostheses and is more
durable than other tissue valves when
threatened with endocarditis.12 In this
respect our early experience with the
Carpentier-Edwards prosthesis is com
parable to that with the Hancock
valve. We did not evaluate preoper
ative patient variables1,3IM0 and conse
quently cannot compare precisely our
survival data to those of others.
The hemodynamic assessment of
the Carpentier-Edwards valve shows
improvement over the Hancock valve
in the aortic position.8,9,11 There ap
pears to be less obstruction to left
ventricular ejection with the Carpen
tier-Edwards prosthesis9 and im
proved effective orifice area when
used in the smaller aortic root.8 The
structural design of the stent may
contribute to the lower pressure
gradients in small aortic prostheses.8
It is recommended that small-size
aortic prostheses be used selectively
according to the body surface area of
the patient.10
With extensive evaluation of the
porcine heterograft valve there is
concern over the long-term dura
bility of the glutaraldehyde-preserved
prosthesis.4’5,13'16,41'45 Primary leaflet
failure caused by tissue fatigue has
occurred in vivo and in vitro.41,42,48,47
In vitro testing has been a poor pre
dictor of long-term durability.46,47
Even with the vulnerability of gluta
raldehyde-preserved tissue to com
pression flexure force, the in vitro
testing is equivalent to 12 to 14 years
of a normal beating heart.48 There is
continued documentation of calcifi
cation
of prostheses,
occurring
mostly in patients with renal failure
and children under 12 years of
age.16,17,19,42,48J51 The cause of this
calcification appears to be a com
bination of tissue degeneration, ac
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celerated rejection and metabolic pro
cesses in both the patient with renal
failure and the growing child.
There has been considerable ultrastructural evaluation of the Hancock
prosthesis.13'15 Porcine valves im
planted over 2 years have shown some
endothelial cells completely obliterated
and areas covered with fibrillar mate
rial.15 Investigators at the National
Heart, Lung and Blood Institute in
Bethesda, Maryland,13-14 have found
that glutaraldehyde-preserved valves
show the same histologic changes
as formalin-fixed valves but that
the cellular reaction is less pro
nounced, indicating that the . porcine
valve is not biologically inert in man.
In the early stage there is disruption
of endothelium, fibrin deposits and
deposition of erythrocytes, macroph
ages, giant cells and platelets while
the late changes are progressive dis
ruption of collagen, erosion of valve
surfaces, platelet aggregation and ac
cumulation of lipids.14 These structural
changes do not affect valve function,13
but the progressive breakdown of col
lagen will likely be critical in de
termining long-term durability.14
Summary

From our early clinical evaluation
of the Carpentier-Edwards porcine
bioprosthesis, we conclude that the
rates of thromboembolism and en
docarditis are as low as those of the
Hancock prosthesis. We have not en
countered a single case of valve dys
function. This could be attributed to
several factors, (a) the short duration
of follow-up with the CarpentierEdwards prosthesis and (b) differences
in tissue selection, preservation and
mounting. The documented ultrastructural changes with the Hancock
valve may have a limited effect on
long-term durability, the superior clin
ical result with the glutaraldehydepreserved prostheses should encourage
the continued use of this biologic
tissue as a cardiac valve substitute.
We extend appreciation to attending
physicians (family physicians, internists
and cardiologists) for their cooperation
in patient evaluation. We thank Colleen
Varcoe, research assistant, division of
cardiothoracic surgery, for her efforts in
the follow-up of our patients and Gayle
Henderson and Diane Steel for their
assistance in preparing the manuscript.
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Valve Replacement for Isolated Mitral Regurgitation
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From Jan. 1, 1964 to Dec. 31,
1977, 89 consecutive patients had
mitral valve replacement for isolated
mitral regurgitation. All but seven
of the survivors were available
for follcw-up. Early mortality
(within 30 days of operation) de
creased from 3 1 % in the period
1964 to 1973, to 1 7 % in the period
1974 to 1977. It was significantly
higher in acute as opposed
to chronic presentation (P
< 0.01), ischemia as opposed to
other causes (P < 0.05) and
prolonged cardiopulmonary bypass
time (P < 0.05) but did not relate
to left ventricular dysfunction
or pulmonary hypertension. Late
mortality was 3 3 % with an average
annual attrition rate of 7 % for
the first 6 years followed by a
plateau thereafter. Late survival
correlated with preoperative ventricular
function, but not with the presence
of coronary artery disease, etiology or
mode of presentation. Of 40 survivors,
in whom the mean follow-up was
54 months, 27 (68% ) improved
by at least one functional class
(New York Heart Association classi
fication). Twenty-three were fully
employed, 6 had limited work capability
and 11 were not working. Nonfatal complications included systemic
emboli in 7 patients and serious
hemorrhage in 12 patients. These
data suggest that the presentation
and etiology are important factors
affecting early mortality. Preoper
ative left ventricular function
affects late survival and should
be considered in the timing of
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valve replacement. Although the annual
attrition rate is appreciable, most
survivors had a good functional
result.

Bien que la baisse annuelle du
nombre de survivants soit appreciable,
la plupart des survivants jouirent
d'un bon resultat fonctionnel.

Du 1 " janvier 1964 au 31 decembre
1977, 89 patients consecutifs ont
eu une valvuloplastie mitrale pour
corriger une regurgitation mitrale
isolee. Tous les survivants sauf sept
ont pu etre retraces pour un
examen de controle. La mortalite
precoce a diminue de 3 1 % durant
la periode de 1964 a 1973, a 1 7% pour
la periode de 1974 a 1977. La
mortalite precoce (durant les 30 jours
qui suivirent I'operation) fut significativement plus elevee dans les
cas aigus par rapport aux cas chroniques (P < 0.001) dans les cas
d'ischemie par rapport aux autres
causes (P < 0.05) et lorsque le
temps de circulation extra-corporelle
fut prolonge (P < 0.05) mais ne fut
pas rattachee a un dysfonctionnement
ventriculaire gauche ou a une
hypertension pulmonaire. La mortalite
retardee fut de 3 3 % avec un effritement annuel des effectifs de 7 %
pendant les premieres 6 annees,
suivi, par la suite d'un plateau.
La survie tardive fut reliee a I'etat
preoperatoire de la fonction ventri
culaire mais non a la presence de
la maladie coronarienne, a I'etiologie
ou aux symptdmes revelateurs de
la maladie. Chez les 40 survivants
qui ont fait I'objet d'une surveillance
de post-cure moyenne de 54 mois,
27 (68% ) se sont ameliores d'au
moins une classe fonctionnelle (clas
sification de la New York Heart
Association). Vingt-trois avaient un
emploi a temps complet, 6 avaient
une capacite de travail limitee et
11 etaient sans emploi. Les com
plications non mortelles inclurent
une emploie generalisee chez 7 patients
et des hemorragies serieuses
chez 12 patients. C es resultats indiquent que les symptdmes et
I’etiologie sont d’importants facteurs
influencant la mortalite precoce.
L'etat preoperatoire de la fonction
ventriculaire gauche affecte la survie
tardive et devrait etre pris en
consideration dans le choix du temps
propice a une valvuloplastie.

Although a number of studies have
reported the overall experience with
prosthetic replacement of the mitral
valve,1'8 little data are available on
the long-term results in patients oper
ated on for isolated mitral regurgita
tion. A number of factors may in
fluence the early and long-term
outcome in these patients. These
factors include the type of presen
tation (acute or chronic), the cause
of the mitral disease, the coexistence
of coronary disease or pulmonary hy
pertension, preoperative left ventri
cular performance and symptomatic
status, and cardiopulmonary bypass
time. A clearer understanding of the
relative importance of these factors
could lead to the development of more
precise criteria for selecting patients
for operation, and perhaps an im
proved outlook for those with mitral
regurgitation. We therefore reviewed
our experience with mitral valve re
placement for isolated mitral regurgi
tation between 1964 and 1977 and
analysed the factors affecting oper
ative mortality, late mortality and
functional status of the survivors.
Patients and Methods

We reviewed the records of 89
consecutive patients (58 men, 31
women) who underwent mitral valve
replacement for isolated mitral regur
gitation at the Toronto General Hos
pital between Jan. 1, 1964 and Dec.
31, 1977. The indication for operation
in all patients was symptomatic de
terioration. Patients with aortic valve
disease or significant mitral stenosis
(end-diastolic gradient of less than 5
mm Hg across the mitral valve), or
both, were excluded from the study.
The mean age of the patients was
50 years (range 22 to 74 years). Nine
patients had acute mitral regurgitation,
defined as the sudden onset of mitral
regurgitation and congestive failure
with no past history of a mitral re
gurgitant murmur. Seventy-three pa
tients had chronic mitral regurgitation,
defined as the presence of a long-
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standing murmur of mitral regurgita
tion, and long-term symptoms of con
gestive heart failure. Seven patients
could not be classified (from the
medical records it was impossible to
tell whether the murmur was long
standing or of recent onset).
Preoperative left ventricular func
tion was graded independently by a
cardiovascular radiologist from con
trast angiograms obtained in 65 pa
tients. A grade 1 left ventricle was
one in which the angiogram showed
an ejection fraction of greater than
60%, in grade 2 the ejection fraction
was 45% to 60%, in grade 3 it was
30% to 45% and in grade 4 it was
less than 30%. The coronary anatomy
was assessed preoperatively by arterio
graphy in 64 patients. Thirty-one pa
tients had significant coronary artery
disease, defined as obstruction greater
than 50% in one or more of the left
main, left anterior descending, cir
cumflex or right coronary arteries. Of
these 31 patients, 11 underwent aorto
coronary bypass grafting at the time
the mitral valve was replaced.
The cause of the mitral regurgita
tion was assessed by inspection of the
valve at operation and pathologic ex
amination of tissue specimens obtained
at operation.
During this study, cardiopulmonary
bypass was performed with mild sys
temic hypothermia, and ischemic ar
rest of the heart was achieved by
cross-clamping the ascending aorta.
The prosthetic valves implanted in
cluded 72 Starr-Edwards, 13 BjorkShiley, 2 fascia lata, 1 Cutter and 1
Beall valve. Operative details, includ
ing duration of cardiopulmonary by
pass and autopsy data on the patients
who died perioperatively, were re
viewed.
Assessment of the 40 surviving pa
tients was by telephone interview using
experienced interviewers or by corre
spondence with the family physician.
Seven patients were lost to follow-up.
Follow-up data obtained on survivors

included subjective response to oper
ation by New York Heart Association
(NYHA) class, employment status,
medications taken, history of throm
boembolism, endocarditis or hem
orrhage.
Statistical Analysis

Actuarial curves were constructed
by the method of Mantel and Breslow, as described by Breslow,9 for
the group as a whole and for the
following subgroups: acute and
chronic onset of mitral regurgita
tion, ischemic and rheumatic or myxo
matous etiology, presence or absence
of coronary disease and concomitant
aortocoronary bypass grafting. The
mathematical formula used to calcul
ate the rate of survival for each year
took into account the number of
deaths, the number of survivors re
maining in the follow-up group and
the number of patients lost to follow
up. Factors affecting early mortality
were compared by analysis.

was of the rheumatic or myxomatous
type. There was no correlation be
tween early mortality and presence of
coronary artery disease, significant left
ventricular dysfunction, pulmonary
hypertension or NYHA class preoper
atively (Fig. 1). There was a signifi
cant correlation (P = 0.03) between
early death and a prolonged cardio
pulmonary bypass time (Fig. 2). Low
cardiac output syndrome was responsi
ble for nine perioperative deaths
(41%), while hemorrhage, neurologic
complications and sudden ventricular
fibrillation were the next most com
mon causes of death (Table II).
Of the 60 patients in whom the
outcome was known, 20 died late
(mean survival 31 months). Fig. 3
illustrates the actuarial survival of the

Results

The three main causes of isolated
mitral regurgitation were rheumatic
endocarditis (24 patients), myxomat
ous degeneration (18 patients) and
ischemia causing papillary muscle dys
function or rupture (14 patients)
(Table I).
Early mortality (death within 30
days of valve replacement) was 25%
(22 patients). From 1964 to 1973, the
early mortality was 31% (15 of 48
patients), and from 1974 to 1977, the
rate was 17% (7 of 41 patients). Fig.
1 illustrates the early mortality in
acute and chronic mitral regurgitation
and ischemic and rheumatic or myxo
matous types. Of the nine patients
who had acute mitral regurgitation,
six died early, all of ischemic causes.
Of the 73 patients with chronic mitral
regurgitation, 16 died early. Seven of
14 (50%) patients with ischemia died
early, compared with 8 of 39 (21%)
patients whose mitral regurgitation

FIG. 1— Factors affecting operative
mortality. Top: Comparison of early
mortality in acute and chronic presenta
tion of mitral regurgitation (MR) ( P <
0.01), and ischemic and rheumatic or
myxomatous types (P < 0.05). Bottom:
Comparison of early mortality, with or
without coronary artery disease (CAD)
including left main stem (L MAIN)
disease by preoperative function of left
ventricle (LV) (grades 1 to 4), preoper
ative mean pulmonary artery (PA) pres
sure (mm Hg) and preoperative New
York Heart Association (NYHA) class.
Differences were not significant.

T a b le 1— C a u s e o f Is o la te d M itra l R e g u r g ita tio n
No. of
p a tie n ts ( * )
(N = 8 9 )

Cause
R h e u m a tic e n d o c a r d itis (to r n c h o rd a e )
M y x o m a to u s d e g e n e r a tio n (to rn c h o rd a e )
Is c h e m ia ( p a p illa r y m u s c le r u p tu r e )
R u p tu r e d c h o rd a e o f u n k n o w n ca u s e
E n d o c a rd itis ( t o r n c h o rd a e )
C o n g e n ita l
Unknow n

24
18
14
6
5
2
20

P e rc e n ta g e

(2 )
(6 )
(1 0 )
(1 )

27
20
16
7
6
2
22

* N o . o f p a tie n ts in e a c h s u b g ro u p w ith to r n ch o rd a e o r p a p illa r y m u s c le r u p tu re .
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FIG. 2— Relation of cardiopulmonary
bypass time to early death.
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T a b le II

entire group, exclusive of early mortal
ity. There was a rapid decline in the
number of survivors in the first 6
years followed by a plateau there
after. The decrease in patient num
bers without a decline in survival in
this plateau period represents patients
lost to follow-up, but alive at last
contact. Figures 4 to 6 present
actuarial survival curves for sub
groups based on preoperative left
ventricular function, time of operation
and cause of mitral regurgitation, re
spectively. Survival was significantly
influenced by preoperative left ventri
cular function (grade 1 or 2 vs grade

C a u s e s o f E a r ly D e a t h

N o. of
p a t ie n t s
C ause

(n =

Low o u tpu t syn d ro m e
H e m o rrh a g e
N e u r o lo g ic
c o m p l ic a t io n s
S u d d e n v e n tr ic u la r
f i b r il la t io n
In f e c t io u s
e n d o c a r d it is
R e s p ir a t o r y fa ilu re
M e s e n t e r ic e m b o lu s
Unknow n

22)

P e rce n ta ge

9
3

41
13

2

9

2

9

1
1
1
3

5
5
5
13

1.00 - r

-i4
3
• ---------. 3

.8 0 -

c

.2
oa

.60
I ______f ______ 6 ______ 5 ______ 4 ______1 ______ 1______ 1 ______ 1 ______ j

o

40-

E
d 20

I

20

40

I

T~

—I—

60

80

100

120

I

140

180

160

Time in months after isolated m itral valve replacement

FIG . 3— A ctuarial survival of patients alive 30 days following operation fo r
m itral valve regurgitation.

1.00-|J-

oe> 8 0 >
>
k-

D
.6 0 o
a.
o
»-

a

.4 0 -

3E
o .2 0 -

»— »

LV g ra d e 1

23 p a tie n ts e n te re d

-----

LV g ra d e 2

11 p a tie n ts e n te re d

■— •

LV g ra d e 3

8 p a tie n ts e n te re d

LV grade 4

in s u ffic ie n t n u m b e rs fo r a ctu a ria l

15

30

~T~
660
0

45

a n a lysis

T
75

90

105

120

Tim e in m o n th s a fte r is o la te d m itra l valve rep la ce m e n t

FIG . 4

Actuarial survival related to preoperative perform ance o f left ventricle.

VOLUME 23, NO. 2, M A R C H 1980

/

3, P < 0.05), but not by the era of
operation or ischemic as opposed to
rheumatic or myxomatous etiology.
Similarly there were no differences
in survival curves, excluding operative
mortality, for acute as opposed to
chronic onset, presence or absence of
coronary disease, or concomitant
aortocoronary grafting in patients with
coronary disease.
In the 40 surviving patients who
were contacted, the mean follow-up
was 54 months (range of 7 to 131
months). Of the survivors, 28 (70%)
had improvement of function by one
or more NYHA classes, 8 (20%)
were unchanged and in 4 (10%) func
tion had deteriorated (Fig. 7).
There was no correlation between
preoperative left ventricular perfor
mance, presence or absence of coro
nary artery disease, or pulmonary
hypertension and the NYHA class at
the time of follow-up. Twenty-three
of 40 patients were employed full
time and 6 had limited work capabili
ty (Table III). The surviving patients’
symptoms are listed in Table IV . Most
patients required digoxin postoperatively and many required diuretics. All
patients were taking warfarin (Table
V).
Nonfatal complications in the 40
survivors included the presence of
systemic emboli in 7 (one per 25.7 pa
tient-years of follow-up) and impor
tant hemorrhage in 12. None of the
surviving patients suffered episodes of
endocarditis.
D iscussion

Although valve replacement for
isolated mitral regurgitation is a com
mon clinical procedure, little infor
mation is available on the immediate
and long-term mortality and morbidi
ty in this group of patients. Barnhorst
and associates1 reported results fol
lowing isolated mitral replacement for
all types of mitral disease in 657 pa
tients. The operative mortality was
14% and the late mortality 25% over
an 11-year period. Starr2 reported an
11% operative mortality and a 13%
late mortality for all types of mitral
valve disease from 1960 to 1970.
Other studies of this era have re
ported an early mortality of up to
17%.3 Starr, Herr and Wood5 clearly
demonstrated that the operative
mortality for isolated mitral valve re
placement has diminished as experi
ence with this condition has increased.
However, no analysis of functional
status was reported in these studies.
Munoz and colleagues4 did review the
functional status of 45 patients over
a 5-year period after mitral valve
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replacement for all types of mitral
valve disease. They showed that im
provement in NYHA class persisted
over this period, although no follow
up was available beyond 5 years.
In our study, the causes of isolated
mitral regurgitation were similar to
two previously reported studies.10,11
Rheumatic, myxomatous and ischemic
disease accounted for over 80% of
the identified causes (Table I). Al
though the overall early mortality was
25% , it decreased from 31% in the
years 1964 to 1973 to 17% in the
1974 to 1977 period. The causes of
perioperative death were similar to
those reported by Litwak and col

leagues;8 decreased cardiac output and
shock were the most common causes
of early death in this group. New
operative techniques for myocardial
preservation, introduced since 1977,
are expected to reduce early mortali
ty further. A number of other factors
also influenced early mortality. Pa
tients with acute mitral regurgitation
had a much higher mortality than
those with chronic regurgitation
(67% versus 22%). The etiology of
the mitral disease was equally impor
tant. Patients with mitral regurgitation
caused by ischemia had a much
higher mortality (50%) than those
with the other types (21%) (Fig. 1).
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The duration of cardiopulmonary by
pass was also identified as an im
portant factor influencing early mor
tality (Fig. 2). In contrast to the find
ings of Litwak and associates,8 we
did not identify preoperative left ven
tricular performance or mean pulmo
nary artery pressure as factors in
fluencing early mortality. Litwak’s
study, however, included both mitral
stenosis and regurgitation. It is in
teresting that neither the presence of
coronary artery disease nor the pre
operative NYHA class significantly
influenced operative mortality.
The annual attrition rate was ap
proximately 7% over the first 6 post
operative years (Fig. 3). Beyond 6
years, the survival curve was flat,
probably because of the small number
of patients surviving. In contrast to
early mortality, preoperative left ven
tricular function significantly (P <
0.05) affected late survival (Fig. 4).
The average annual attrition rate was
16% for patients with moderately im
paired ventricular function over the
first 4 years after operation but
averaged only 5% for patients with
normal or mildly impaired ventricular
function. This finding suggests that
mitral valve replacement for isolated
mitral regurgitation should be per
formed before the onset of serious
left ventricular dysfunction. The era
of surgery (before as opposed to
after 1973) (Fig. 5) and the cause
of the mitral regurgitation (Fig. 6)

180

160

Time in months after isolated mitral valve replacement

Table III—Employment Status of Survivors

FIG. 5— Actuarial survival related to era of surgery.
Status
Full employment
Housework
Part time
Limited housework
Medically
unemployable

144

No. of
patients
(n = 40)

Percentage

15
8
1
5

38
20
2
12

11

28

FIG. 6— Actuarial survival related to cause of mitral regurgitation.

FIG. 7— Comparison of preoperative
and postoperative NYHA functonal class
class in 40 long-term survivors.
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Table IV — Symptoms in Surviving Patients (n = 40)
No. of patients with
lim iting symptoms

Symptom
Chest pain
Fatigue
Shortness of breath
Paroxysmal nocturnal dyspnea
Palpitations
Lightheadedness
Swelling of ankles

3
19
1
0
1
0
0

Table V— Medicinal Agents Used
by Survivors (n = 40)

Agent
Digoxin
Diuretics
W arfarin
N itrates
Anti platelets
Antihypertensives
Propranolol
Antiarrhythm ics

No. of
patients

Percentage

33
26
40
1
1
0
4
3

82
65
100
3
3
0
10
8

did not appear to influence long-term
survival, which was also not in
fluenced by the presence of coronary
artery disease or concomitant aorto
coronary bypass grafting. Of particular
importance is the fact that although
acute onset of mitral regurgitation is
an important predictor of early mor
tality, it did not influence long-term
survival by actuarial analysis. Hence,
if these patients survive their opera
tion, they have the same life ex
pectation as other patients with mitral
replacement.
The majority of survivors (68%)
enjoyed an improved functional
status after operation (Fig. 7); in
fact, 57% were fully employed
(Table III). Of the postoperative
symptoms (Table IV), dyspnea was the

No. of patients w ith
non-lim iting symptoms
20
9
3
3
17
13
2

commonest limiting symptom, al
though chest pain, palpitations and
lightheadedness were also quite fre
quent. Also, most patients continued
to take at least two or three medica
tions (Table V). Systemic embolism
and hemorrhage secondary to antico
agulation in our survivors occurred
with a frequency similar to those in
previously reported studies.12,13
This study demonstrates several im 
portant features of valve replacement
for isolated mitral regurgitation. In
patients with acute onset, regurgita
tion of ischemic etiology or a long
cardiopulmonary bypass time, early
mortality was high. The only feature
that significantly influenced long
term survival was preoperative left
ventricular function. The majority of
survivors had a useful functional
status and over half were fully em
ployed.
We thank Jeri Azuma and Susan
Smarden for their assistance in inter
viewing patients, and Julie McCoy for
help in preparing the manuscript.
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S E S A P II Q u e s tio n
1. If adequate iron stores are maintained, what is the maximum num ber of units of blood a patient can
donate safely during the two weeks prior to an elective surgical procedure during which autotransfusion is
planned ?
(A) One
(B) Two
(C) Three
(D) Four
(E) Five
For the question above select the answer that is best of the five given.
For the critique of Item 1 see page 162 of this issue.
(Reproduced by permission from SESAP 11 Syllabus: Surgical Education and Self-assessment Program N o. 2.
For enrolment in the Surgical and Self-assessment Program No. 3, please apply to the American College of
Surgeons, 55 East Erie St., Chicago, IL 60611).
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Perfusion in Cardioplegia: an Experimental Study
A. A ddetia ,

m b , ch b , frcs [c ]* and

A new myocardial support system has
been developed and a study of this
system is reported.
Cardioplegia was induced by
continuous infusion of potent “ cardioplegic” agents (potassium chloride
and potassium chloride with
propranolol) at the aortic root in
12 dogs subjected to cardiopulmonary
bypass with total body hypothermia
(20°C ). A low-flow normal-pressure
perfusion was maintained with the
aid of a norepinephrine drip.
During the period of hypothermia
the blood pH was maintained at 7.6
and serum magnesium concentration
was increased to an average of
2.1 m m o l/l by parenteral infusion of
magnesium sulfate. At no time was
ischemia induced and the aorta was
not cross-clamped.
The functional recovery to normal
and preservation of the ultrastructure
of the subendocardium after 4 hours
of perfusion in cardioplegia were
remarkable. The control hearts from
hypothermic dogs that were allowed to
fibrillate spontaneously showed
severe damage.
Un nouveau systeme de soutien
myocardique a ete mis au point
et une etude de ce systeme fait
I'objet de cette publication.
La cardioplegie a ete induite
par la perfusion continue de puissants
agents “cardioplegiques” (le chlorure de potassium et le chlorure de
potassium associe au propranolol)
dans la racine de I’aorte chez
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J.C. C allaghan ,

12 chiens soumis a une circulation
extracorporelle avec hypothermie
corporelle totale (20°C ). Une per
fusion a debit lent et a pression
normale fut maintenue avec I'aide
d’un goutte-a-goutte de norepinephrine.
Durant la periode d'hypothermie,
le pH sanguin fut maintenu a 7.6
et la concentration serique de
magnesium fut augmentee a une
moyenne de 2.1 m m ol/l par perfusion
parenterale de sulfate de magnesium.
En aucun temps une ischemie ne
fut provoquee et I'aorte ne fut pas
clampee.
Le retour des fonctions a la
normale et la conservation de I’uitrastructure du sous-endocarde
apres 4 heures de perfusion en
cardioplegie fut remarquable. Les
coeurs de chiens hypothermiques
temoins que Ton laissa fibriller
spontanement revelerent des alte
rations graves.

b sc , ms , facs ,

FRCs[c]f

M aterial and M ethods

Twelve mongrel dogs weighing be
tween 17 and 30 kg were each an
esthetized with 30 mg/kg sodium
pentobarbital. An endotracheal tube
was inserted and the animal was
maintained on positive-pressure ven
tilation using a Bird Mark 8 ventilator
(Bird Corp., Palm Springs, Calif.)
with compressed air. An arterial pres
sure line was inserted through the
left femoral artery. An esophageal
temperature probe (Yellow Springs
Instrument Co., Yellow' Springs,
Ohio) was positioned.
The chest was entered through a
midline sternotomy. Each animal was
given heparin (3 mg/kg). An arterial
perfusion cannula was introduced into
the root of the aorta and connected
to the appropriate line from the
pump. A large venous catheter was
inserted in the right atrium to drain
the systemic and coronary sinus blood.
Cardiopulmonary
bypass was begun.
It is customary for surgeons to pro
tect the ischemic myocardium at the A small cannula was placed in
time of cardiac surgery. Recent studies the aorta, proximal to the main per
have indicated that such measures fusion cannula, for infusion of the
serve mainly to retard, rather than to “cardioplegie solution”. A left ven
halt, the deleterious effect of ische tricular vent was inserted through an
mia.1,2 The magnitude of the ischemic apical stab wound, and a ventricular
insult3 is such that it still places a pressure line was inserted into the
time limit on the safety of the pre vent line. A needle thermistor (Yellow
paration and this fact has prompted Springs Instrument Co.) was used
some to use intermittent perfusion4 or intermittently to measure the intraoxygen-carrying infusates for cardio myocardial temperature and to ensure
plegia.5,6 More recently, one group1 its close correlation with the eso
has arrested the heart a second time phageal temperature.
The apparatus for cardiopulmonary
after its recovery from the initial
period of hypothermic arrest. This bypass included a Sarns roller pump
was done with potassium-carrying (Sarns Inc., Ann Arbor, Mich.) and
oxygenated blood in an attempt to a Harvey bubble oxygenator (William
Harvey Division of C.R. Bard, Inc.,
restore the energy balance.
In the experimental preparation Santa Ana, Calif.). The system was
presented here we have avoided primed with 500 to 700 ml Ringer’s
ischemia. The heart was arrested at lactate with 500 ml Rheomacrodex®.
the time of total body hypothermic All dogs received 500 mg hydrocor
perfusion without aortic cross-clamp tisone intravenously. Experimental
ing. The supply of bioenergy was groups were established as follows:
thereby maintained at the time of group 1, three dogs that underwent
great reduction in demand. We hypo normothermic bypass for an average
thesized that true myocardial support of 5 Vi hours; group 2, three dogs
might be possible in a preparation in subjected to hypothermia at 20°C for
which the demand was reduced but 4 hours; group 3a, three dogs sub
the supply remained adequate. The jected to hypothermia at 20°C and
early results of our study lend support cardioplegia using potassium chloride
(2 mmol/ml solution) for 4 hours;
to this hypothesis.
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and group 3b, three dogs subjected to
hypothermia at 20°C and cardio
plegia using potassium chloride with
propranolol (1 mg of propranolol in
50 ml potassium chloride (2 mmol/ml
solution) for 4 hours.
The animals in groups 1 and 3
received an infusion of 5 g of mag
nesium sulfate diluted in 250 ml of
5% dextrose in water. Flows at
normothermia were maintained be
tween 65 and 100 ml/kg •min with a
mean blood pressure of 70 mm Hg.
Hypothermia was induced slowly
by reducing the perfusate temper
ature to 16°C and then maintaining
the esophageal temperature at 20°C
for the allotted time. Parallel reduc
tion of flow was carried out to 33%
to 50% of normal. A mean pressure
of 70 mm Hg was maintained during
hypothermia in animals in group 3
by a norepinephrine drip (4 ml of 1%
solution in 250 ml of 5% dextrose
in water). The blood pH at the time
of hypothermia was maintained at
7.6 using sodium bicarbonate infusion.
In the event of ventricular fibrillation
or cardioplegia, the left ventricular
vent was opened to drain at zero
pressure.
Cardioplegia was induced by the
continuous infusion of the “cardioplegic” agent through the catheter at
the aortic root. An initial bolus of 5
to 10 ml of the solution was given
for quick arrest at 20°C followed by
a continuous infusion maintained by
a syringe mounted on a continuous
infusion pump (Razel pump; Scientific
Instruments, Inc., Stamford, Conn.).
The pump speed was adjusted to

obtain sustained arrest at the lowest
rate of infusion. Flaccid arrest was
confirmed by observation and pal
pation.
Rewarming following hypothermia
was carried out by 10°C increments
of perfusate temperature. In group 3
animals the infusion of the cardioplegic agent was stopped when re
warming was begun. This group re
ceived an additional infusion con
taining 5 g of magnesium sulfate.
The animals in group 1 were
weaned from bypass and a biopsy
of the myocardium was obtained
30 minutes later. The animals in
groups 2 and 3 were weaned when
the ventricular performance appeared
adequate on rewarming. In the event
of unsatisfactory cardiac action,
several attempts at weaning were
made at normothermia and using
inotropic support. In all cases, the
experiments were terminated 30 min
utes from the time of the first attempt
at weaning.
The electrocardiogram and the
pressures were displayed and intermit
tently recorded using a physiological
recorder (Electronics for Medicine,
White Plains, NY). Statham strain
gauges (Statham Instruments, Oxnard,
Calif.) were used for the pressure
signal. Blood samples were obtained
and analysed for blood gas tension
and hematocrit, and for hemoglobin,
serum electrolyte and serum mag
nesium concentrations.
At the end of the experiment a
biopsy of the left ventricle measuring
1 x 5 X 5 mm was rapidly obtained
from the area of the subendocardial

FIG . 1— U ltrastructure o f normal dog subendocardium (reduced by 34% from
original magnification X 40 000).
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muscle that appeared most altered.
The specimen was fixed in 4%
glutaraldehyde in cacodylate buffer
at pH 7.4 and stored at 4°C until
processed and examined by an ex
perienced electron microscopist. Fig. 1
shows normal subendocardium.
Results
G roup 1

The animals were weaned from
bypass easily. The electrocardiogram
remained normal. Dissection of the
heart at autopsy revealed minor
hemorrhage confined to the site of
the left ventricular vent. Electron
microscopy of the subendocardium
demonstrated moderate depletion of
glycogen in all specimens and sub
stantial edema in one (Fig. 2).
G roup 2

None of these animals could be
weaned from bypass despite ino
tropic support. During hypothermia,
ventricular fibrillation occurred spon
taneously in all three animals. On
rewarming and defibrillation, cardiac
arrhythmia was evident as multiple
premature ventricular contractions.
Autopsy examination of the heart re
vealed pale areas in the subendocar
dium, with minimal hemorrhage. In
two specimens the ultrastructural
change was limited to severe depletion
of glycogen. In one specimen, how
ever, severe ischemic-type damage
was seen (Fig. 3).

F IG . 2— E x ten t of subsarcolem m al
edem a (SSE) seen in group I dogs (re
duced by 28% from original m agnifica
tion X 25 000).
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Group 3a
One of the animals in this group
could not be weaned from bypass
because massive pulmonary edema
developed secondary to fluid overload
and hemodilution (hematocrit 13%).
Further attempts at weaning were
abandoned in this animal and the
biopsy was obtained after 30 minutes.
The other two dogs were weaned
easily. Tachyarrhythmia was evident
on rewarming. Autopsy revealed wide
spread ecchymotic hemorrhage of the
subendocardium. Ultrastructure was
well preserved in all hearts and gly
cogen depletion was moderate.

EKG —
★

PP

100T

----------WhWW(tV)Wiri()^

* 0 i
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Group 3b
All these animals were weaned
from bypass easily. The induction and
the reversal of cardioplegia were
better in this group than in group 3a
(Fig. 4). Transient changes in the T
wave seen on the electrocardiogram
improved with further rewarming. The
resulting sinus rhythm was very stable.
At autopsy minimal hemorrhage was
seen in the subendocardium. The
ultrastructure was completely pre
served; glycogen was moderately de
pleted (Figs. 5 and 6).
None of the group 3 hearts fibrillated during induction or reversal of
cardioplegia.
The average serum potassium value
after 2 hours of cardioplegia in group
3 was 9.5 mmol/1 and it dropped to
7.0 mmol/1 at the end of the experi
ment. The average baseline serum

FIG. 3—Example of severe damage in
group 2 dogs. Note disruption of mi
tochondria (MIT) (reduced by 30%
from original magnification X 12 000).
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FIG. 4—(a) Tracing obtained during cardioplegia showing flat electrocardio
graphic tracing (EKG), perfusion pressure (PP) at about 80 mm Hg and ventricular
pressure (V) at almost zero, (b) Tracing after recovery from 4 hours of cardioplegia.
This tracing resembled that obtained before cardioplegia was induced, AOP = aortic
pressure, * = pressures in mm Hg.

FIG. 5—Example of ultrastructural preservation seen in group 3 dogs. There
is no edema and mitochondria are normal (reduced by 36% from original magnifi
cation X 12 000).
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magnesium value was 0.9 mmol/1 and
this increased to 2.1 mmol/1 with the
infusion of magnesium sulfate. An
average total of 200 mmol of potas
sium chloride was infused in the
group 3 animals.
Discussion and Conclusions

Recognition of the serious compli
cations that may follow normothermic coronary perfusion and
normothermic ischemic arrest7,8 has
initiated intensive research into means
of protecting the myocardium during
cardiac surgery. It is well established
that one way to protect against
ischemia is to decrease cellular de
mands for energy.9 Research findings
have indicated that the perfusionrelated ischemic damage may be due
mainly to the abnormal elevation of
intramyocardial tissue tension causing

redistribution of regional blood flow
in the perfused, fibrillating heart.9'10
Measures for protection when used
in the ischemic heart apparently suc
ceed only in delaying the deleterious
change initiated by ischemia.1"2 If, on
the other hand, the supply of energy
could be maintained while the demand
was reduced, a theoretical possibility
exists of improving the energy balance
in the diseased myocardium. Thus, the
zone of borderline ischemia in acute
myocardial infarction might benefit
specifically from myocardial support.
The following prime objectives
were considered in our approach to
intraoperative support: (a) to mini
mize the damaging side effects of in
duced changes, (b) to improve the
energy balance in the diseased myo
cardium during the period of support
and (c) to provide adequate technical
conditions for operation.

Table 1— Objectives of Study
Primary objective
To minimize the damaging
side effects of induced
changes

Secondary objective
To avoid ischemia
To abolish intramyocardial
tissue tension gradient
To avoid ventricular
distension
To take empiric measures
to facilitate hypothermic
perfusion

To improve the energy
balance in the myocardial
cell

To maintain energy supply
To reduce energy demand

To provide adequate tech
nical conditions for su r
gery

To decrease amount of
blood in field
To provide a quiet field
To allow greater amount of
time for cardiac proce
dures

Fig. 6a

Methods employed
Continuous perfusion
Cardioplegia
Drain left ventricle
Maintain pH at 7.6, and se
rum M g2+ at about
2 mmol/1, low-flow nor
mal-pressure perfusion,
administer steroids
Continuous perfusion
Hypothermia
Cardioplegia
Low-flow perfusion
Cardioplegia
Avoid ischemia by conti
nuous perfusion

Fig. 6b

FIG 6.—(a) Detail of mitochondria from group 3 dog compared with (b) that of
normal animal (reduced by 40% from original magnification X40 000).
VOLUME 23, NO. 2, MARCH 1980
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The approach we adopted is sum
marized in Table I.
The outstanding features of the
preparation and the results obtained
from the study were as follows:
• The hearts of all dogs subjected
to cardioplegia had complete preser
vation of ultrastructure after 4 hours
of arrest. This suggests that perfusion,
as used in this study, is tolerated
without ill effect, presumably because
the tension gradient of the intra
myocardial tissue is abolished by ar
resting the heart. The complication of
edema reported in connection with
the perfused arrested heart5 was not
seen.
• We believe that the moderate
depletion of glycogen indicates con
tinuing metabolic exchange, not un
like that in normothermic animals,
rather than deficient supply due to
inadequate blood flow. This, perhaps,
represents general body depletion of
energy stores as a result of stress and
may not be confined to the myo
cardium.
• The mechanism and the impor
tance of the varying degree of sub
endocardial hemorrhage seen in all
groups were not clear.
• The possible complications from
the use of concentrated potassium
solution did not occur in this study
perhaps because dilution was ade
quate by the method used.
• The combination of propranolol
with potassium chloride, arrived at
during empirical trials, seemed to
facilitate both the induction and the
reversal of cardioplegia.
® Hibernators have a low cardiac
output and near-normal blood pres
sure at the time of hibernation.11
A pH of about 7.612 and a high serum
magnesium concentration13 are also
found in the hibernating animal. We
tried to create a similar internal en
vironment in this study to minimize
the side effects of prolonged hypo
thermia.
• In the dogs having cardioplegia,
ventricular fibrillation was avoided
completely during both induction and
reversal of cardioplegia. We think
that this was made possible by slow
induction of hypothermia, thus mini
mizing the development of differential
temperature gradients. It was our
impression that cardiac irritability
was also reduced by using magnesium.
The ability of the heart to support
the circulation after 4 hours of arrest
and the remarkable preservation of
the ultrastructure seen in six conse
cutive experimental animals indicate
that this type of preparation could be
developed into a system of myo-
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Journal Prescribing Information
cardial
support. However, some
points, specific to the situation must
be considered:
• The empirical features need
study to arrive at a safe means of
arresting the heart and conducting
hypothermic perfusion.
• The theoretical possibility of en
couraging the build-up of energy
stores, perhaps by some form of sub
strate enhancement and stimulus for
anabolism, should be explored.
• With regard to the pathogenesis
of subendocardial hemorrhage and
necrosis, further knowledge of the
behaviour of the cardiac microcirculation appears necessary. It is
important to find out if overper
fusion 14 or even abnormal shunting
of blood 15 takes place at the time of
artificial perfusion of the coronary
arteries.
• It is reasonable to suppose that
total body perfusion, with the arterial
cannula in the ascending aorta, is
analogous to the natural system. The
aortic input impedance16 to flow may
be similar, whether this flow is from
the heart itself or from an artificial
pump. Once the aorta is crossclamped at the time of selective
coronary perfusion, however, the in
put impedance may be quite dif
ferent. Furthermore, the inherent
ability o f the general vasculature to
allow redistribution of blood is no
longer present. It is well known that
the flow through the subendocardial
microcirculation is essentially di
astolic .9 To achieve this phasic and
dynamic beat-to-beat regulation of
flow, it seems important that the
compliance and facility for redistri
bution be in a state of dynamic
equilibrium with the coronary cir
culation. These factors and their re
lative importance in an artificial sys
tem should be evaluated before the
question o f selective perfusion of the
coronary arteries can be solved with
confidence, even when applied to the
arrested heart.
We express our special thanks to Dr.
T.K. Shnitka, professor, department of
pathology, University of Alberta Hos
pital, for his expert help with the study
of the ultrastructure. We also thank our
technical staff: J. Henricksen, A. Wells,
D. Johnson and B. Brown for their con
tinuing help.
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Point de vue des malades apres une chirurgie
a coeur ouvert
A ndree Bourgeois, M ichel Boulanger, R aymonde L avoie
et D enis D esaulniers, md, facs, frcs[c]
Vingt patients choisis au hasard ont ete
surveilles oralement et par question
naire avant et apres la chirurgie a
coeur ouvert. L'echantillonnage
comptait neuf professionnels ou
hommes d'affaires, deux employes de
bureau, quatre travailleurs manuels
et cinq personnes sans emploi. Les
actes chirurgicaux comprenaient huit
remplacements valvulaires, neuf
pontages aorto-coronariens et
trois corrections de cardiopathies
congenitales.
Les facteurs d’anxiete preoperatoires
etaient la crainte de la mort (55%
des cas), I’invalidite (15% ) et la
convalescence (10% ). Aucune anxiete
n'a ete avouee par 20% des patients.
La fam ille s'est revelee un facteur
negatif dans 31% des cas, surtout
chez I'epouse des professionnels.
Aux soins intensifs, 47% se sont
plaints du bruit et 26% des soins de
nuit. La douleur n'a ete signalee
que par 21% des patients.
Plus de 70% des malades ont affirme
apprecier le soutien d’une personneressource au cours de leur hospita
lisation et de leur convalescence.
Twenty patients, selected at random,
were followed up by means of
interviews and questionnaires before
and after open-heart surgery. Nine were
professional or business people,
two w ere office clerks, four were
manual labourers and five were
unemployed. The operative procedures
consisted of valve replacement in
eight patients, aortocoronary bypass
in nine and correction of congenital
cardiopathy in three.
Anxiety factors before the
operation centred around the fear
of death (55% ), invalidity

(15%) and convalescence (10%).
No anxiety was found in 20%. The
family proved to be a negative factor
in 31%, especially in wives of profes
sionals.
In the intensive care unit,
47% of patients complained of the
noise and 26% of the nursing during
the night shift; only 21% complained
of pain.
More than 70% of the patients
appreciated the support of the inter
viewer, and especially the continuity
of the follow-up throughout the
hospital and convalescence phases.

L’objectif de tout traitement medical
etant l'amelioration de la survie et de
la qualite de la vie, nous avons exa
mine, globalement, I’impact des principaux facteurs intervenant sur le
malade qui subi une chirurgie cardiaque: l’equipe medicale, la famille,
le travail et les loisirs.
Nous avons cherche a decouvrir
quels sont les besoins ressentis et
exprimes par le patient et sa famille
face a un evenement aussi important
dans leur vie.
Methodes

Vingt patients ont ete choisis au
hasard a partir de la liste operatoire,
le seul critere considere etant que le
patient devait avoir une chirurgie cardiaque sous circulation extra-corporelle.
Un questionnaire oral fut rempli
(a) lors de l’admission du patient,
(b) la veille de l’operation, (c) au
retour a l’unite de soins intensifs et
(d) lors du depart de l’hopital.
Comme il fallait retrouver un climat de confiance entre le patient et
la personne-ressource, apres divers
essais avec formulaires et magne
Du service de chirurgie, Institut de
tophone, il fut decide de completer
Cardiologic, Hopilal Laval, Quebec, PQ le questionnaire hors de la presence
Travail presente a la 32e rencontre
du malade, a la fin de chaque enannuelle de la Societe canadienne de
cardiologie le 19 octobre 1979, a Quebec trevue.
Un questionnaire ecrit fut envoye
Accepte pour publication le 15 janvier
un mois apres le retour a la maison.
1980

partit en 12 hommes et 8 femmes
dont la moyenne d’age etait de 49
ans (ecart de 18 a 68 ans). Neuf
etaient des professionnels ou hommes
d’affaires, deux des employes de bu
reau, quatre des travailleurs manuels
et cinq etaient sans emploi.
Les actes chirurgicaux compre
naient huit remplacements valvulai
res, neuf pontages aorto-cononariens
et trois corrections de cardiopathies
congenitales.
Les craintes exprimees par les pa
tients face a leur operation concernaient la mort (55%), I’invalidite
(15%), la convalescence (10%). Au
cune anxiete n’a ete manifestee dans
20% des cas.
La crainte de I’invalidite et de la
convalescence preoccupait surtout les
professionnels dont la securite economique etait le principal souci.
La famille, face a la chirurgie,
etait favorable dans 65% des cas
mais elle n’exprimait aucune reac
tion dans 5%. Lorsqu’interroges
seuls, plus de 30% des conjoints des
patients disaient ne pas accepter
l’operation. La majorite de ces reac
tions negatives provenaient d’epouses
de professionnels operes. L’epoux
etait plus positif face a l’operation
de sa conjointe que I’epouse face a
I’operation de son conjoint.
L’influence des patients deja ope
res sur le departement se revela parfois positive, parfois negative, mais
sans preponderance.
Soins intensifs

L’evaluation apres le sejour aux
soins intensifs revela que 15 patients
etaient satisfaits des soins re$us, que
4 patients n’avaient aucun commentaire, et qu’un seul etait insatisfait.
Certains facteurs negatifs furent cependant soulignes: 20% des malades
mentionnerent la douleur, 10% le
froid, 10% la lumiere, 15% les autres patients (particulierement les jeunes enfants), et 50% le bruit.
Le sejour de nuit aux soins inten
sifs a fait l’objet de commentaires
chez 26% des patients. Certains se
Patients et resultats
plaignirent du bruit, d’autres d’une
L’echantillonage des patients se re- certaine indifference du personnel.

Les demandes de tires a part doivent
etre adressees au: Dr Denis Desaulniers,
2725, cliemin Ste-Foy, Quebec, PQ
G1V 4G5
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A pres la sortie de I’hopital

apres la sortie de l’hopital. La famille
est mentionnee comme soutien chez
50% de ces patients. Aucun n’aurait
eprouve le besoin de nouveaux loi
sirs. Plusieurs patients se contentaient
de cocher les reponses, sans ajouter
de commentaires personnels comme
le premier groupe.

Au depart de l’hopital, le patient
recevait une feuille de route indi
quant la date de reprise de differentes
activites telles que la marche, les
voyages, les sports, la duree de la
convalescence et les problemes susceptibles d’etre rencontres durant la
convalescence. A ce moment, le pa
Discussion
tient etait averti qu’il recevait un
questionnaire ecrit au bout d’un mois.
Cette breve etude a permis de resApres la sortie, 35% des patients serrer les liens entre le malade, sa
telephonerent a la personne-ressource famille et l’equipe medicate, par le
concernant certaines apprehensions biais d’une personne-ressource. La
telles que la douleur, la constipation, presence d’une telle personne a favol’oedeme des membres inferieurs et rise la communication et la compre
hension mutuelle. Le contact avec le
divers autres problemes.
Nous avons obtenu 80% de re- groupe temoin, peut-etre plus imperponse au questionnaire envoye a do sonnel, s’est caracterise par la sechemicile. Les faits suivants ont ete resse et la reticence des reponses.
Les resultats nous ont fait decouobserves:
vrir
certains points faibles et nous
• Le protocole de la marche (i.e.,
ont permis de les ameliorer. Par
reprendre progressivement 15 jours
apres leur sortie des promenades a contre, certaines donnees, telle la
l’exterieur) etait suivi par 60% des crainte de la mort, sont des realites
que le cardiaque doit affronter. Meme
patients.
• Plus de 30% accusaient encore les meilleures statistiques, tel le ris
des douleurs thoraciques reliees a la que operatoire inferieur a 2% dans
le pontage aorto-coronarien, ne peusternotomie.
• Un des neuf patients avec pon vent predire qui mourra (2%) et qui
survivra (98%).
tage aorto-coronarien se plaignait de
La famille est une ressource bien
douleur d’apparence angineuse.
negligee par l’equipe medicale; le
Le besoin d’un soutien moral de soutien familial n’a ete retrouve que
la part de la famille a ete signale chez 50% du groupe temoin, compar 80% des patients; un seul pa parativement a 80% du groupe etu
tient n’avait pu 1’obtenir.
die et suivi par une personne-ressour
La chirurgie avait permis a quatre ce. La famille a exprime des com
personnes de se creer de nouveaux mentaires en reponse au questionnai
loisirs, alors que d’autres n’avaient re ecrit dans le groupe etudie, mais
meme pas repris les loisirs qu’ils jamais dans le groupe temoin.
pratiquaient avant l’operation.
Les soins intensifs de nuit sont une
La majorite des patients connais- realite tres complexe, a la fois pour
saient le nom et Taction de tous le patient, qui doit etre surveille de
leurs medicaments, et revoyaient re- pres et pouvoir se reposer, et pour
le personnel, qui doit assurer cette
gulierement leur medecin referant.
Le retour au travail etait attendu surveillance intensive au cours d’une
avec hate chez 40% des patients, periode normalement de repos pour
avec apprehension chez 30% des pa les deux parties. Les modifications
tients, alors que 30% ne desiraient psycho-physiologiques des patients
traites dans de telles unites sont bien
pas retourner au travail.
connues,3
mais celles du personnel
Ces resultats corroborent (prospeccommencent
a etre etudiees.3 Une
tivement) une etude faite en 1975
solution
adequate
pour les deux par
sur 100 patients ayant eu un pontage
aorto-coronarien, oii environ 70% des ties demeurera toujours un comprosujets ont repris leur travail un an mis.
Le retour au travail semble deter
apres l’operation.1
mine avant l’intervention, comme le
Les impressions personnelles des temoigne le groupe etudie et la revue
patients face a leur operation variaient
de 100 patients un an apres pontage
du grave incident de parcours et du aorto-coronarien. Le conditionnement
cauchemar au bonheur de se sentir physique n’est pas le seul facteur;4
ameliore dans la majorite des cas.
une therapie de groupe peut ame
Douze patients, non suivis par une liorer les resultats.5
personne-ressource, mais operes au
En conclusion, aucun facteur d’incours de la meme periode, regurent fluence ne doit etre neglige pour fale meme questionnaire ecrit un mois voriser la reintegration du cardiaque
VOLUME 23, NO. 2, MARCH 1980
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dans la societe, apres une operation.
L’equipe medicale, la famille et la
societe (travail, loisirs) doivent joindre leurs ressources et favonser la
recuperation fonctionnelle la plus
normale possible du patient apres
une intervention chirurgicale cardia
que.
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“MEDICAL DIRECTOR”
EMERGENCY
A full-time Medical Director is re
quired for the Emergency and Ambu
latory Department of a 323-bed acute
treatment general hospital. The De
partment deals with approximately
65,000 cases a year and is the 24 hour
emergency centre for the Region.
There are presently 4 full-time and 17
part-time medical positions in the
Department, with back-up support of
specialists in all available specialties
and diagnostic modalities.
The successful candidate will be a
physician eligible for licensure in
Ontario with experience in Emergen
cy Medicine.
It would be considered an asset for
the applicant to have had previous
administrative and teaching experi
ence including formal training in
Emergency Medicine, as the Director
will assume management responsibil
ity for all medical matters pertaining
to emergency services and will pro
vide training to associated medical
nursing and paramedical staffs.
Please forward applications and
enquiries in confidence to:

Chief of Staff
SU D BU RY GENERAL HOSPITAL
700 Paris Street
Sudbury, Ontario P3E 3B5
Tel.: (705) 674-3181 - Ext. 170
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Specialization: What It Holds for the Future
of Medicine
O. Swenson ,

Specialization in medicine developed
in response to the ever-increasing
volume and complexity of scientific
knowledge. While diverse factors may
have contributed to improved health of
people in the United States, the medical
profession undoubtedly played an
important role. Despite this achievement
our profession is held in low esteem
probably because of the high cost of
medical care and unsubstantiated
charges in the United States that some
surgery is performed unnecessarily.
In contemplating the future we must
guard against the establishment of
unrealistic small areas of specialization.
Specialty groups must refrain from
making exclusive claims in the
treatment of disease entities or
anatomical regions. Such claims indicate
self-aggrandizement and lead to
acrimonious, destructive disputes
within the profession.

La specialisation medicale s'est
developpee en response a la somme
toujours grandissante et a la
complexity des connaissances scientifiques. Bien que divers facteurs
aient pu contribuer a une amelioration
remarquable de I'etat de sante
general de la population des Etats
Unis, la profession medicale y a,
sans aucun doute, joue un role
important. Malgre cette realisation,
notre profession est tenue en faible
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estime probablement a cause du
cout eleve des soins medicaux
et des accusations non fondees
portees aux Etats-Unis a I'effet que
certaines interventions chirurgicales
sont pratiquees inutilement.
En regardant vers I'avenir, nous
devons nous garder d'etablir des
champs exagerement restreints
de specialisation. Les speciaiistes
doivent s’abstenir de pretendre
a une exclusivity dans le traitement
de certaines maladies ou des
regions anatomiques. De telles alle
gations sont signes de suffisance
et engendrent des disputes acrimonieuses et destructrices au sein
de la profession.

Specialization and its kindred notion
of division of labour developed inde
pendently of medicine. Adam Smith
espoused this idea in his writings on
political economy. Darwin repeatedly
referred to the concept in his disserta
tions on biology and Emile Durkheim
saw the need for it in his writings on
sociology. Undoubtedly these develop
ments outside medicine have influenced
specialization in our profession.
From the height of the Middle Ages
down through the 18th century three
corporate groups provided medical
services: physicians, surgeons and apo
thecaries. Physicians, fewer in number,
were the architects of medicine, deleg
ating tasks to the more numerous sur
geons and apothecaries. There were
considerable differences in the educa
tional, social and legal status of these
groups. Surgeons and apothecaries were
members of craft and trade guilds and
physicians were members of the liberal
university professional group. This
model applied more closely to condi
tions in Western Europe than elsewhere.
In England, apothecaries won the
legal right to engage in general med
ical practice in 1703. However, they
remained subservient as a group to the
Royal College of Physicians.
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There were public discussions in the
15th century regarding the value of
specialization in medicine. The topic
of one debate held in Paris in 1638
was whether good or evil had arisen
from the division of the parts of med
icine among physicians, surgeons and
apothecaries. One interesting argument
set forth was that a single individual,
unlike three individuals, could not shirk
complete responsibility for the patient s
care— an argument still repeated today.
A clearer idea of early thoughts on
specialization in the United States can
be gained from John Morgan’s dis
course on the institution of medical
schools in America published in 1765.1
In his discourse he advocated a common
knowledge base for physicians and sur
geons and a further separation from
pharmacy. In his practice he adhered
to these principles and is known to
have referred to surgeons patients in
need of operation. There were other
indications of the rise in status of the
surgeon as he severed his ties with the
London Barbers’ Guild in 1745, while
the legal entity of barber-surgeon passed
into extinction in Paris in 1743.
It was not until the beginning of
this century that specialization bur
geoned and this growth coincided with
the organization of boards granting
certificates of proficiency to candidates
upon successful completion of exhaus
tive examinations. Boards were devel
oped to protect the patient by providing
to the public certification that approved
individuals were adequately trained and
experienced in a designated area of
medical or surgical problems, a deter
mination that the layman was unable
to make. This objective is sound and
should be appreciated by the layman.
It is to be expected that such groups
of specially trained physicians are at
times tempted to claim exclusive rights
to treat a certain disease or diseases in
a specific anatomic area. We must
never yield to this temptation for it
gives the appearance of being selfserving and will be so judged by the
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public. Furthermore, it has in the past
and can in the future lead to acrimo
nious disputes which are damaging to
the whole of medicine.
In 1917 the American Board of Oph
thalmology was formed, followed by
otolaryngology in 1924.2 Since then 18
additional boards have been formed.
More recently subspecialties have been
recognized by the granting of special
certificates of proficiency by the es
tablished boards and 28 of these have
been formed. Thus, the past 60 years
have witnessed a phenomenal growth
of specialization. When one considers
the remarkable acceleration in the ac
cumulation of medical knowledge that
has taken place in the same span of
time the development of specialization
is not surprising. A graphic apprecia
tion of the amount of knowledge that
has accumulated can be gained by com
paring the size of the cumulative “Index
Medicus” of 1950 with the current is
sue; one month’s listing of papers in
1978 is larger than the annual publi
cation of 1950.
The crucial question is whether this
has been a desirable development. It
seems reasonable to review what has
happened to the health of the general
public during this time, in order to
answer this question objectively.
Citizens of the US are healthier today
and live longer than in any other
period since statistics were recorded.
The death rate is the lowest on record
and, when adjusted for an aging popula
tion, is roughly 40% below that of
1940. An American baby born in 1976
can expect to live 72.8 years, a gain
of nearly 10 years since 1940.
Infant mortality has progressively de
creased so that of 1000 live births there
are fewer than 15 deaths. More than
30 000 babies lived in 1976 who would
have died in 1965. In addition the qual
ity of life that cannot at present be
measured statistically has improved
dramatically. Age-adjusted cardiovas
cular mortality has declined 32% over
the past 30 years.
There is no reasonable objection to
the assumption that the medical profes
sion has been the predominant factor
in this improvement. During this period
of health improvement there was a
simultaneous increase in specialization
in the US. It is hard to deny that this
change in medical practice was a con
tributing factor and that specialization
has proven to be an asset in health
care. Despite the fact that Americans
enjoy the best health in the history of
our country, our profession has received
mounting criticism from the govern
ment and the news media. One wag
has predicted that the public will not
VOLUME 23, NO. 2, MARCH 1980
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be satisfied with the medical profes
sion until it is guaranteed indefinite
sexual vigour and immortality at no
cost!
The phenomenal increase in medical
care cost has contributed substantially
to these unprecedented criticisms.
Charges of unreasonable costs, poor
distribution of services and unnecessary
surgery are prevalent. The American
surgical profession has responded to
these claims in a positive manner by
preparing an exhaustive and objective
study of surgical services in the US.3
This had its inception in the American
Surgical Association in 1969 when Dr.
Owen Wangensteen established a com
mittee, chaired by Dr. Jonathan Rhoads,
to study the future course of that
organization. This led to the appoint
ment of Dr. George Zuidema to a
special committee to consider surgery
in the US. Simultaneously the Board
of Regents of the American College of
Surgeons appointed a committee under
the chairmanship of Dr. Francis Moore
to study the distribution and adequacy
of surgical care. It was quickly
appreciated that these would be du
plicate efforts and the two organiza
tions joined to form a single study
group which has published its findings.3
This is an objective study and anyone
interested in the adequacy of surgical
services in the US and changes needed
for the best surgical care in our coun
try in the future should consult this
detailed report.
The question of cost has motivated
comparison of surgical services of the
US and England. On cursory examina
tion the US appears oversupplied with
surgeons. In England 11 % of the med
ical force is devoted to surgery com
pared with 25% for the United States.
It must be explained that the 25% in
cludes as a surgeon any physician who
performs an operation. Thus general
practitioners who perform as few as
one or two operations a year are listed
as surgeons and are included in the
25%. A fairer comparison is the per
centage of board certified surgeons in
the US. This figure is 18% which is
more in line with the percentage in
England. In most countries between
10% and 16% of the medical pro
fession are surgeons. The notable ex
ception in Japan where the figure is
21 %.

To evaluate the comparison with the
English profession it is important to
realize that the referral systems of the
two countries are basically different.
Referrals to British surgeons are from
other physicians, while in the US two
or three out of five patients seen by
the average surgeon are direct lay re

ferrals. Consequently the American
surgeon must function as a primary
care physician in that the nonphysician
referrals have to be carefully studied
to establish a diagnosis and many will
prove to have no disease or a minor
medical problem not worthy of referral
which is treated by the surgeon or, in
more serious matters, referred to
another, more qualified physician. All
of this consumes a considerable portion
of the American surgeon’s time.
Some data indicate that operations
are more frequently performed in the
US than in England. The assumption
that unnecessary operations are com
mon in our country is not based on
factual evidence. There are some dif
ferences in ideas concerning preven
tion of disease and modes of treatment
in the two countries. More important
there are honest differences of opinion
concerning the need for operation in
some conditions, and there is a differ
ence in the availability of surgical care.
In a sense there is a rationing of sur
gical services for elective operations in
England because the central govern
ment controls the availability of sur
gical treatment by limiting the number
of surgeons, which seems to work well
in that country. In contrast our free
system provides enough surgeons— per
haps too many. Nevertheless, our
government has flatly charged that too
many unnecessary operations are per
formed in the US and claims their
elimination could save huge sums of
money and many lives.
To learn how these figures are ar
rived at is enlightening. Lance and
Haug4 have reported the basis for the
government’s allegation of unnecessary
surgery. In 1974 McCarthy and Widmer5 reported on the effect of second
opinions before elective operations were
undertaken. In the mandatory program
the second opinion failed to confirm
the need for operation in 17% and
this was partially the basis for the
charge of unnecessary surgery. Mc
Carthy6 subsequently reported the
reasons for nonconfirmation: in one
third there was no evidence of a path
ologic condition, in one third medical
treatment was superior or had not been
in effect for long enough and in 10%
further diagnostic tests were recom
mended.6 Later a substantial number
did undergo operation. Thus, it is clear
that the charge of unnecessary surgery
was not based on rational grounds.
Furthermore, the program of second
opinion assumed that the second
opinion was superior to the first. The
government funded two state programs
of second opinion to evaluate such a
procedure and this was proper. Inno-
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vative ideas are desirable; however, in
our complex society some well intentioned concepts prove in practice to
have the most unexpected, undesirable
side effects. So a trial in a small but
suitable area is mandatory before na
tional application. However, before
these two trial projects were under
way the US Department of Health and
Welfare decided to launch the program
nationally. At a meeting of the Institute
of Medicine in 1977 the Undersecretary
for Health and Welfare, Hale Cham
pion, said that despite the absence of
data there was need to think and act
more positively and decisively. This
appears to have been a political deci
sion. Action of this sort accounts for
the medical profession’s lack of con
fidence in the government’s ability to
improve medical care.
To consider the question of unneces
sary operations some firm definitions
are essential. There are degrees of ne
cessity. When pathologic tissue is
removed no further discussion of pro
priety is generally needed. When per
sonal or social needs are involved judge
ment becomes more difficult. Urinary
incontinence and intestinal fistula are
two conditions that fall into this cate
gory. Indications for some operations
such as tonsillectomy and duodenal
ulcer operations are a matter of judge
ment. Operations to alleviate endurable
or tolerable symptoms such as mildly
symptomatic gallstones and mild claudi
cation involve the patient in the deci
sion-making. All operations are not
viewed with the same degree of ne
cessity by all physicians or surgeons
and thus there are honest differences
of opinion. The Board of Regents of the
American College of Surgeons has re
peatedly spoken in favour of consulta
tion. However, the way these second
opinion programs have been promoted
is objectionable. The statement that
there is a large amount of unnecessary
surgery performed in the US is a
frightening accusation to make to the
public and likely has swayed individ
uals away from beneficial surgery. It
is not based on factual evidence.
Whether unnecessary surgery exists
and if it does to what degree depends
on the viewpoint you accept. For in
stance, my indications for tonsillectomy
are few and stringent. Yet colleagues
in my hospital have varying views; a
number have far more liberal indica
tions. Both points of view can be de
fended by a number of studies. What
is needed are more prospective well
arranged long-term studies to gather
data that would delineate the indica
tions more precisely. Such studies are
expensive to conduct and the govern

ment through the Department of Health
and Welfare has not viewed such
studies with favour. If the government
is as anxious as our profession is to
eliminate any operation that does not
have a substantial gain over risk factor,
it should change its research policies
and fund such programs more readily
than it has in the past.
A more substantial criticism of our
specialization trend has been that we
have too few primary care physicians.
There has been a decline in numbers of
medical graduates entering general
practice because of the popularity of
specialization. In 1931 there were
112 000 general practitioners in the
US, 80% of all physicians. In 1972
there were 55 000, less than 20%. It
must be remembered that there were
68 000 internists, pediatricians and
gynecologists, all of whom supplied a
considerable amount of primary care.
Clawson,7 in a study of primary care
availability in Washington State, Alas
ka, Montana and Idaho found no real
lack of primary care due to the in
volvement of internists, pediatricians
and gynecologists. A smaller study in
King County, New York by Petersdorf8
yielded similar data. It is argued that
the specialist is not prepared by train
ing or interest to give primary care
and this has convinced most students
of this problem to urge that 50% of
our medical population be devoted to
primary care. Numerous new pro
grams in medical schools to train
family practitioners have been in
augurated. The establishment of a
board for family practice has proven
successful in recruiting more graduates
into primary care.
There is concern that there will be
an increasing demand for more sub
specialty recognition and that there
will be harmful fragmentation. There
is a mechanism in the United States to
prevent such a development. The
American Board of Medical Specialists
has evolved from earlier organizations
and has the power to prevent unrea
sonable further subspecialization by
not approving new boards.
A more serious problem is the over
production of surgeons. Because of
medical school enlargements we now
have about 1500 more medical school
graduates annually than we had a few
years ago. Since the percentage of
graduates entering surgery has been
about 25% since 1920 this may result
in an increased demand for surgical
training. This does not seem likely
since most of the increase is in female
graduates who are less likely to opt
for surgical training than men. More
important there are more surgical res
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idency programs than are needed. It
is estimated that 2000 surgical grad
uates annually will adequately supply
our surgical work force, taking into
consideration retirements, deaths and
population changes for some years to
come. Yet we have training programs
with a potential to graduate more than
3000 a year.
The Liaison Committee on Gradu
ate Education, through its residency
review committee, has the power to
solve this problem. To promote the
best medical care a number of poorer
programs must be discontinued to bring
supply more in line with demand.
Specialization has been a positive
factor in improved health care in our
country. Board certification assures the
public of adequately trained specialists.
The specialty group must beware of,
and not take, the tempting step of
claiming exclusive right to treat specific
diseases and anatomic areas. This is
a retrogressive move that will always
be regarded as self-aggrandizement by
colleagues and the public. It will cause
endless disputes between specialists.
These problems must not be dealt with
by national pronouncement but rather
by action at the local level where only
qualified surgeons should be granted
the privilege of performing specific
operations. The specialists are wrong
to claim areas of exclusiveness by de
cree; rather they must and can de
monstrate their superiority by results.
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Microvascular Free Flaps in Head
and Neck Reconstruction
R.M.

Z u k e r , md, frcs[c ],

I B R osen,
N.H. M cKee , md,

Microvascular free tissue transfer
can be applied to head and neck
reconstruction where: (a) conventional
flaps have been used successfully,
(b) conventional flaps are
extremely difficult to use and such
procedures are undertaken with
reservation and (c) conventional flaps
cannot accomplish the recon
structive goal. The authors describe
examples of these applications
and summarize their experience
in their first 10 cases. All flaps
survived completely; there were four
minor complications. Reconstruc
tion with microvascular free flaps
has many advantages over conven
tional techniques. The flap tissue
retains its vascularity— important
in irradiated tissue— there are no
open wounds and this single-stage
procedure is associated with a
high rate of flap survival. Specifically,
the flap can be oriented with ease,
without restriction caused by a
tight pedicle. The donor sites are
less conspicuous and previous
use of conventional donor sites is
not important. Most importantly
compound skin and bone flaps can
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be used simultaneously to re
construct mandibular and lining
defects. This application is not
possible with techniques other than
free flap transfer.
Le transfert d'un tissu libre pourvu
d'une micro-vascularisation peut etre
applique a la restauration chirurgicale
de la tete et du cou la
(a) ou les greffons conventionnels
ont deja ete utilises avec succes,
(b) oil les greffons conventionnels
sont extremement difficiles d'emploi
et oil de telles interventions
sont entreprises avec reserve et
(c) ou les greffons conventionnels
ne peuvent rencontrer les buts
de reconstruction vises. Les
auteurs donnent des exemples de
ces applications et resument leur
experience des 10 premiers cas. Tous
les greffons survecurent completement;
il n'y eut que quatre complications
mineures. La reconstruction a I'aide
de greffons libres pourvus d'une
micro-vascularisation compte plusieurs
avantages sur les techniques
conventionnelles. Le tissu greffe
conserve sa vascularite (un facteur
important dans un tissu irradie),
il n'y a pas de plaie ouverte et cette
operation en un seul temps est
rattachee a un taux eleve de survie
du greffon. En particulier, le lambeau
peut etre oriente facilement sans
les restrictions imposees par un
pedicule serre. Les zones de
prelevement des greffons sont moins
apparentes et I’utilisation prealable
des zones de prelevement conven
tionnelles n'est pas importante.

Le plus important est le fait que des
lambeaux de peau et d'os peuvent
etre employes simultanement pour
la reconstruction des defauts du
maxillaire inferieur et de la muqueuse.
Cette application n’est pas possible
avec des techniques autres que
celle du transfert d'un greffon libre.

Although the microscope has been in
use for over a century, it awaited
the refinement of surgical instru
ments and materials, particularly mi
crosutures, for its application to re
constructive surgery. In the early
1960s, the concept of vascularized
tissue transfer took hold as success in
replantation was realized. This con
cept was soon applied to head and
neck reconstruction. The first success
ful free skin flap in humans was used
for scalp reconstruction by Harii
in 1972 (personal communication,
1977).1 Following this, the use of
microvascular free tissue transfer or
free flaps has mushroomed and the
technique has been applied to recon
struction in many difficult areas.2,3
A free flap is a portion of tissue,
entirely supplied by a specific artery
and drained by a specific vein, which
is capable of being revascularized at a
new site by means of microvascular
anastomoses.
In head and neck reconstruction,
free flap transfer can be used in
three circumstances: (a) where con
ventional flaps have been used suc
cessfully, (b) where conventional flaps
are extremely difficult to use and
such procedures are undertaken with
reservation and (c) where convenTHE CANADIAN JOURNAL OF SURGERY
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Table 1--The Toronto Experience of Reconstruction with Microvascular Free Flaps from October 1978 to May 1979
Previous
irradiation

Patient

Age, yr

JK

63

Yes

KW

55

Yes

AM

51

BP

Flap used

Problem

Result and complications

SCC of left buccal mucosa
involving bone
Recurrent SCC of oral cavity
involving bone

Dorsal foot

Complete flap survival

Dorsal foot and
2nd metatarsal

Yes

Recurrent SCC of oral cavity
involving bone

Dorsal foot and
2nd metatarsal

62

Yes

Groin flap

JC

60

Yes

AP

49

Yes

Recurrent SCC of oral cavity;
forehead and dorsal foot flap
used previously
Recurrent SCC of floor of mouth
involving bone
SCC of left buccal mucosa

Complete flap survival; 2 cm
dehiscence on anterior of
flap border
Complete flap survival; wound
infection in right neck;
minimal wound dehiscence
Complete flap survival;
inability to swallow

JM

44

Yes

Radiation necrosis of mandible

LC

53

Yes

Recurrent SCC of base of tongue
and hypopharynx

Dorsal foot and
2nd metatarsal
Dorsal foot

BM

45

Yes

Recurrent SCC of neck and mandible

ML

55

Yes

Recurrent SCC of tongue and neck

Dorsal foot and
2nd metatarsal
Dorsal foot

Dorsal foot and
2nd metatarsal
Dorsal foot

Complete flap survival
Complete flap survival;
infection beneath flap
Complete flap survival; exposed
interosseous wires
Complete flap survival; major
wound infection; fistula
formation
Complete flap survival
Complete flap survival

SCC = squamous cell carcinoma.

are two distinct advantages of
free flaps in this situation. First, a
free flap maintains its blood supply
indefinitely but a regional pedicle flap
must eventually be separated from its
pedicle. This is important in previously
irradiated patients.
All of our
Where Conventional Flaps
patients who have undergone re
Would Suffice
constructive procedures of head and
The use of regional flaps in the neck had been irradiated before oper
head and neck area has gained wide ation. Second, the donor defect, be it
acceptance. In experienced hands these forehead or anterior chest, is con
flaps are reliable and provide satis spicuous, whereas the defect of a free
factory reconstruction. However, there flap taken from either the groin or

tional flaps cannot accomplish the re
constructive goal.
It is in this third circumstance that
reconstructive surgeons have been able
to do what was never before possible.

Fig. lc

Fig. la

Fig. lb

FIG. 1__Case 1. (a) Defect after resection, (b) Dorsal foot flap elevated, (c)
Flap in place, (d) Final result.
158

VOLUME 23, NO. 2, MARCH 1980

/

Fig. Id

THE CANADIAN JOURNAL OF SURGERY

the dorsum of the foot is much less
conspicuous.
The following case report illustrates
the reconstructive potential of free
flaps in a case where a conventional
flap would have been adequate.
Case 1.—A 63-year-old man (JK,
Table I) had a recurrence of his previ
ously irradiated oral cancer. He had not
undergone surgery previously. A biopsy
confirmed the diagnosis and he under
went surgical excision of the tumour
with partial mandibulectomy and radical
neck dissection. The defect included the
buccal mucosa, floor of mouth and in-

tervening buccal-gingival sulcus (Fig.
la ). This defect was reconstructed by
an immediate free vascularized skin flap
from the dorsum of the foot (Fig. 1,
b and c). His flap survived completely,
the incision lines healed primarily and
he regained good speech and swallowing
ability (Fig. Id). He was discharged
from hospital 2Vi weeks after operation.
Alternative methods of reconstruction
would have been with pedicled flaps,
such as the forehead flap, the deltopectoral flap or the myocutaneous pectoral
flap. These staged procedures usually
have greater morbidity and require longer
hospitalization than the single-stage free
flap procedure.

Where Conventional Flaps
Are D ifficult

N o Regional Donor Site Available
When the available donor sites from
the forehead and chest have been
used in previous reconstruction, re
current disease necessitates further
surgical extirpation. Conventional re
constructive techniques would require
transfer of a distant flap, either by
carrier or migration. Immediate free
flap reconstruction obviates these
rather complicated procedures with
their unpredictable results.
Case 2.—In 1977, BP, a 62-year-old
man, was found to have oral cancer. In
January 1978, he underwent a Com
mando procedure (combined hemimandibulectomy and radial neck dissection on
the same side) for recurrent cancer of
floor of the mouth which developed
after irradiation. Reconstruction was by
means of a forehead flap. In November
1978, he presented with multiple areas
of squamous cell cancer in residual
tongue and buccal mucosa. He was then
subjected to a near-total glossectomy,
near-total mandibulectomy and excision
of the previously reconstructed area of the
floor of the mouth. The defect was re
constructed by a free iliac crest bone
graft and a free vascularized groin flap.
As expected, he had difficulty in speak
ing and swallowing, and drooling gave
him problems. The flap survived com
pletely (Fig. 2).
Areas D ifficult to Reconstruct
with Regional Flaps

Fig. 2a

Fig. 2b

Fi8- 2c

Fig. 2d

F,G- 2—Case 2. (a) Defect after resection and iliac bone graft rabbetted into
ascending ramus mandibularis. (b) Groin flap elevated and detached, (c) Groin flap
in place, (d) Final result.
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There are certain anatomical areas
in the head and neck which are at the
outer limit of safety for the survival
of regional flaps. These areas include
both sides of the anterior floor of the
mouth. Conventional forehead flaps
are stretched to their limit to obtain
coverage in these regions. Because of
this, complications of flap breakdown
or necrosis, or both, are more com 
mon. These areas can be recon
structed satisfactorily with a microvascular free flap transfer.
Case 3.—A 51-year-old man (AM,
Table I) with a lesion on the right side
of his tongue, proved by biopsy to be
a squamous cell carcinoma, underwent
radiotherapy. The lesion recurr J with
further involvement of the rigb anterior
segment of the mandible. His tongue was
swollen and eating became increasingly
difficult. A large ulcer was noted at the
right gingival margin so a Commando
resection with extensive glossectomy, in
cluding a tumour-free area, was under
taken. A large lining defect in the ante
rior oral segment resulted. This was
reconstructed with a free vascularized
dorsal foot flap, including the second me
tatarsal, for the mandibular defect. The
flap was revascularized by way of the
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right facial artery and drained by the
right facial vein. Exposure of the recip
ient vessels and positioning of the flap
was carried out easily. Following revas
cularization, the flap became pink and
had good capillary return. Postoperatively, the flap remained well vascular
ized and the neck wounds healed by
primary intention. The patient had a
gastrointestinal hemorrhage on day 8
after operation. This responded to trans
fusion and antacids. Despite the limited
amount of tongue tissue, his speech and
swallowing ability improved steadily. An
abscess developed beneath the graft but
responded to drainage and debridement
and did not impede subsequent wound
healing. He later regained good intel
ligible speech and normal swallowing
(Fig. 3).

cases we used a dorsal foot plus
second metatarsal flap. In four pa
tients we used a dorsal foot flap alone
and in one patient we used a groin
flap.
Technique

The procedure is best carried out
by two operating teams. The first
team resects the lesion. This fre
quently involves a radical neck dis
section. At the same time the second
team elevates the flap. Great care
must be taken in order to avoid dam
age to the nourishing vessels of the
flap. The dorsal foot is particularly

useful for head and neck reconstruc
tion as a long vascular pedicle can be
obtained by extending the pedicle up
to the anterior tibial vessels.
The vessels that will nourish the
flap are then prepared in the reci
pient bed. One artery and one vein
are all that is necessary. The artery
is usually a branch of the external
carotid. We have also used the internal
maxillary, the facial, the lingual and
superior thyroid arteries. The vein is
usually a branch of the internal jugu
lar.
When the recipient bed and vessels
have been prepared and the flap has

Where Conventional Flap
Reconstruction Cannot Be Used

In composite resections resulting in
combined defects of lining and of
bone, conventional reconstruction of
the mandible depends on the use of
prostheses or free bone grafts. These
grafts have a high failure rate, parti
cularly in the irradiated patient. In
microvascular free flap transfer, auto
genous compound tissue, including
skin and bone, can be transferred
together and revascularized, providing
immediate mucosal coverage and vas
cularized bone reconstruction. The
viability of such a flap overcomes the
major problems of wound healing
posed by irradiated tissue. This tech
nique is a major advance in the re
constructive options in composite
tissue resections.

Fig. 3b

Fig. 3a

Case 4.—In January 1978, JM, a 44year-old woman with oral carcinoma,
underwent radiotherapy, but in July of
that year she had a recurrent lesion on
the floor of the mouth which required
excision and reconstruction with a tongue
flap. She was readmitted in December
1978 for biopsy which revealed only
radionecrosis. In January 1979, she pre
sented with a pathologic fracture of the
right mandible, presumably due to ra
dionecrosis. She underwent upper neck
dissection and mandibulectomy. The de
fect was reconstructed by a dorsal foot
and second metatarsal osteocutaneous
flap. Following revascularization, both
the skin and bone bled freely from their
cut margins. Pathologically, there was
no residual tumour. When she left hos
pital 2Vi weeks after operation she was
able to swallow and speak normally
(Fig. 4).
Experience with Microvascular
Free Flaps

Our experience with microvascular
free flap reconstruction for head and
neck lesions began in the fall of 1978.
At the time of writing, we have used
the technique on 10 patients. In five

Fig. 3c
FIG. 3— Case 3. (a) Tumour at right
gingival margin, (bj Defect after re
section. (c) Dorsal foot flap elevated,
(d) Flap in place in mouth, (e) Final
result.
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been fully elevated, the flap is com
pletely detached and transferred for
revascularization. It is gently tacked
in place. The microvascular anasto
moses are then carried out. The oper
ating microscope is moved into place
and the vessels are carefully prepared
under 10 to 15 X magnification. The
vein is usually repaired first and then
the artery, both with 10-0 monofila
ment nylon interrupted sutures. A
technically perfect anastomosis is
mandatory to ensure complete flap
survival. After revascularization, the
flap should become pink and warm
and exhibit good capillary return.
The flap is then sutured into its
bed with care. Minor trimmings are
possible with due regard to the artery
and, particularly, to the position of
the vein. Interrupted mattress sutures
are preferable.
Ancillary procedures, such as tra
cheostomy and gastrostomy, are then
performed.
Results
All flaps in our 10 patients sur

vived completely (Table I). There almost any direction so that the re
were, however, some complications. construction is not limited by a tight
They included minor intraoral wound pedicle attached to the forehead or
separation (JK), subflap abscess chest. The regional flap donor sites
(AM ), intraoral exposure of mandi with their associated deformities can
bular wire (JM) and formation of a be exchanged for donor site defects
fistula with wound infection (RC). in less conspicuous areas. In addition,
All of these patients, but only these, where traditional flaps have failed’
required a second operation. All donor the reconstructive surgeon has other
sites healed. Ambulation in the pa donor sites available. Certain regions
tients with the dorsal foot flap began in the head and neck are difficult to
on day 10 after operation and has reconstruct with regional flaps. Such
not been a problem. There were no defects offer no major obstacle to
deaths in the series. Speech, swallow free flap reconstruction. Through the
ing and cosmetic appearance have all use of compound microvascular free
been gratifying with one exception tissue transfer, the reconstructive sur
(BP) who underwent near-total glos- geon can now replace defects of lin
sectomy and mandibulectomy. Even ing and bone simultaneously with
this patient has made progress in vascularized tissue. This constitutes a
rehabilitation.
major advance in reconstructive sur
gery.
Discussion
In addition to these specific advant
ages related to head and neck surgery,
Advantages (Table II)
microvascular free tissue transfer has
Microvascular free flap reconstruc the following general advantages:
tion provides an acceptable alternative
• It is a single-stage operation.
to conventional reconstructive tech
• The tissue brings in a new vas
niques. The flap can be oriented in cular supply that is permanent. This
is a definite advantage in previously
irradiated tissue.
• As demonstrated by our series,
a high rate of flap survival can be
achieved.
• The procedure eliminates the
need for open wounds and, thus, re
duces morbidity and nursing prob
lems.
T a b le 11— A d v a n t a g e s o f F r e e F la p
R e c o n s t ru c t io n
G e n e ra l

S in g le -st a g e , p ro c e d u r e
N e w v a s c u la r iz e d t is s u e
b r o u g h t in
R e lia b le fla p s u r v iv a l
C o m p le te ly c lo s e d w o u n d s
M in im a l n u r s i n g r e q u ir e m e n t s

S p e c ific

L e s s c o n s p ic u o u s d o n o r s it e s
E a s e in r e c o n s t r u c t in g a n y
a n a to m ic a re a
C o m p o u n d t is s u e p o s s ib le

-M
Fig. 4b
FIG. 4— Case 4. (a) Pathologic frac
ture of right body of mandible, (b) Dorsal
foot flap with second metatarsal, (c)
Mandibular reconstruction, (d) Final re
sult—note contour and viable flap.
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Disadvantages
There are, however, several disad
vantages to free flap reconstruction.
Considerable expertise is needed to
ensure safe elevation of the flap and
consistently reliable revascularization.
The procedure may be longer than
that with the regional flap technique,
but with the two-team approach and
further experience, this time differ
ence is being reduced. With the use
of the dorsal foot flap, the patient
must remain in bed with the foot
splinted for 10 days after operation to
allow the skin graft on the donor
site to be revascularized.
Summary

The use of microvascular free flap
transfers has proven safe and reliable.
All 10 attempts at reconstruction with
this technique have been successful.
There are certain situations where a
free flap may be preferable to con
ventional flap reconstruction in head
and neck surgery. Microvascular free
flap transfer also affords the recon
structive surgeon the possibility of
transferring composite vascularized
tissue. This has never before been
possible and is a notable advance over
conventional techniques.
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1980 DAVIS & GECK SURGICAL ESSAY AWARD
FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical resident submitting
the best paper on a surgical topic to the Canadian Journal of Surgery. This
award is intended to promote scientific and literary excellence among
Canadian surgeons in training. In the event that there is no paper of
sufficiently high calibre, the award will not be made.
The conditions of entry for the 1980 award are the following:—
1. Candidates shall currently be engaged in a recognized surgical residency
program leading to eligibility for Fellowship of the Royal College
of Physicians and Surgeons of Canada in one of the surgical specialties
(cardiovascular and thoracic surgery, general surgery, neurosurgery,
obstetrics and gynecology, ophthalmology, otolaryngology, orthopedic
surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript
relating to work in which a surgical resident is or has been the prime
or major investigator. Prior oral presentation at a Royal College meeting
or a surgical forum meeting will not be a disqualification, but prior
publication as a formal paper in a journal will. The paper should relate
to any field of surgical interest. The manuscript must conform to the
style requirements of the Journal and must not exceed 3000 words of
text and six tables and/or six figures. Coauthors are permitted on the
understanding that the candidate shall be the first author and that only
the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than
June 30, 1980. Each entry must be submitted to the editorial office of
the Canadian Journal of Surgery. PO Box 8650, Ottawa, Ont. K1G 0G8
with a letter stating that the paper is being submitted as an entry for
the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal of
Surgery unless returned to the author without publication.
All papers submitted will be judged by an independent committee com
prising at least one member of the editorial advisory board of the Journal,
one fellow of the Royal College of Physicians and Surgeons of Canada and
one representative of the Canadian Medical Association, together with other
fellows invited to serve at the discretion of the three permanent members
of the committee. For the purpose of judging, the candidates will be
anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be
announced in the November 1980 issue of the Journal.

Critique of Item 1 (SESAP II)
The administration of homologous blood electively has inherent risks, hepatitis, sepsis antigens, and, possibly,
transfusion reactions. The safety and ease with which a patient can be provided with his own blood shou
orient the surgeon to a consideration of this technique. Besides, the use of this technique reduces expe
for the patient and helps prevent diminution of blood bank stores.
Virtually any patient receiving adequate nutrition can give 1 to 2 units of his blood for his future intra
operative and postoperative needs. Larger amounts of blood can be obtained preoperat.vely if iron supple
ments are given intravenously. Usually no more than 3 units are removed during a two-week preoperative
period.

0
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ROYAL COLLEGE PAPERS

Visual Abnormalities after Severe Head Injuries
D uncan P. A nderson ,

md , frcs [c ]* and

R obert M. F ord ,

md,

FRCs[c]f

The authors studied 12 patients with
major abnormalities of the afferent
visual system following closed injury
to the head. The anatomic sites of
injury were the eye in five patients,
the optic nerve in seven patients, the
chiasm in four patients and the optic
radiations in four patients. A technique
for rapid evaluation of the afferent
visual system in patients with multiple
injuries is presented. Three represen
tative examples of permanent visual
loss following closed head injury
are reported.

A substantial number of visual abnor
Visual acuity.— In the conscious
malities associated with head injury patient visual acuity between 20/20
are at present being overlooked. In a and 20/200 is measured in the usual
large series of cases of closed head way using the hand-held Snellen eye
trauma1,2 a 1% to 2% incidence of chart. There is a great range of useful
visual abnormalities was reported. vision below 20/200 and this should
Pathological examinations of autopsy b especifically tested for. The count
specimens in 84 patients who died of fingers range of vision is between
acute closed head injury demonstrated 20/200 and 1/200. The size of the
ischemic necrosis and shearing lesions index finger is approximately equal to
of the anterior visual pathways in that of the 20/200 Snellen letter so
44% ;3 24% of the lesions were bila we can do a quick bedside test of
teral. More patients are recovering vision by having the patient count
from serious multiple trauma and are fingers. If he can count fingers at
often left with severe and unusual 20 feet he has 20/200 vision, at 5
Les auteurs ont etudie 12 patients
visual defects which may be their feet he has 5/200 vision and at 1 foot
ayant eu de serieuses anomalies du
major disability.
he has 1/200 vision. When one con
systeme visuel afferent a la suite d’un
siders that the dividing line between
traumatisme cranien. La localisation
Patients and Methods
ambulatory and nonambulatory vision
anatomique de la blessure etait dans
Approximately 90 patients with is 3/200 and that the lower limit of
I'oeil chez cinq patients, le nerf
multiple trauma are admitted to the useful low vision aids is approximately
optique chez sept patients, le chiasma
Montreal General Hospital each year 5/200, it can be seen that even though
chez quatre patients et les radiations
and of these one third have serious these levels of vision are low, they
sensitives optiques dans quatre cas.
neurosurgical
problems. We studied can be extremely important to the
On presente une technique permettant
12 patients with major visual disabi patient.
I evaluation rapide du systeme visuel
The ability to recognize hand
lity
following closed head trauma. The
afferent chez les patients victimes
movements
is the next level of vision;
sites of injury causing visual loss were
de blessures multiples. Trois exemples
patients with this degree of vision can
the
eye
in
five
patients,
optic
nerve
types de perte permanente de la
in seven, chiasm in four and the optic avoid moving objects. Next on the
vision suite a un traumatisme cranien
radiations in four. We selected the scale is light projection; a patient with
sont presentes.
patients on the basis of injury to the this level of vision can tell the direc
afferent visual system. Three of the tion from which light is coming. This
From the departments of *ophthalmology
12 patients had a carotid cavernous implies that there is a substantial area
and 1neurosurgery, Montreal GeneraI
of residual visual field whereas light
fistula and 10 of the 12 had asso
Hospital and McGill University,
perception
may be present with only
Montreal, PQ
ciated eye movement disorders follow
one
retinal
receptor intact. No light
ing the head trauma.
Presented at the 48th annual meeting
perception is difficult to test because
of the Royal College of Physicians
the patient can hear the click of the
Patient Examination
and Surgeons of Canada, Montreal,
flashlight and feel the heat of the
PQ, Feh. 7, 1979
Evaluation of the visual system in bulb.
Accepted for publication Apr. 6, 1979
patients with multiple injuries can be
Visual field testing.—Visual fields
difficult. After the patient has been should next be measured one eye at
Reprint requests to: Dr. Duncan P.
stabilized a 1- to 2-minute examina a time by the usual confrontation
Anderson, Rm. 4813, Livingston Hall,
1650 Cedar Ave., Montreal. PQ
tion of the afferent visual system will methods. They should be clearly re
H3G 1A4
uncover any serious conditions.
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is the patient looking at his own
visual fields (Fig. 1). The field from
each eye is clearly labelled. Each
field is divided into four quadrants,
the point of visual fixation being
where the quadrants meet in the
centre while the small spots temporal
to fixation represent the physiologic
blind spots.
Pupillary reaction tests.— Even in
the unconscious patient visual acuity
and optic nerve function may be in
ferred from pupillary light testing.
There are three possible situations.
• If the pupils are equal and react
equally to the swinging flashlight test
one may infer that both optic nerves
and both oculomotor nerves are
normal.
• If the pupils are equal but one
pupil is less reactive to the swinging
flashlight test, then this eye has re
duced optic nerve conductivity. This
is known as a relative afferent pupil
defect.
• If the pupils are unequal this
implies an efferent or motor pupil
defect and one must use the normal
pupil’s direct and consensual response
in looking for an associated afferent
pupil defect.
R ed reflex and fundus testing.—
Once it has been established that there
is abnormal vision in one or both
eyes it is then important to determine
whether this is primarily ophthal
mologic or neurologic. If the findings
of the red reflex (Fig. 2) and the
fundus examinations are normal then
the abnormality is neurologic. If there
is an abnormal red reflex (Fig. 3) or
a fundus lesion then the problem is
ophthalmologic.

and optic radiations. The third patient
suffered a split optic chiasm.

Case 2

A 37-year-old man with a head in
Case 1
jury walked into the emergency room;
A 29-year-old man was admitted to he had a right frontoparietal skull
hospital with a traumatic subarachnoid fracture. While his scalp laceration
hemorrhage. Neurologic examination, was being sutured a right 3rd nerve
apart from a confused mental state, gave palsy with a fixed dilated pupil and left
normal results. Over the next 4 weeks hemiparesis developed. He became co
his mental status improved but he com matose. A right frontotemporal epidural
plained of blindness. On examination hematoma was removed and the patient
there were poor red reflexes bilaterally was eventually discharged. He com
and no fundus detail was seen (Fig. 4) plained of poor vision in the right eye
indicating that bilateral vitreous hemor but was otherwise neurologically normal.
rhages were present. Six months later When seen by an ophthalmologist several
the vitreous hemorrhages had not cleared months later he had light perception
so he underwent a left vitrectomy to vision and optic atrophy in the right eye
and normal vision and disc in the left
remove the hemorrhages. Unfortunately
a post-traumatic macular hole was dis eye. The visual field was absent in the
covered (Fig. 5) and his vision improved right eye and there was a previously
only slightly. This young man is legally unsuspected temporal hemianopia in the
blind but has otherwise made a com left eye (Fig. 6).
Comment.—This patient had an injury
plete recovery from his subarachnoid
to
the right optic nerve in the optic
hemorrhage.
Comment.—This patient had bilateral canal where it is firmly fixed to the
vitreous hemorrhages secondary to suba dura. Injuries to the optic nerve may
rachnoid hemorrhage (Terson’s syn also occur in the subarachnoid space
drome). This is due to sudden increase secondary to tearing and shearing lesions
in the optic nerve sheath pressure from when the moving brain pulls on the fixed
the subarachnoid hemorrhage, which optic nerve. Optic nerve injuries in the
causes obstruction of the central retinal orbit are rare because here the nerve
is protected by orbital fat. This patient s
vein and bleeding into the vitreous.

Case Reports

The following three case reports are
representative examples of patients
who had permanent visual loss follow
ing closed head injury. The first pa
tient lost vision from vitreous hemor
rhage secondary to subarachnoid
hemorrhage. The second patient had
traumatic injury to the optic nerve

FIG. 1—Method of recording visual
fields. Lines intersect at point of fixation
and physiologic blind spots are temporal
to fixation.
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FIG. 2— Normal red reflex indicating
clear ocular media.

FIG. 3— Poor red reflex
opacity in ocular media.

indicating
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FIG. 4— Case 1. Vitreous hemorrhage
obscuring detail of fundus.

FIG. 5— Case 1. Post-traumatic ma
cular hole discovered following vitrecto
my.
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left temporal hemianopia was due to the
right parietal epidural hematoma which
caused uncal herniation. This herniation
produced both a right 3rd nerve palsy
and obstruction of the right posterior
cerebral artery causing the left homony
mous hemianopia. This patient made a
complete neurologic recovery but was
left with only a nasal island of vision in
one eye and severe persistent visual di
sability.
Case 3

A 17-year-old girl was admitted with
multiple frontal fractures, cerebrospinal
rhinorrhea and diabetes insipidus result
ing from a serious motor vehicle ac
cident. Her mental status gradually im
proved and when she was discharged she
was neurologically normal apart from a
frontal lobe syndrome. She had many
complaints including confused or double
vision, no depth perception, difficulty in
reading and clumsiness. She was diffi
cult to test and at times her complaints
were thought to be functional.

When examined by an ophthalmologist
she was found to have good central vision
bilaterally, but there was a previously
undetected complete bitemporal hemiano
pia—the right eye saw only left of the
midline and the left eye only right of the
midline (Fig. 7). Because there was no
overlapping visual field there was no
stimulus for fusion and the eyes gradually
drifted apart producing intractable diplo
pia. Since there was no common retinal
image there was no depth perception. The
eyes were not aligned, therefore the
patient was forced to read with one eye
at a time. If she read with the right eye
she was constantly reading into her blind
area and hence read along a line of print
extremely slowly. If she read with her
left eye she could read along a line of
print quite well but when she went back
to start the next line she entered a blind
area again and could not find the new
line. This unfortunate girl was a chem
istry major and despite neurologic re
covery her persistent visual abnormality
was incapacitating.

Comment.—This patient had a trau
matic split chiasm which is usually due
to sudden anteroposterior skull decelera
tion with basal skull fracture. The syn
drome is often associated with diabetes
insipidus and is probably more common
than has been recognized.
Conclusion

We believe that careful evaluation
of the visual system in patients with
multiple traum a can bring to light
m any previously unrecognized visual
abnormalities and help greatly in the
short- and long-term m anagement of
these unfortunate patients.
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Mitral Valve Prolapse as a Cause of
Hemodynamically Important Mitral
Regurgitation
F red C. G u y , md , frcs[c ],* R osalind P .R . M acD onald, b sc,* D avid B. Fraser, md , F R C P [ c ] f
and E ldon . R . Smith , md , frcp [c ]*

To determine the relative importance
of mitral valve prolapse (M VP)
as a cause of hemodynamically im
portant mitral regurgitation, the
authors reviewed the echocardiographic, hemodynamic and angiogra
phic findings in 131 patients with
moderate or severe mitral
regurgitation, detected during routine
cardiac catheterization, and the
operative and pathologic findings in
a series of 103 patients who underwent
mitral valve replacement.
In the catheterization series,
rheumatic valve disease (RVD) was
responsible for the mitral regurgi
tation in 35% of cases, MVP in
2 5 % , coronary artery disease in
2 1 % , cardiomyopathy in 5 % and
miscellaneous conditions in 14% .
W hen only those patients with
isolated mitral regurgitation were
considered, MVP was the single
most common cause (3 8 % ).
Moreover, of the 31 patients in
this series who were operated
upon, MVP was responsible for
the mitral regurgitation in 4 8 % .
In the series of patients whose
mitral valve was replaced, RVD
(m ostly mitral stenosis) was
present in 72% but MVP was
the cause of the valvular disease
in the majority of the remaining
patients (2 0 % ).
It is concluded that MVP is a
common cause of moderate or
severe mitral regurgitation and in
this study represented the single
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most common cause of isolated
mitral regurgitation requiring operative
correction. Preoperative determi
nation of MVP as the cause of this
condition is important, because
of the possibility of operative
repair, thereby avoiding the problems
associated with placement of a
valve prosthesis.
Dans le but de determiner I'importance relative du prolapsus valvulaire
mitral (PVM ) comme cause d'une
regurgitation mitrale hemodynamiquement importante, les auteurs ont
etudie les mesures echocardiographiques, hemodynamiques et angiographiques chez 131 patients ayant
une regurgitation moderee ou grave
qui avait ete decelee lors d'un
catheterisme cardiaque de routine
et les observations operatoires et
pathologiques chez une serie de
103 patients qui avaient subi une
valvuloplastie mitrale.
Dans la serie de patients catheterises, une cardiopathie valvulaire
rhumatismale (CV R ) fut responsable
de 35% de cas de regurgitation
mitrale, un PVM de 25%, la maladie
coronarienne de 21% , une
cardiomyopathie de 5 % et diverses
affections de 14%. Lorsque seuls
les patients ayant une regurgitation
mitrale isolee ont ete consideres,
le PVM fut la cause unique la
plus frequente (3 8 % ). De plus, chez
les 31 patients de cette serie qui
furent operes, le PVM etait responsable
de la regurgitation mitrale dans
48% des cas. Dans la serie de
patients qui subirent une valvulo
plastie, une CVR (thrombose mitrale
surtout) etait presente chez 72%
des patients mais un PVM etait la
cause de la valvulopathie dans
la majorite des cas residuels (2 0 % ).
On conclut que le PVM est une
cause frequente de regurgitation mi
trale moderee ou grave et que,
dans cette etude, il represente la
cause unique la plus frequente
de regurgitation mitrale isolee exigeant
une correction chirurgicale. L'identification pre-operatoire de cette
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affection est importante a cause de
la possibility d’une correction
chirurgicale qui eviterait les problemes
associes a la pose d’une prothese
valvulaire.

Recent clinical investigations*'3 have
suggested that 5% to 10% o f most
study populations have some features
o f the mitral valve prolapse (M V P )
syndrome. Although the natural his
tory o f this disorder is generally be
nign, one of the recognized com pli
cations
is the
development
of
progressive
mitral
regurgitation.4
Ironically, proof that M V P is the
cause o f the hemodynamic lesion in
such patients may be extremely dif
ficult. Thus, the characteristic auscul
tatory abnormalities o f a nonejection
systolic click and a late systolic mur
mur are replaced by a pansystolic
murmur, and the angiographic fea
tures5 that have traditionally been ac
cepted as the standard for a diagnosis
o f M VP frequently are not discern
ible in the presence o f severe mitral
regurgitation. Finally, although echo
cardiography has proved useful in de
tecting prolapse, debate continues con
cerning the diagnostic sensitivity and
specificity o f this noninvasive tech
nique. Using generally accepted echocardiographic criteria, we have been
impressed by the frequency with
which M VP is associated with m oder
ate or severe mitral regurgitation.
Since rheumatic fever has tradi
tionally been considered the chronic,
hemodynamically important
major
cause o f mitral regurgitation, the
present study was undertaken to de
fine the etiologic spectrum o f this
lesion in two groups o f patients, those
subjected to routine diagnostic cardiac
catheterization (group 1) and patients
whose mitral valve was replaced
(group 2 ).
Patients and Methods

Catheterization Series (Group 1)
The records o f all patients who
underwent left ventriculography at the
Victoria General Hospital in Halifax,

THE C A N A D IA N JOURNAL OF SU RG ERY

Nova Scotia, during the period May
1, 1973 to Dec. 31, 1977 were re
viewed; patients having previously had
a mitral valve operation or those with
an atrial septal defect were excluded
from further analysis. Of the remain
ing 3514 patients, mitral regurgita
tion was present in 505 (14% ). In
204 of these 505 patients, the mitral
regurgitation was considered moderate
or severe (angiographic grades mild,
moderate and severe); the study group
consisted of 131 of these 204 patients
who had echocardiography and whose
records were technically adequate for
evaluation. There were 74 men and
57 women whose ages ranged from
15 to 79 years (mean 54 years).
In each case, the echocardiographic,
hemodynamic and angiographic data
were reviewed to determine the cause
of the mitral regurgitation; the causes
included rheumatic heart disease, is
chemic heart disease, mitral valve
prolapse and congestive cardiomyo
pathy. A diagnosis of rheumatic dis
ease was accepted if there was echo
cardiographic evidence of mitral valve
thickening with or without angiogra
phic and hemodynamic evidence of
mitral stenosis or aortic valve disease.
The cause was considered to be is

chemic if there was significant coro from our laboratory.8 In the presence
nary artery disease (CAD) but no of severe mitral regurgitation, the
echocardiographic or hemodynamic usual features of MVP may not be
evidence of a structural disorder of visible in the right anterior oblique
the mitral valve. Significant CAD was projection so we placed considerable
defined as at least 70% stenosis of reliance on the left anterior oblique
the lumen of one or more major view in which prolapse of either leaf
vessels or 50% stenosis of the left let may be evident, even when severe
main coronary artery. A diagnosis of mitral regurgitation is present (Fig.
congestive cardiomyopathy was ac 2 ).
cepted if there was echocardiographic
Finally, patients with unusual
and angiographic evidence of in causes of mitral regurgitation and
creased left ventricular volume with those with some, but not all, of the
diffuse hypokinesis but no CAD or features of one of the major diag
structural valvular disease. Because nostic subsets were included in a mis
criteria for the diagnosis of MVP are cellaneous group.
controversial6’7 this diagnosis was ac
Operative Series (Group 2)
cepted only if there was both echo
cardiographic and angiographic evid
The operative and pathological
ence of the disorder. Mitral valve findings from a consecutive series of
prolapse was considered present on 103 patients who had mitral valve
echocardiographic examination
if replacement were reviewed. There
echoes from the mitral leaflets were were 56 women and 47 men whose
displaced posteriorly from the systolic ages ranged from 27 to 79 years
closure line by 10% or more of the (mean 54 years). In each case the
maximum diastolic excursion of the operative report was scrutinized for
anterior leaflet. Two echocardiogra a description of the operative find
phic patterns were accepted: abrupt ings. Similarly, the pathologist’s de
mid-systolic buckling (Fig. 1A) and scription of the gross and microscopic
pansystolic posterior bowing (Fig. appearance of the operative specimen
IB). The angiographic criterion for was reviewed in all cases and, when
MVP was that previously reported indicated, was re-evaluated.

FIG- 1— Echocardiographic patterns accepted as indicative of mitral valve prolapse (MVP): (A) abrupt mid-systolic
(arrow) prolapse, (B) smooth posterior bowing throughout systole. PCG = phonocardiogram, ECG = electrocardiogram.
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Results
Group 1

The causes of the mitral regurgi
tation are set forth in Table I. The
commonest cause was chronic rheu
matic valvular disease, in 46 (35% )
of the patients. Of note is the find
ing that in 33 patients (25% ) MVP

was the cause of their mitral regurgi
tation.
Of the 131 patients in this group,
31 (24%) underwent mitral valve
surgery. In each case the cause de
termined by the echocardiographic,
hemodynamic and angiographic meth
ods was confirmed by operative or
pathological assessment, or both.

Table 1—Cause of Mitral Regurgitation in Group 1 Patients
No. of patients
(and % )

Cause

Total

Rheumatic heart disease
Ischemic heart disease
Mitral valve prolapse
Congestive cardiomyopathy
Miscellaneous

10 (32)
3 (10)
15 (48)

131 (100)

31 (100)

No. of patients
(and % )
2 (2)
27 (31)
33 (38)
7 (8)
18 (21)

3 (10)

Table III—Cause of Mitral Valve Disease
in 103 Consecutive Patients Who
Underwent Mitral Valve Replacement

Table II—Causes of Isolated Mitral
Regurgitation in 87 Patients

Cause

(35)
(21)
(25)
(5)
(14)

46
27
33
7
18

Rheumatic heart disease
Ischemic heart disease
Mitral valve prolapse
Congestive cardiomyopathy
Miscellaneous

Patients subsequently
operated on,
no. (and % )

Cause

No. of patients
(and % )

74 (72)
Rheumatic heart disease
Mitral valve prolapse
(myxomatous degeneration) 21 ( 20)
6 ( 6)
Ischemic heart disease
2 ( 2)
Miscellaneous

Chronic rheumatic heart disease was
present in 32%, ischemic heart dis
ease in 10% and miscellaneous causes
accounted for another 10% . However,
the single most common indication
for surgery in these 31 patients was
MVP, accounting for 48% of cases.
Of the 46 patients with rheumatic
disease as the cause of mitral regur
gitation, 42 also had echocardiogra
phic and hemodynamic findings of
mitral stenosis (with or without aortic
valve disease) and another 2 patients
had important aortic stenosis. Thus,
mitral regurgitation was the sole le
sion in only two of these cases. In
total, there were 87 patients with iso
lated mitral regurgitation; the etiologic distribution of these cases (Table
II) was quite different from that of
the entire group. The most common
cause was MVP (in 38% of cases)
and the least common cause was
chronic rheumatic disease (2% of
cases).
Group 2

Of the 103 patients in group 2,
the mitral valve condition was caused
by rheumatic heart disease in 74
(72% ) and by ischemic heart dis
ease in 6 (6%) (Table III). However,
in 21 patients (20%) the operative
and pathological findings were con
sistent with MVP. Rupture of the
chordae was a common feature in
these 21 patients, being recognized
during operative inspection in 14.
Preoperative echocardiograms were
available for all 21 patients considered
to have MVP-induced mitral regur
gitation as the indication for valve
replacement. In one patient the tech
nical quality of the echocardiogram
was inadequate for assessment. Of the
remaining 20 patients, the echocardio
graphic diagnosis was definite MVP
in 17 and probable MVP in 2. In one
patient the mitral valve was consi
dered to be normal on the echocardio
gram. Thus, using the operative and
pathological features as the diagnos
tic standards, the diagnosis of MVP
was evident in 19 of 21 patients (sen
sitivity 90% ) by routine echocardio
graphic examination.
Discussion

f i g . 2— Left anterior oblique projection of end-systolic left ventriculogram
from patient with severe mitral regurgitation secondary to MVP. Prolapsed posterior
leaflet is seen in profile (arrow) bulging into densely opacified left atrium.
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Clinical,1’2’6'8 echocardiographic,1’3'6’8
angiographic6’8’10 and autopsy11 studies
all indicate that MVP is a com
mon disorder, affecting 5% to
10% of the populations evaluated. In
view of this prevalence, one must
assume that the natural history of
this syndrome is generally benign, al-
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though it is well recognized that some
patients do have complications.
The results of our study clearly in
dicate that MVP is an important
cause of hemodynamically significant
mitral regurgitation. Indeed, in pa
tients who underwent routine diag
nostic cardiac catheterization, MVP
was the causative factor in 25% of
those with moderate or severe mitral
regurgitation and was the most com
mon single cause of isolated regurgi
tation at the mitral valve. Moreover,
of the patients from this group who
subsequently had valvular surgery,
MVP was the cause in approximately
one half. This finding emphasizes the
clinical severity of the hemodynamic
abnormality caused by MVP in such
patients. The findings in our operative
series are in concert with these obser
vations. Prolapse-induced mitral re
gurgitation was the indication for sur
gery in 20% of patients in whom
mitral valves were replaced at our
institution, being second only to rheu
matic mitral stenosis as an indication
for this operation.
These results are somewhat surpris
ing in view of the traditional concept
that rheumatic heart disease is re
sponsible in the majority of patients
with chronic, hemodynamically im
portant mitral regurgitation.12'13 How
ever, the diagnosis of rheumatic heart
disease has often been based on a
clinical history of an illness believed
to have been acute rheumatic fever—a
history that is also frequently noted in
patients without evidence of valvular
disease. Since a history of acute rheu
matic fever is lacking in 40% to 50%
of patients presenting with mitral
stenosis of rheumatic origin,14 it ap
pears that such historical data are
both insensitive and nonspecific and
probably should not be accepted as
evidence for or against a rheumatic
cause. In our study, we avoided this
problem by using only nonhistorical
criteria for determining the cause of
mitral regurgitation.
One might argue that use of echocardiographic criteria results in under
estimation of the true prevalence of
rheumatic disease. However, we noted
a close correlation between the echocardiographic finding of mitral valve
thickening, the presence of a diastolic
gradient during hemodynamic study
and the characteristic pathological
findings of fibrosis, calcification and
commissural fusion, all of which argue
against this possibility. Another con
cern might be that our diagnostic
methods could result in an overestima
tion of the true prevalence of MVP.
A number of observations make this
VOLUME 23, NO. 2, MARCH 1980
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possibility unlikely. We were acutely
aware of the problems of overdiag
nosing MVP6,8 and because of this
we accepted the diagnosis only if both
echocardiographic and angiographic
criteria were satisfied. Thus, a number
of patients with either echocardiogra
phic or angiographic evidence of MVP
were included in the miscellaneous
group rather than in the MVP group.
Since we did not wish to bias the
results in favour of MVP, we also
excluded from analysis all patients
with a diagnosis of atrial septal de
fect because of the current contro
versy concerning the association be
tween this condition and MVP.10
Finally, of the 31 patients from group
1 subjected to valve surgery (15 of
whom had MVP), operative and pa
thological findings were in agreement
with the echocardiographic and angio
graphic diagnoses in all instances.
Thus, we feel reasonably assured that
we have neither underdetected rheu
matic disease nor overdiagnosed MVP.
Accepting this, we believe our data
indicate that chronic rheumatic val
vular disease is a very uncommon
cause of isolated moderate or severe
mitral regurgitation.
Clearly, in only a small number of
patients with auscultatory, echocar
diographic and angiographic features
of MVP does hemodynamically im
portant mitral regurgitation develop.
The factors predisposing to this com
plication are poorly understood al
though our data, as well as those of
others,4,15 indicate that chordal rupture
is frequently associated. At present we
are unable to predict which patients
are most prone to this or any other
complication of MVP. Careful long
term studies are obviously required.
They may not only improve our abil
ity to diagnose MVP but also develop
methods of recognizing patients at
risk of more serious complications. If
a population at substantial risk of he
modynamically important mitral re
gurgitation could be identified, it
would then be possible to assess the
role of prophylaxis. For instance,
decreasing the amount of prolapse
with a /J-blocking agent may lessen
the likelihood, or delay the develop
ment, of chordal rupture. If, as the
data suggest, chordal rupture is an
important factor in the development
of severe mitral regurgitation, such
an approach might favourably influ
ence prognosis.
Establishing the cause of mitral re
gurgitation is of more than academic
interest, particularly when operation
is being considered. Although valve
replacement has been the preferred

mode of management for severe mitral
regurgitation, there is now convincing
evidence that patients with nonrheu
matic valve disease (i.e., MVP) may
obtain long-lasting symptomatic im
provement from reparative rather
than replacement procedures.16-17 Re
pair of the valve offers an attractive
alternative to valve replacement in
terms of the subsequent occurrence
of thromboembolism, bacterial endo
carditis and mechanical or biologic
deterioration of the prosthesis itself.
Recent experience at our institution
supports the view that surgical repair
should be the procedure of choice
for patients with MVP complicated
by severe mitral regurgitation.
In summary, the results of this
study indicate that the MVP syndrome
is a more common cause of hemody
namically important mitral regurgita
tion than has generally been appre
ciated. Even when multiple rigid cri
teria were required for diagnosis,
prolapse was the single most common
cause of angiographically determined
isolated moderate or severe mitral re
gurgitation and represented the indi
cation for valve replacement in 50%
of patients requiring operation. D e
spite this prevalence, the diagnosis of
MVP may not be apparent unless a
high index of suspicion is combined
with careful echocardiographic and
angiographic examinations. Preoper
ative diagnosis is important because
surgical repair of the mitral valve in
such patients provides prolonged
symptomatic improvement without
many of the problems associated with
a prosthesis.
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BOOK REVIEWS
CRC MANUAL OF NUCLEAR MED
ICINE PROCEDURES. 3rd ed. Edited
by John W. Keyes, Jr. 213 pp. CRC
Press, Inc., West Palm Beach, Fla.,
1978. Price not stated. ISBN 0-84930707-4.

Despite protestations to the contrary, this
manual is a “cookbook” in which nine
contributors give brief descriptions of
most standard in vivo nuclear medical
procedures and selected in vitro assays
relating to thyroid disease. Each proced
ure is described under the headings of:
principle, indications, limitations, radio
pharmaceutical and dose, patient prepara
tion, procedure, notes and interpretation.
With an average of just over two small
pages for each procedure, the style is ne
cessarily terse, and brevity often begets
inadequacy. Those who are familiar with
a procedure will find the text inadequate
as a working manual and it is not suffi
ciently detailed to be useful otherwise. It
is to be hoped that those wishing to in
troduce a new procedure will feel obliged
to seek out an original description which
gives much greater detail under all head
ings than is possible in this format. How
ever, that may be a naive view. If an
attitude of “when all else fails read the
instructions” is more common in nuclear
medicine than we care to admit, then this
book has a place as an elementary guide.
The sections on indications and limita
tions generally do not consider alternative
techniques which may be preferable from
both a diagnostic and safety viewpoint.
Thus, there is no mention of ultrasono
graphy as an alternative to placental
scanning or to transmission scans for peri
cardial effusion.
The statement of the radiation dose
associated with each procedure is welcome
particularly in the light of present con
cern about unnecessary or excessive doses
of radiation administered during diagnostic
investigations and the difficulty in find
170

ing authoritative figures in this regard.
Unfortunately, there are inconsistencies
from procedure to procedure and some
of the radiation doses stated are question
able. The single page devoted to radio
immunoassay techniques is derisory, re
vealing such noninformation as the fact
that many tests are available in kit form
from commercial manufacturers and that
most give accurate results and that the kit
can be used by staff in an average hos
pital laboratory.
The 30 pages devoted to quality as
surance are welcome and helpful. They
are not so seriously impaired by brevity
as the section on clinical procedures. Un
fortunately, only quality control of in
strumentation is described, and quality
control of radiopharmaceuticals, whether
purchased or produced locally, is not
mentioned here or elsewhere.
This book can be recommended only
in the spirit referred to in its introduction,
namely, the hope that even superficial
knowledge will aid in the performance
of quality work.
M.J. Chamberlain , md , fr c p [c]

Chief of nuclear medicine,
University Hospital,
University of Western Ontario,
London, Ont.
PRECIS DE CHIRURGIE INFANTILE.
Diagnostic, indications et principes therapeutiques. Marcel Bettex, Franyois
Kuffer et Alois Scharli. 372 pp. Illust.
Masson, Paris, 1978. $68.75, broche.
ISBN 2-225-48521-6.

Ce livre de chirurgie infantile a ete redige
a l’intention des etudiants en medecine par
une equipe de chirurgiens pediatriques
suisses. L’expose schematique et le style
telegraphique utilises ont ete voulus par
les auteurs. Le resultat est un texte concis,
bien illustre par des schemas et des radiographies, facile a comprendre et a retenir.
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Les affections chirurgicales sont groupees par ordre anatomique: celles du cou,
de la tete, du thorax, de l'abdomen, etc.
Les affections chirurgicales du canal uro
genital occupent pres du tiers du volume.
Certaines notions d’orthopedie et de neurochirurgie sont incluses.
Publie en 1978, ce livre contient plusieurs donnees recentes telles que l’elevation de l’activite de l’acetylcholinesterase
et la manometrie rectale dans le diagnos
tic du megacolon congenital. Par contre
l’utilisation de la tomodensitometrie dans
le diagnostic des lesions intracraniennes
n’est pas mentionnee.
Le chapitre traitant de l’atresie de
l’oesophage est tres bien fait: l’embryologie,
les formes anatomiques et les signes cliniques sont decrits avec concision. En
quelques lignes et deux figures, les moyens
de confirmer le diagnostic sont expliques.
Le traitement preoperatoire ne fait cependant pas mention de deux points importants: la position du patient ainsi que
l’aspiration continue sur le cul-de-sac oesophagien proximal. La correction chirurgicale des differents types d’atresies est
erxpliquee, suivie des complications precoces et tardives, et, enfin, du pronostic.
L’aspect traitement n’est qu’effleure, volontairement d’ailleurs, dans ce livre.
C’est pourquoi il ne sera pas tres utile
aux residents en chirurgie ni aux chirur
giens. De plus, sur plusieurs sujets, les
opinions emises par les auteurs different
de celles qui sont enseignees en Amerique du Nord. Ainsi le drainage mediasti
nal dans le pneumo-mediastin du nourrisson n’est guere utilise ici. D’autre part,
le traitement de l’invagination intestinale
par lavement baryte, considere comme sur
et efficace dans un grand nombre d’institutions, est juge dangereux par les auteurs.
Ceux-ci preconisent encore la resection
sub-totale de la tunique vaginale avec
continued on page 182
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Parasternal Mediastinoscopy in Bronchial
Carcinoma of the Left Upper Lobe
A. P age,

C. M e r c ie r , MD,t A. V erdant , m d , t R. C o s s e t t e ,
L. DONTIGNY, MDf AND L.C, PELLETIER, MD*

m d ,*

M e d ia s tin a l ly m p h a tic sp re a d o f lung
c a n c e r o f the le ft lo b e is
p re d o m in a n tly to the le ft p e ria o rtic
n o d e s. In a s e r ie s o f 101 p a tie n ts
w ith su ch ca n c e r, 59 (grou p 1) w e re
e v a lu a te d p re o p e ra tiv e ly by sta n d a rd
c e r v ic a l m e d ia s tin o s c o p y ; 16 node
b io p s y s p e c im e n s c o n ta in e d m a lig n a n t
c e lls . T w en ty-n in e p a tie n ts u n d e r
w e n t th o ra co to m y an d re s e c tio n ;
in 10 th e n o d e s in th e le ft
m e d ia s tin u m in the p e r ia o rtic area
w e re fo u n d to have m a lig n a n t
c e lls . In 22 p a tie n ts (g ro u p 2) the
p re o p e ra tiv e in v e s tig a tio n w a s by
both c e r v ic a l and p a ra ste rn a l
m e d ia s tin o s c o p y . A ll b io p s y s p e c im e n s
o b ta in e d by c e rv ic a l m e d ia s tin o 
s c o p y w e re n e g a tiv e fo r m a lig n a n t
c e lls bu t 13 o f 32 s p e c im e n s
o b ta in e d by le ft p a ra ste rn a l m e d ia s 
tin o s c o p y gave p o s itiv e re s u lts .
T h e re w a s one fa ls e -n e g a tiv e re s u lt
in gro u p 2 b io p sy s p e c im e n s —
a su b a o rtic node w a s fo u n d to co n 
ta in c a n c e r at th o ra co to m y .
T w e n ty c a n c e rs o f th e le ft u pp er
lo b e (gro u p 3) w e re in v e s tig a te d
by le ft p a ra ste rn a l m e d ia s tin o s c o p y
o n ly. Ten b io p sy s p e c im e n s
c o n ta in e d m a lig n a n t c e lls . T hus, in
le ft u p p e r lo b e tu m o u rs, p o s itiv e
b io p s y re s u lts w e re o b ta in e d in
20% o f p a tie n ts by c e r v ic a l m e d ia s ti
n o s co p y and in 55% by le ft

Le c a n c e r b ro n c h o g e n iq u e du lo b e
s u p e rie u r g a u ch e m e ta s ta s ie habitu e lle m e n t a la c h a in e ly m p h a tiq u e
p re a o rtic o c a ro tid ie n n e , p a r I'interm e d ia ire du g a n g lio n du canal
a r te r ie l. C e s ly m p h a tiq u e s s'a v e re n t
in a c c e s s ib le s par m e d ia s tin o s c o p ie
c e r v ic a le m a is p e u v e n t e tre b io p s ie s
p a r une m e d ia s tin o s c o p ie p a ra ste rn a le
g a u ch e . D an s u n e s e r ie de 101
c a n c e r s du lo b e s u p e rie u r gauche,
59 p a tie n ts (g ro u p e 1) o n t su bi
u n e m e d ia s tin o s c o p ie c e rv ic a le e t
16 b io p s ie s fu re n t p o s itiv e s . D an s
c e g ro u p e , 29 re s e c tio n s p u lm o n a ire s
fu re n t p ra tiq u e e s, co m p re n an t
12 lo b e c to m ie s e t 17 p n e u m o n e c
to m ie s . C h e z 10 d e c e s p a tien ts
d e s g a n g lio n s de la re g io n peria o rtiq u e ga uche e ta ie n t m e ta sta tiq u e s .
C h e z 22 p a tie n ts (g ro u p e 2) la
m e d ia s tin o s c o p ie c e r v ic a le et la
m e d ia s tin o s c o p ie p a ra ste rn a le g a u c h e
fu re n t c o m b in e e s . L es b io p s ie s
s 'a v e re r e n t n e g a tiv e s d a n s to u te s
le s m e d ia s tin o s c o p ie s c e r v ic a le s m a is
13 d e s 22 m e d ia s tin o s c o p ie s
p a ra s te rn a le s g a u c h e s d e m o n tre re n t
d e s m e ta s ta s e s a u x g a n g lio n s p eriao rtiq u e s g a u ch e s. E n fin c h e z 20
p a tie n ts (grou pe 3), s e u le une m e 
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d ia s tin o s c o p ie p a ra s te rn a le gauche
fu t p ra tiq u e e , fo u rn is s a n t 10
b io p s ie s p o s itiv e s . D an s le s g ro u p e s
2 e t 3, 18 p a tie n ts a v e c b io p s ie s
n e g a tiv e s s u b ire n t une re s e c tio n
p u lm o n a ire , s o it u n e lo b e c to m ie
d a n s 13 c a s , s o it une p n e u m o n e c to m ie
d a n s 5 c a s . Un g a n g lio n m e ta sta tiq u e
p e r ia o rtiq u e a e te re tro u v e dans
un d e c e s c a s lo rs de la thoracoto m ie . A in s i, d a n s le s c a n c e rs
du lo b e s u p e rie u r g a u ch e , des
b io p s ie s g a n g lio n n a ire s p o s itiv e s
o n t e te re tro u v e e s da ns 20% d e s
c a s p a r m e d ia s tin o s c o p ie c e rv ic a le
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p a ra s te rn a l m e d ia s tin o s c o p y . T h e re 
fo re , in d e te rm in in g th e extent
o f c a n c e r s o f th e u p p e r lobe o f
th e le ft lung, p re o p e ra tiv e le ft
p a ra s te rn a l m e d ia s tin o s c o p y is p re 
fe r re d to c e r v ic a l m e d ia s tin o sc o p y ,
w h ic h m ay be u s e fu l in c a n c e rs
o f th e le ft h ila r re g io n and of
o f the lingu la.

/

m d ,+

p a r o p p o s itio n a 55% d e s c a s
p a r m e d ia s tin o s c o p ie p a ra s te rn a le
g a u c h e . C e d e rn ie r e x a m e n d o it
e tre p r e fe re a I'au tre p o u r 1 'e v a lu a tio n
d e s g a n g lio n s du m e d ia s tin p o u r
c e s c a s . T o u te fo is , la m e d ia s ti
n o s c o p ie c e r v ic a le p e u t e tre
c o m p le m e n ta ire d a n s le s le s io n s
tu m o ra le s d e la re g io n h ila ir e
g a u c h e e t d e la lin g u la .

Precise staging of mediastinal lymph
nodes is necessary for selecting the
proper treatment in cases of bronchial
carcinoma. Cervical mediastinoscopy
is useful for detecting metastases to
superior mediastinal lymph nodes1’5
but lymphatic spread of bronchogenic
carcinoma of the left upper lobe is
often to an area that is inaccessible
to this procedure. Pearson and as
sociates3 reported 100 patients with
cancer of the left upper lobe and left
hilar region in whom biopsy speci
mens obtained at cervical mediastino
scopy were negative for malignant
cells, but in 22 of these patients
cancer was found in the anterior
mediastinal and subaortic nodes at
operation. Bowen and associates,4
using left anterior mediastinotomy,
found metastatic cancer in periaortic
nodes in 10 of 28 patients with left
upper lobe tumours. Cervical mediasti
noscopy is inadequate for detecting
spread of cancer to mediastinal lymph
nodes from cancer of the left upper
lobe. The left periaortic lymph nodes
(Fig. 1) should be examined by left
parasternal mediastinoscopy.

node.
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Discussion

Patients and Method

We reviewed the records of 101
patients with cancer of the left upper
lobe of the lung examined between
Jan. 1, 1969 and Dec. 31, 1978.
Evaluation of mediastinal lymph nodes
was done by cervical mediastinoscopy
in 59 patients (group 1). Twenty-two
underwent cervical and parasternal
mediastinoscopy (group 2). Left pa
rasternal mediastinoscopy alone was
performed in 20 patients (group 3).
Parasternal mediastinoscopy was
performed by a simple modification
of the anterior mediastinotomy des
cribed by McNeill and Chamberlain.5
Through a transverse incision, a short
segment of the second left intercostal
cartilage is removed, the internal mam
mary artery and vein are ligated, the
mediastinal pleura is reflected, the
mediastinoscope is introduced along
the side of the aortic arch and the
periaortic nodes are sampled. All
nodes are needle-aspirated before
biopsy. Parasternal mediastinoscopy
can often be performed without car
tilage resection, through the second
intercostal space. This avoids the
slight deformity produced by resec
tion.
Results

Biopsy specimens of the mediastinal
nodes were positive for malignant cells
in 16 of the 59 group 1 patients.
In 22 group 2 patients, all biopsy
specimens obtained by cervical medi
astinoscopy were negative for malig
nant cells but 13 of the 22 specimens
obtained by left parasternal mediasti
noscopy were positive. In group 3, 10
of the 20 patients were found to have
metastatic spread to mediastinal
nodes. Thus, biopsy demonstrated
malignant cells in the mediastinal
lymph nodes in 20% of patients ex
amined by cervical mediastinoscopy
and in 55% examined by left paras
ternal mediastinoscopy. Among the
patients with negative biopsy results
in group 1, 29 underwent surgical
resection; 12 had lobectomy and 17
pneumonectomy. In 10 of these, metastases were found in lymphatic nodes
in the periaortic area. In groups 2
and 3, there were 18 resections, of
which 13 were lobectomies and 5
were pneumonectomies. A node with
metastasis was found in the subaortic
area in only one of these patients.
No death occurred as a result of
left parasternal mediastinoscopy; two
patients had superficial wound infec
tion and one had transient recurrent
laryngeal nerve palsy.
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Results of surgical resection for
lung cancer depend on the degree
of spread of the disease.6 Tumours
with involvement of the mediastinal
nodes are often resectable but the
value of such resection is debatable.7
Some8-10 have recommended radical
resection in certain lung cancers with
mediastinal spread. However, if pre
operative evaluation demonstrates
metastasis to mediastinal nodes we
prefer not to subject patients to tho
racotomy, and to treat them with
radiotherapy. This approach is en
dorsed by others.11'12 Preoperative
evaluation of mediastinal nodes is thus
important since the results determine
the treatment.
Cervical mediastinoscopy detected
metastases to mediastinal nodes in
cancers of the left upper lobe in only
20% of our patients. Furthermore, 10
of 29 patients (34%) whose nodes
showed no malignant change by cervi
cal mediastinoscopy and who under
went thoracotomy had metastatic
mediastinal lymph nodes in an area
inaccessible to cervical mediastino
scopy. Left parasternal mediastino
scopy yielded positive biopsy results
in 55% of cases and at thoracotomy
following negative biopsy only 1 of 18
patients (6%) had a metastatic suba
ortic node. Also, the incidence of
lobectomy was only 41% in group 1,
as opposed to 72% in groups 2 and 3.
A much better selection of patients
is thus obtained when left parasternal
mediastinoscopy is used for biopsy.
The lymphatics of the superior re
gion of the left upper lobe drain into
Botallo’s ligament node and then to
the periaortic nodes. This may be the
usual drainage route for bronchogenic
cancer of the left upper lobe, but the
ligament node may also communicate
with the left paratracheal area. The
lower region of the left upper lobe
has lymphatic connections with Bo
tallo’s ligament node and the tracheo
bronchial nodes.13,14
Although lymphatic spread of left
upper lobe carcinoma may be to the
paratracheal or to the periaortic re
gions, spread to the latter by way of
the ligament node is preferred since
in 23 (55%) of 42 left upper lobe
tumours metastatic spread was de
monstrated by biopsy of these nodes
by left parasternal mediastinoscopy.
This pattern of lymphatic spread has
also been shown by others.3'4
In conclusion, while preoperative
cervical mediastinoscopy may be use
ful in determining the presence or
absence of metastases in lesions of
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the left hilar region and of the lingula,
left parasternal mediastinoscopy is
preferred for cancers of the left upper
lobe.
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Indications for and Results of Reoperation
for Coronary Artery Disease
A. K oshal ,

md , frcs [c ],

O f 2124 coronary artery bypass
operations performed in the University
of Ottawa Cardiac Unit, 77 were
reoperations. Three patients had had
their initial operation at other centres;
74 had two operations and 3 had
three operations. There was one
early death at 4 weeks after
reoperation (congestive heart failure)
and one late death at 9 months
(unknown cause). Myocardial infarc
tion occurred in the perioperative
period in four patients at the
initial operation and in eight patients
at the second operation. The
mean time between operations was
28.4 months. It was 9.2 months for
32 patients who had surgery for
occlusion or severe stenosis of
grafts, 1 month for 2 patients in
whom there had been a technical
error at the first operation, 55.2
months for 13 patients whose
disease progressed in other coronary
arteries and 36.8 months for
33 patients with both progressive
disease and occlusion of one or
more grafts. Angiography performed
after the initial operation or the
second operation (in the three
patients who had a second re
operation) was necessitated by angina
in 58 patients (total 61 cases)
and was done on a routine basis
in 19 patients. The improvement
in New York Heart Association
classification of symptoms was 1.9
classes at follow-up, and 74.2%
of patients have returned to work.
Follow-up angiography after reoperation
on 41 patients demonstrated a
patency rate of 7 6 % .
The authors believe that re
operation for coronary artery disease
can be performed safely, with
substantial alleviation of symptoms.

W. K eon , md , frcs [c], P. B edard,
AND M. BRAIS, MD, FRCS[C]

Routine postoperative angiography
increased the rate of reoperation
but appeared to reduce late
mortality.
Sur 2124 pontages coronariens
pratiques a I'unite de cardiologie de
I'universite d'Ottawa, 77 furent des
reinterventions. Trois malades avaient
subi leur premiere operation dans
un autre centre; 74 eurent deux
operations et 3 eurent trois operations.
II n'y eut qu’un deces precoce
survenant 4 semaines apres la rein
tervention (d ’insuffisance cardiaque)
et une mort tardive apres 9 mois
(de cause inconnue). Un infarctus
du myocarde frappa quatre patients
durant la periode peroperatoire lors de
la premiere intervention, et huit
malades lors de la second operation.
L’intervalle moyen entre les opera
tions fut de 28.4 mois. II fut de
9.2 mois pour 32 patients qui eurent
une intervention pour une occlusion
ou une stenose grave des greffons,
de 1 mois pour 2 patients chez
qui une erreur technique avait ete
commise lors de la premiere
operation, de 55.2 mois pour 13
patients dont la maladie evolua dans
d’autres arteres coronaires et de
36.8 mois pour 33 patients ayant
une maladie evolutive et une
occlusion d'un ou plusieurs greffons.
L’angiographie pratiquee apres I'operation initiale ou apres la seconde
operation (chez trois malades qui
subirent une deuxieme reinter
vention), fut commandee par I’angine
chez 58 patients (pour un total de
61 cas) et fut realisee systematiquement chez 19 malades. L’amelioration des symptomes selon la
classification de la New York Heart
Association fut de 1.9 classes a la
postobservation, et 74.2% des
patients ont repris le travail. Une
angiographie de controle pratiquee
apres une reintervention chez
41 patients a demontre un taux
de permeabilite de 7 6 % .
Les auteurs croient qu'une reinter
vention dans les cas de maladie
coronarienne peut etre realisee en
toute securite et procurer une
amelioration marquee des symptomes.

md , frcs [c ]

L'angiographie post-operatoire systematique a augmente le taux de
reintervention mais a semble red u ire
la mortalite tardive.

The surgical treatment of coronary
artery disease has met with great en
thusiasm. Saphenous venous bypass
grafting is the most widely used form
of myocardial revascularization result
ing in symptomatic improvement and
return to normal activity.1'3 Never
theless, there have been reports of re
operation necessitated by residual or
recurrent angina resulting from failure
of the original procedure, progression
of disease or inadequate primary re
vascularization.4'7
We reported on our initial exper
ience with reoperation in 1977,8 when
we had completed reoperations on 34
men. No early (within 30 days) or
late (more that 30 days) deaths re
sulted and 25 patients (73%) had
complete relief of angina. Studies
from other centres have shown accept
ably low early mortality ranging from
2.8%5 to 12%.6 However, the clinical
results have varied considerably. Nor
wood, Cohn and Collins7 found symp
tomatic improvement in only 11 of
23 patients (48%) of whom 30%
were asymptomatic. The Cleveland
Clinic group4 reported improvement
on follow-up in 176 of 202 patients
(87%) of whom 65% were asymp
tomatic. Allen and colleagues5 re
ported improvement in 42 of 62 pa
tients (68%) of whom 31% were
asymptomatic. In this paper we eval
uate our experience and define the
indications for reoperation for coro
nary artery disease.
Patients
Of 2124 coronary artery bypass
operations performed up to Dec. 31,
1977 at the University of Ottawa
Cardiac Unit, 77 (3.6%) were reoper
ations. Three patients had had their
initial operation at other centres. Sev
enty-four had two operations and 3
had three operations. There were 74
men and 3 women. Their mean age
at the time of the second operation
was 45.6 years. The mean time be-
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In two patients, routine postoperative
angiography revealed that technical er
rors had been made at the original
operation. In one case an anastomosis
had inadvertently been performed
proximal to an area of stenosis while
in the other, two diagonal grafts were
performed instead of two marginal
grafts. Both these patients underwent
reoperation within 1 month and these
errors were corrected. At the time
of reoperation, single-vessel disease
was documented in 2 patients, double
vessel disease in 21 and triple-vessel
disease in 54 patients.
Classification of left ventricular
function is made by a joint decision
of cardiologists, cardiac surgeons and
radiologists. It is based on a foursegment assessment of the ventricles
in the right anterior oblique view:
patients with class I left ventricular
function have one hypokinetic seg
ment, class II patients have two hypo
kinetic segments, class III patients
have dysfunction in three segments
and class IV patients have four mal
functioning segments (Fig. 1). Fig. 2
shows the classification of patients
before the initial operation and before
reoperation and also the change in
function during the time between the
two procedures. There was a general
trend towards increased ventricular
dysfunction between operations. Eight
patients originally classed as normal
had increased dysfunction; three pa
tients progressed to class I, three each
to classes II and III and two to class
IV (Fig. 2).

tween operations was 28.4 months
(range 2 weeks to 108 months).
The principal clinical indication for
reoperation in most other centres has
been severe, incapacitating angina.
This has not been the case at our
unit where only 58 of the 77 patients
presenting for reoperation had angina.
Approximately 30% of our cardiac
surgical caseload is referred by the
National Defence Medical Centre
where follow-up angiography is per
formed on a routine basis at 3 weeks
and 1 year after bypass grafting. On
routine postoperative angiography 19
patients were found to have abnor
malities that necessitated reoperation.
Table I presents a summary of the
indications for reoperation in our unit.
Of the 32 patients requiring reopera
tion because of occlusion or severe
stenosis of one or more of the existing
grafts, only 20 had angina. In the
remaining 12, the stenosis was dis
covered at routine postoperative angio
graphy. The mean time between oper
ations for this group of patients was
9.2 months.
Thirteen patients required reopera
tion because of progression of disease
in the native coronary vessels. Twelve
of these patients had angina and the
mean time between their operations
was 55.2 months.
Occlusion of one or more grafts
together with progression of disease
also necessitated reoperation. Only 4
of the 33 patients in this group were
without angina and the mean time
between operations was 36.8 months.

T a b le 1

At the time of their first operation,
12 (15.5%) of the patients were clas
sified as being emergencies, 9 as
having unstable angina and 3 as
having acute myocardial infarction.
At the second operation, only five
(6.5%) were classed as being emer
gencies, three as having unstable an
gina and two as having myocardial
infarction.
Operative Procedures

Table II shows the various proced
ures performed at the first and second
operations.
One patient had reoperation for
resection of a left ventricular aneu
rysm 46 months after the initial oper
ation and 17 months later required a
third operation because of stenosis of
a right coronary artery graft. This
was done without placing the patient
on cardiopulmonary bypass. Two
other patients did not require cardio
pulmonary bypass at reoperation; one
had received a right coronary artery
graft and the other had had a graft
placed in the left anterior descending
coronary artery.
Most of the technical complications
reported at reoperation occurred dur-

I n d ic a tio n s fo r R e o p e ra tio n

In d ic a tio n
A n g io g r a p h ic d e m o n s tra tio n
o f t e c h n ic a l f a ilu r e at
in it ia l o p e ra tio n
O c c lu s io n o r s e v e re
s te n o s is o f g ra fts
P r o g r e s s io n of d is e a s e
O c c lu s io n o r s te n o s is o f g r a fts
a n d p ro g re s s io n o f d is e a s e

N o. o f p a tie n ts
w ith a n g in a

T im e b etw e e n
o p e ra tio n s , mo
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0
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1
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1
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FIG. 1— Angiographic classification of
left ventricular contractility.
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ing opening of the sternum. In our
series, one patient’s functional graft
was divided on reopening the sternum
and a second patient had a perfora
tion of the left ventricle. Both of
these were corrected without adverse
effects.

We use several methods for reopen
ing the chest depending on the individ
ual situation. We have used the Stry
ker saw, sternal saw, the Luebsche
knife, and a combination of these.
For our earlier reoperations we used
normothermic perfusion and anoxic

myocardial arrest. More recently we
have changed to hypothermic potas
sium arrest at 5°C. We do not rou
tinely close the pericardium at first
operation and have not encountered
any difficulties at reoperation attrib
utable to this.
Results

One patient died 4 weeks after re
operation of congestive heart failure,
giving an operative mortality of 1.3%.
One patient died at 9 months of un
known cause. The 77 patients included
in this study received, at initial oper
ation, an average of 2.4 grafts per
patient and at second operation an
average of 1.9 grafts per patient.
There was no significant difference in
the number of vessels grafted per
patient in the symptomatically im
proved group compared to those pa
tients who remained in the same New
York Heart Association class postoperatively (excluding the patients who
were asymptomatic preoperatively).
Sixty-eight of the 75 surviving pa
tients were followed up for a mean of
22.5 months (range 6 weeks to 60
months). According to the NYHA
classification, 40 patients were asymp
tomatic, 19 were class II, 8 were class
Change in Ventricular Classification
III and 1 was class IV. If those who
were asymptomatic before the opera
FIG. 2— Classification of ventricular function of patients before initial operation
(a) and before reoperation (b). Semicircle represents one patient, full circle re tion were excluded, 16 patients had
improved by one class, 21 by two
presents two patients.
classes and 10 by three classes. Ten
patients remained in the same class
(Fig. 3).
At follow-up the work status of 62
of the patients was known. Forty-five
patients were working full time and 1
part time. Of the remaining 16 pa
tients, 9 were not working because of
disabling angina, 1 in class IV and 8
in class III. One patient who was
capable of working was not employed
because no work was available. Six
patients were retired; their mean age
was 61.5 years.
Perioperative infarction occurred at
the first operation in 5.2% (four
patients) and at reoperation in 10.4%
(eight patients). Seventeen patients
(22%) had myocardial infarction dur
ing the interval between the two sur
gical procedures.
Postoperative angiography (after
reoperation) was performed on 41 pa
tients (53%) who received 62 grafts.
The graft patency rate was 76% (47
of 62). These grafts were widely pa
tent with good distal run-off. The
remaining 15 grafts were occluded.
This figure of 76% is substantially
FIG. 3— Change in New York Heart Association (NYHA) class between initial
operation (a) and reoperation (b). Semicircle represents one patient, full circle
lower than our total patency rate
represents two patients.
of 89% for 1400 grafts studied postV O L U M E 23, NO. 2, M A R C H 1980
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operatively. It is interesting that four
of the eight patients having myocar
dial infarction perioperatively had one
occluded graft demonstrated by angio
graphic examination.
Discussion

In 1977 we reported on our initial
experience with reoperation for coro
nary artery disease.8 The number of
reoperations for myocardial revascu
larization performed at our unit has
increased steadily. This is not unex
pected since the total population from
which candidates for reoperation are
derived is cumulative. Our rate of
3.5% is slightly higher than the rate
of 2% to 3% reported by the Cleve
land Clinic.4
The hazards of performing repeat
myocardial revascularization opera
tions are very real.6-7,9,10 Normally
there is a higher operative mortality
although this was not the case in
our series (1.3%). There is also a risk
of damage to functioning grafts, the
native coronary circulation, or the
heart musculature itself. We had only
one case of damage to a functioning
graft and this was repaired without
incident. On one occasion, the left ven
tricle was perforated on opening the
chest and this also was repaired
without incident. It appears that most
complications arise on opening the ster
num. Various precautions such as de
flation of the lungs, division of the
sternum from the xiphisternal end
upwards, gentle dissection of the heart
from the under surface of the sternum
and retrograde dissection of the func
tioning grafts to their origin at the
aorta can assist in reducing accidents.
Certainly, the anticipation of techni
cal problems at reoperation is not
sufficient reason to deny this to a pa
tient particularly if that patient is
incapacitated by angina.
At most institutions the primary
indication for cardiac catheterization
at reoperation is recurrent disabling
angina.4’7 Approximately 30% of the
cardiac surgical caseload in our unit
is referred by the National Defence
Medical Centre in Ottawa where fol

low-up angiography is done on a rou
tine basis at 3 weeks and 1 year
postoperatively. Table III illustrates
the advantages of routine angiography.
Of patients referred to us from the
National Defence Medical Centre, 6%
had reoperation and the late mortality
was only 1.1%. This is in contrast to
the figure for the remaining group of
patients in which the rate of reopera
tion was only 2.5% and the late
mortality 7.3%. Of the 77 patients in
this series, 58 (75%) had angina of
varying degree. However, 19 patients
(25%) had conditions which indicated
the necessity for reoperation (Table I)
and these were discovered at routine
follow-up angiography. The consider
able increase in late mortality (6.2%)
for those patients not having routine
postoperative angiography and the fact
that 25% of the patients requiring
reoperation were asymptomatic under
line the importance of this diagnostic
procedure. It is valuable not only in
assessing the results of operation but
in leading to an early diagnosis of
inadequacies resulting from the first
operation. In this way, a second opera
tion is not delayed until symptoms
are present and, therefore, the late
mortality decreases.
Routine follow-up angiography may
demonstrate evidence of a defective
operation in an asymptomatic patient
(2 of 77). Such a defect leaves the
patient at serious risk of infarction
which may or may not be fatal. We
also believe that adequate assessment
of the effect of initial revasculariza
tion on late mortality cannot be made
unless the operation is satisfactory
from a technical viewpoint and that
the criteria defining “satisfactory tech
nical operation” require further study.
It is well accepted that initial direct
revascularization results in complete
relief or marked reduction of angina.
Our clinical results suggest that re
operation, also is successful. Of 68
patients available for follow-up, 78%
of those who were asymptomatic be
fore reoperation improved postoper
atively. Moreover, 74% of them re
turned to work.

Table III— Angiographic Follow-Up*

Referred from
National Defence Medical Centre,
Ottawa
Ottawa Civic Hospital

No. of
patients
607
1437

Reoperation
----------------No.
%

Late mortality
----------------No.
%

37
37

7
105

61
2.6

"Excludes 3 patients who had their first operation at another centre.
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1.1
7.3

Most graft failures have occurred
within the first few weeks after opera
tion.11-'2 This is in agreement with the
findings in our series. The interval
between operations for the patients
with occluded grafts was 9.2 months,
compared with 36.8 months and 55.2
months, respectively, for patients with
occlusion or stenosis of grafts in addi
tion to progression of disease and those
patients with progression of disease
alone. There was no direct correlation
between blood flow recorded intraoperatively at either first or second opera
tion and subsequent occlusion of the
graft. This supports our earlier theory8
that low flow rates at operation are
not necessarily indicative of future
graft occlusion.
Conclusions

We conclude that an aggressive ap
proach is necessary for patients who,
on follow-up angiography, whether
routine or necessitated by recurrent
symptoms, are found to have a vas
cular deficit that is correctable. Al
though reoperation is technically
challenging, repeat operation for myo
cardial revascularization can be per
formed without undue morbidity or
mortality and is justified by the im
proved clinical conditions observed in
previously symptomatic patients. Our
results also indicate that rehabilitation
can be effective. We suggest that post
operative angiography should be per
formed routinely. Even though an
giography increased the rate of
reoperation, it appears to reduce the
late mortality following initial aorto
coronary bypass grafting by revealing
indications for reoperation in patients
who are asymptomatic and may be at
serious risk of sudden death.
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Early Changes following Injection Injury
of Peripheral Nerves
F. G e n t il i ,

m d , m sc , A.R. H udson , m b , ch b , f r c s ( e d in ), f r c s [c ]
D. K l in e , m d and D. H u n ter , rt

Using light and electron microscopy
and a fluorescent tracer technique,
the authors have studied various
aspects of injection injuries to nerves
in an attempt to elucidate the
pathophysiology of this condition
and to help establish a rational
basis for treatment.
In 72 animals 144 nerve injections
were carried out, using five
drugs in current use and commonly
adm ir:~*"-“ d by intramuscular
injection. The nerves were examined
at varying times (10 minutes to
10 weeks) following injection.
Pathological alterations in the nerve
were evident as early as 30 minutes
after injection. The mechanism of
injury appears to be a direct
neurotoxic effect on the nerve
fibre— both axon and Schwann
cell— with a breakdown in the
blood-nerve barrier.
A I'aide du microscope optique
et du microscope electronique ainsi
qu'avec une technique de marquage
par fluorescence, les auteurs ont
etudie divers aspects des lesions
nerveuses par injection dans une
tentative pour elucider la pathophysiologie de cette affection et afin
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de participer a I'etablissement de
fondements rationnels pour son
traitement.

factor in determining the degree of in
jury. Extrafascicular injection pro
duced minimal or no evidence of in
On a pratique, chez 72 animaux,
jury to the nerve fibre. By contrast,
144 injections de cinq medicaments
nerve injury following intrafascicular
d’utilisation courante regulierement
injection varied from minimal or none
administres par voie intramusculaire.
to severe axonal and myelin degenera
Les nerfs ont ete examines a divers
tion, depending upon the agent used.
moments (de 10 minutes a 10
The degree of damage was also partly
semaines) apres I'injection. Des mo
related to the dosage of the drug
difications des nerfs etaient visibles
used. Wallerian degeneration was
aussi tot que 30 minutes apres
noted distal to the site of injection,
I’injection. Le mecanisme lesionnel
suggesting that segmental demyelinasemble relie a un effet neurotoxique
tion was not the primary pathologic
direct sur la fibre nerveuse (aussi
feature. Moreover, regeneration was
bien sur I’axone que sur la cellule
a constant finding; even nerves with
de Schwann) avec un bris de la
total axonal degeneration subsequent
barriere hemato-nerveuse.
ly regenerated.
Clinical experience has shown that
Injury to peripheral nerves after deep there is a group of patients in whom
intramuscular injections of therapeutic recovery does not occur following in
and other agents is well documented1-5 jection injury and in whom extensive
and in today’s drug-oriented society intraneural fibrosis is often found at
is not uncommon. 8 The sciatic nerve operation. We have postulated that
is most commonly affected, but in failure of the nerve to regenerate in
jection injury to other peripheral these patients may be related to the
nerves, including the radial, ulnar, axil effects of an admixture of drug and
lary, posterior interosseous and lateral blood elements on the nerve or to
femoral cutaneous, have been re associated vascular injury with dam
ported. 2' 7,8 The pathophysiology of the age to the blood-nerve barrier which
injury remains obscure3,5,9-13 and little normally acts to protect nerve
is known of the precise time-course fibres from the possible toxic effects
of this type of injury. 14
of agents injected near the nerve. The
Only a few experimental studies, present study was designed to in
based primarily on light microscopic vestigate the changes in the perineuobservations, have been reported. 8,15-18 rial diffusion barrier and endoneurial
Recently, using light and electron mi microcirculation following injection
croscopy, we reported on the patho injury. We also focused our attention
logical changes in the sciatic nerve of on the earliest changes following in
rats following injection of various jection injury to determine whether
chemotherapeutic and prophylactic the axon or Schwann cell with its
agents into or near that nerve. 19 The myelin sheath was the primary target
exact site of injection was a crucial of injury. The effects of injecting a
THE CANADIAN JOURNAL OF SURGERY

177

drug alone and together with blood
components were also compared.
Animals and Method

Seventy-two adult Wistar rats,
weighing 150 to 400 g, were anes
thetized with Nembutal® (30 to 50
mg/kg) administered intraperitoneally. The sciatic nerve was carefully
exposed in the upper thigh using
aseptic precautions and with the aid
of the operating microscope. With a
tuberculin syringe and a 30-gauge
needle, the nerve was injected in all
rats at a standard location near the
origin of a proximal hamstring
branch. Injections were made using
finger pressure, either directly into
the nerve fascicle (intrafascicular in
jection) or within the surrounding
epineurium (extrafascicular injection).
The site was marked with a 10-0
nylon stitch in the epineurial tissue
and the wound closed with 3-0 silk
suture.
Light and Electronmicroscopic

Studies
Eighty-four injections were made
in 42 animals. All injections in
this group were intrafascicular. Sev
eral agents, known from our previous
work19 to produce substantial nerve
fibre injury following intrafascicular
injection, were used. They were ce
phalothin sodium (Keflin®), benzylpenicillin (penicillin G potassium),
diazepam (Valium®), meperidine hy
drochloride (Demerol®) and chlordiazepoxide (Librium®). Autologous
blood alone and blood mixed with
either benzylpenicillin or diazepam
were also injected. Physiologic saline
was used as the control.
To assess the earliest changes re
sulting from nerve injection, 48 sciatic
nerves were examined at 5, 10 and
30 minutes and at 1, 2, 3, 4, 5, 6
and 24 hours after injection. The
remaining nerves were harvested at
1 to 8 weeks after nerve injection.

The various agents, the number of
injections and the dose and volume
of each agent used are shown in
Table I.
Animals were killed with an over
dose of Nembutal® and a 2-cm seg
ment of the injected sciatic nerve
was immediately removed and cut
into blocks 1 to 2 mm long and fixed
in Karnowsky’s fixative. Secondary
fixation was with osmium tetroxide.
The tissue was embedded in Araldite
502 (CIBA-Geigy Canada Ltd., Dorval, PQ) and sections of the nerve
1 /j. thick were stained with toluidine
blue for examination by light micro
scopy. Representative blocks were cut
with an LKB-3 ultramicrotome (LKB
Instruments, Inc., Rockville, Md.) and
specimens prepared for use in the
electron microscope.
Blood-Nerve Barrier Studies with
Evans’ Blue Albumin
Changes in vascular permeability
were investigated in 30 animals by
fluorescent microscopic tracing of in
travenously injected serum albumin
labelled with Evans’ Blue. This solu
tion was prepared by tagging 5%
bovine albumin (Nutritional Biochem
ical Corporation, Cleveland, Ohio)
with 1% Evans’ Blue (Fisher Scien
tific Company, Ltd., Toronto, Ont.),
here called Evans’ Blue albumin
(EBA). A standard dose of solution
(1 m l/100 g body weight) was injected
slowly in the femoral vein.
In 12 animals EBA was injected
intravenously immediately before in
trafascicular injection injury to the
sciatic nerve with benzylpenicillin.
Rats were killed in groups of three
after 10 and 30 minutes and after
1 and 24 hours. In a second series
of 12 animals, the sciatic nerve
was injected intrafascicularly with
either benzylpenicillin or cephalothin
sodium. After 15, 30 and 60 minutes
and 3 days, groups of three rats re
ceived an intravenous injection of

EBA and were killed 15 minutes later.
To provide controls, six rats were
either not injected or were injected
with normal saline before or after
administration of EBA, and subse
quently were killed at similar time
intervals.
For fluorescence microscopy, the
nerves were fixed in 5% formalin for
24 hours. Frozen longitudinal sec
tions 10 to 15 fi thick from various
levels of the nerve were mounted in
50% aqueous glycerine and viewed
under a Leitz SM-Lux fluorescent
microscope (E. Leitz, Inc., Rockleigh,
NJ), equipped with an N2 filter sys
tem. With this combination of filters,
the EBA complex emits a bright red
fluorescence.20 The method permits
detailed histologic localization of the
EBA tracer in thin tissue sections.
Results
Early Gross Changes
Successful intrafascicular injection
resulted in a localized swelling of the
nerve at the injection site. The solu
tion injected spread extensively along
the injected fascicle in both directions,
but there was no leakage outward
into the external sheath unless an
excessive volume (usually greater than
0.5 ml) was injected; this resulted in
disruption of the perineurium. The
injection of normal saline did not re
sult in any further notable gross
changes. By contrast, after intrafas
cicular injection of benzylpenicillin,
cephalothin chlordiazepoxide
and
meperidine, the nerve appeared pale,
often with many small petechial
hemorrhages on the surface of the
fascicle. At 24 hours, swelling at the
injection site was less marked, although
a grey discolouration was still evident
for a short distance both proximal and
distal to the injection site. Although
the nerve continued to show minor
discolouration at periods from 1 to 8

T a b le 1— D e ta ils o f A g e n ts In je c te d (L ig h t a n d E le c tro n m ic ro s c o p ic S tu d ie s )

Agent
C e p h a lo th in s o d iu m ( K e f l i n ® )
C h lo rd ia z e p o x id e ( L i b r i u m ® )
B e n z y lp e n ic illin
(p e n ic illin G , p o ta s s iu m )
B e n z y lp e n ic illin a n d blood
D ia z e p a m ( V a liu m ® )
D ia z e p a m and b lo o d
M e p e r id in e h y d ro c h lo rid e ( D e m e r o l® )
B lo o d
N o r m a l s a lin e ( 0 .9 % )

178

N o . o f s c ia tic
n e r v e s in je c te d
(in tr a fa s c ic u la r )

D oses

V o lu m e
in je c te d , m l

In te r v a l b e tw e e n in je c tio n
an d n e r v e e x a m in a tio n

10
14

20 m g
12 .5 m g

0 .1 a n d 0 .2 5
0.25

10 a n d 30 m in , 1 , 3 an d 6 h
10 an d 30 m in , 1, 2 , 3 , 4 , 5, 6 and 24 h

10
6
8
6
4
8
18

250 000 u n its
250 000 u n its
5 an d 10 m g
5 a n d 10 m g
5 mg

0 .3
0.35
0.25
0.30

5 ,1 0 a n d 30 m in , 1 , 4 a n d 8 w k
4 and 8 w k
1, 2 and 4 wk
4 and 8 w k
2, 3 a n d 6 h
1, 6 a n d 24 h , 1 a n d 4 wk
10 and 30 m in , 1, 2 , 3 , 4 , 5, 6 an d
24 h , 1 , 2 a n d 4 w k
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0.1
0.3
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weeks after injection, there was min
imal or no enlargement of the nerve
at the injection site. Significant ad
hesions to surrounding tissues were
rarely observed and, indeed, the in
jection site could generally be identi
fied only by the suture marker.
Microscopic Changes

Microscopic changes were evident
almost immediately after intrafascicular injection. At 5 to 10 minutes,
all nerves showed separation of axons

FIG. 1— Electronmicrograph of rat
sciatic nerve 1 hour after intrafascicular
injection of benzylpenicillin. Note dam
age to myelinated nerve fibres (a) with
areas of splitting of myelin lamellae (b).
A = axon, S = Schwann cell (lead ci
trate stain, X4560).

which were often displaced towards
the periphery of the fascicle; this was
related to the pressure effects of the
injection. Although in nerves injected
with normal saline no further changes
were demonstrable by light micros
copy, electron microscopy did reveal
minor changes in axons and myelin
sheaths in a few nerve fibres around
the injection site.
By contrast, at 30 to 60 minutes
following the intrafascicular injection
of penicillin, cephalothin and chlordi-

FIG. 3— Electronmicrograph o f rat
sciatic nerve 24 hours after intrafasci
cular injection of chlordiazepoxide. There
is complete disruption of myelin with
dissolution of myelin sheath (m). Axons
(A) also show damage with condensation
and distortion of axoplasm (lead citrate
stain, X5472).

azepoxide, marked abnormalities of
myelin sheaths were already evident
on light microscopy. Ultrastructure
studies revealed these earliest changes
to consist of splitting of myelin la
mellae in local areas (Fig. 1). At 3
to 4 hours, there was further splitting
and fragmentation of myelin and
axon; Schwann cells also exhibited
changes, with clumping and con
densation of both nuclear and cyto
plasmic material. Axons were less al
tered and changes were characterized
by slight swelling of mitochondria
within the axoplasm. Although most
marked at the site of injection, these
changes were seen for up to 1 cm
proximally and distally. The histologic
picture at 6 hours was similar to that
seen after 3 hours, except that the
myelin sheaths were further frag
mented and the nuclear membrane of
the Schwann cell was lost, with disso
lution of nucleoplasm (Fig. 2). There
were further changes in the axon,
with condensation of axoplasm and
marked swelling of mitochondria with
disruption of the cristae.
At 24 hours, the degree of damage
to nerve fibres was striking. At the
site of injection there were areas of
complete delamination and fragmenta
tion of the myelin sheath (Fig. 3).
Some axons were quite distorted, lying
eccentrically along one side of the
myelin sheath, while others had com
pletely disintegrated. Although the de
gree of damage decreased distally from
the injection site, important axonal
and myelin degeneration was still
evident 1 cm away.
Injection of Drug and
Blood Products

FIG. 2— Electronmicrograph o f myeli
nated nerve fibre 6 hours afer intrafas
cicular injection of chlordiazepoxide.
There is further damage to myelin sheath
(m) and clumping of nuclear and cyto
plasmic material in Schwann cell. Axonal
changes are less evident. N = nucleus
of Schwann cell (lead citrate stain,
X8208).
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FIG. 4— Sciatic nerve 5 weeks after
combined intrafascicular injection of
penicillin and blood. Note severe damage
to all nerve fibres with no evidence of
regeneration
(toluidine
blue
stain,

X1000).

/

The intraneurial injection of blood
alone produced no appreciable nerve
injury. At 4 weeks, there was degener
ation of only a few nerve fibres at
the injection site. The results of inject
ing admixtures of penicillin or diaze
pam with autologous blood were
similar to those observed with the
injection of these agents alone.19 Se
vere axonal and myelin degeneration
was followed ultimately by substantial
regeneration. However, the injection
of these agents with blood did prolong
degeneration and retard the regener
ative process. At 4 weeks after intra
fascicular injection of penicillin and
blood, there was still active degenera
tion with no evidence of regeneration
(Fig. 4); in contrast, at 4 weeks, rats
injected with penicillin alone showed
active regeneration of nerve fibres
(Fig. 5). Furthermore, there was a
greater degree of intraneurial fibrosis
and substantial numbers of fibro-

THE C AN AD IA N JOURNAL OF SU RG ER Y

179

blasts were present in the endoneurium in rats injected with drug and
blood.
Distribution of Evans'
Blue Albumin

The EBA conjugate is easily local
ized in sections of nerve tissue by
its bright red fluorescence when
viewed with the appropriate filter

FIG . 5— Rat sciatic nerve 4 weeks
after intrafascicular injection of penicillin
alone showing regeneration with dense
population of small thinly myelinated
regenerating fibres (toluidine blue stain,
X 1000).

system. Following injection of EBA,
the distribution of the labelled com
plex in control rat nerves was simi
lar to that described in other mam
mals.20,22 The red fluorescent marker
was seen in the epineurium, appear
ing not only in the lumen and
wall of the epineurial blood vessels,
but also immediately adjacent to the
vessels. This diffuse red fluorescence
in the epineurial sheath extended to
the inner layers of the perineurium,
but never into the adjacent endoneurium (Fig. 6). By contrast, fluo
rescence seen within the endoneurium
was confined to the lumen of the endoneurial capillaries, none appearing
outside the vascular walls (Fig. 7).
This impermeability of the endoneurial capillaries and inner layers of
perineurium to various macromole
cules, preventing their passage into
the extravascular space immediately
surrounding the nerve fibres in the
endoneurium, is considered to consti
tute a blood-nerve barrier.23,24
The distribution of EBA was mark
edly altered after intrafascicular injec
tion of penicillin and cephalothin.
Animals injected with EBA intraven
ously immediately before or after
nerve injection injury showed a sub
stantially increased extravascular fluo
rescence in the epineurium, with
penetration into the endoneurium
(Fig. 8). In the endoneurium, fluo
rescence was no longer confined
within the endoneurial capillaries, but
was also found outside the vascular
lumen (Fig. 9). Leakage of tracer

FIG. 6— Fluorescence micrograph of normal rat sciatic
nerve 1 hour after intravenous injection of Evans’ Blue albumin
(EBA). Red fluorescent marker seen in epineurial sheath ex
tends inwards to inner layers of perineurium (P) but not into
adjacent endoneurium (En). Ep = epineurium (reduced by
3% from X2800).
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from the endoneurial vessel was seen
for up to 1 cm from the site of in
jection. At 24 hours there was further
extravasation of EBA from the en
doneurial capillaries, with appreciable
extravascular fluorescence in the ex
tracellular spaces between the nerve
fibres.
Extrafascicular injection of these
agents did not substantially alter the
distribution of EBA from that ob
served in control, noninjected nerves.
D iscussion

The clinical picture of nerve injec
tion injury in man is characterized by
the sudden onset of severe pain at the
time of drug injection, followed either
immediately or within minutes by
profound sensory and motor paral
ysis. Our experimental observations
indicate that nerve injury is related to
a direct toxic effect of the injected
drug on the nerve fibre. Damage to
nerve fibres was evident as early as
30 minutes following drug injection,
and at 24 hours severe axonal and
myelin degeneration was seen. Burkel
and McPhee7 have also reported mi
croscopic changes as early as 10 min
utes after the injection of phenol into
the sciatic nerve of the rat. Although
in the present study the earliest
changes were seen in the Schwann cell
and its myelin sheath, axonal damage
was ultimately quite severe and de
generation of both elements of the
nerve fibre was found following this
type of injury. These results, together
with our observations of only minimal

FIG. 7— Fluorescence micrograph of normal rat sciatic
nerve 1 hour after intravenous injection of EBA showing en
doneurial microvessel. Note that fluorescence is confined to
lumen (L) of capillary, none appearing in extravascular endo
neurial space. En = endoneurium (reduced by 5% from
X2800).
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extraneural scarring, indicate that
nerve dysfunction is related to intrafascicular damage and not to com
pression from progressive external fi
brosis, as suggested by some.20 Fur
thermore, the intraneurial nature and
rapid development of pathologic
changes also suggest that early surgi
cal intervention would be of little
value in managing this type of lesion.
In a previous study, we noted sub
stantial regeneration following injec
tion injuries to the rat sciatic nerve.19
The regeneration was usually well ad
vanced by 4 to 5 weeks and was
associated with a minimal degree of
intrafascicular fibrosis.
Injection of an admixture of drug
and blood in the present study re
sulted in a considerable delay in the
regenerative process which often was
not evident until 7 or 8 weeks after
injection. Furthermore, regeneration
was accompanied by a degree of in
trafascicular fibrosis not seen follow
ing the injection of drug alone. Al
though one must be cautious in
extrapolating results obtained from
the few animal studies to man, our
findings suggest that coincident he
morrhage may contribute to the endoneurial fibrosis often found in patients
who show little or no recovery follow
ing injection injury.
It is now well established that under
normal conditions, nerve fibres in a
peripheral nerve function in a unique
environment created and maintained
by the blood-nerve barrier22,25'26
Waggener, Bunn and Beggs,23 using
ferritin, and Klemm,24 using peroxi

dase, found that when these sub
stances were injected into the epineurium or applied to the outside of
the peripheral nerve, they did not pass
beyond the inner layer of the peri
neurium.
Similarly,
Olsson and
Reese,20 using horseradish peroxidase
as an electron-dense marker, observed
that following intravenous injec
tion the peroxidase was confined to
the lumen of the endoneurial micro
vessel and did not leak out into the
extravascular endoneurial space. Thus,
the innermost layers of the perineu
rium and the walls of the capillaries
in the endoneurium, in preventing the
passage of certain macromolecules
into the extracellular space immedi
ately surrounding the nerve fibres, are
believed to constitute the principal
anatomic sites of the blood-nerve
barrier. Any damage to this barrier
may, therefore, increase the possible
deleterious effects of agents injected
into or near a nerve and result in
increased damage to the nerve fibre.
The present study showed a marked
increase in the permeability of the
perineurium and endoneurial capil
laries to fluorescent-labelled albumin
following an intrafascicular injection
injury to the rat sciatic nerve. This
suggests that there is a breakdown in
the blood-nerve barrier in this type
of injury. Although difficult to quanti
tate, the degree of extravasation of
the labelled albumin complex corre
lated broadly with the severity of in
jury seen by light and electron mi
croscopy. Following extrafascicular
drug injection associated with minima]

or no degree of nerve damage, there
was no appreciable alteration in the
distribution of the fluorescent tracer
from that of normal nerve. Others22
have shown that increased vascular and
perineurial permeability to serum pro
teins may persist for months following
crush injury of peripheral nerves.22
Breakdown of the blood-nerve
barrier following injection injury may
be due to direct damage to the vessel
wall by the injected agent or may
simply reflect one of the cardinal
features of the inflammatory response
which occurs following any injury to
a peripheral nerve.
Summary

The early changes following injec
tion injury of peripheral nerves were
studied using light, electron and fluo
rescence microscopy. The main find
ings were:
1. Pathological changes were evi
dent within 30 minutes after intra
fascicular injection injury of the rat
sciatic nerve. The mechanism of in
jury appeared to be a direct toxic
effect of the injected agent on both
elements of the nerve fibre-—axon
and Schwann cell with its myelin
sheath— which ultimately resulted in
severe axonal and myelin degenera
tion.
2. Injection of mixtures of drug and
blood resulted in a delay in regenera
tion and was associated with a greater
degree of intraneurial fibrosis.
3. Under normal conditions, both
the perineurium and endoneurial
blood vessel are impermeable to la-

En
FIG. 8— Fluorescence micrograph of rat sciatic nerve 1 hour
following intrafascicular injection of benzylpenicillin with prior
intravenous injection of EBA. Note marked penetration of
tracer into endoneurium (En). Ep ~ epineurium (reduced by
5% from X2800).
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FIG. 9— Fluorescence micrograph of rat sciatic nerve 1 hour
after intrafascicular injection of penicillin with prior intrave
nous injection of EBA showing endoneurial capillary. Note
that fluorescence is no longer confined to lumen (L) of mi
crovessel. There is leakage of tracer into adjacent endoneurial
space (F). W = wall of capillary (reduced by 5% from
X2800).

THE CANADIAN JOURNAL OF SURGERY

181

ministered by perineural and extramuscular injection in rats. Arch
Phys Med Rehabil 55: 33, 1974
H anson DJ: Intramuscular injection
injuries and complications. GP 27:
109, 1963
T arlov IM, P erlmutter I, Berman
AN: Paralysis caused by penicillin
injection: mechanism of complica
tion — warning. J Neuropathol Exp
Neurol 10: 158, 1951
Woodall B, Broadbent TR, T aver
I: Neuropathology of antibioticinduced peripheral nerve paralysis.
Surg Forum 1: 394, 1950
19. G entili F, H udson A, K line DG,
et al: Peripheral nerve injection in
jury: an experimental study. Neuro
surgery 4: 244, 1979
20. Olsson Y, R eese TS: Permeability
of vasa nervorum and perineurium
in mouse sciatic nerve studied by
fluorescence and electron micro
scopy. J Neuropathol Exp Neurol
30: 105, 1971
21. Olsson Y, K ristensson K: The
perineurium as a diffusion barrier
to protein tracers following trauma
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belled albumin and are thought to
constitute a blood-nerve barrier.
4.
Following injection injury, there 16.
was rapid and marked extravasation
of labelled tracer suggesting a break
17.
down in barrier formation which may
contribute to the deleterious effects
on the nerve fibres seen in this type
of injury.
18.
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BOOK REVIEWS
continued from page 170
retournement de celle-ci comme traitement
de l’hydrocele. II est pourtant plus simple,
plus facile et surtout plus efficace de
ligaturer et de resequer la partie proximale de la communication avec la cavite
peritoneale.
Ce livre peut certainement etre utile
aux etudiants en medecine, en particulier,
pour la preparation des examens. Les re
sidents en pediatrie et les pediatres l’utiliseront comme un livre de reference qui
se consulte rapidement. Les chirurgiens et
les residents en chirurgie d’autre part n’y
trouveront que peu d’interet, etant donne
le choix des auteurs de ne pas insister
sur l’aspect therapeutique.
J.C. D ucharme,

m sc(med), frcs [c]

Hopital Sainte-Iustine,
3175, chemin Cote Ste-Catherine,
Montreal, PQ
THE SURGEON’S MANAGEMENT OF
GANGRENE. William Reid and John
G. Pollock. 230 pp. Ulust. Pitman Med
ical Publishing Co. Ltd., Tunbridge
Wells, Kent, 1978. $36.50. ISBN 0-27279350-7.

This well written book by two experi
enced vascular surgeons from Glasgow
describes in excellent clinical detail the
management of patients with rest pain
and gangrene. Each chapter includes a
short historical review and a fairly ex
tensive bibliography; the references are
listed at the side of the appropriate page
and include most of the classic references.
The clinical diagnosis of patients with
gangrene is thoroughly presented, stressing
useful and important Signs. The longest
chapter in the book deals with the various
techniques of arterial reconstructive sur
gery, including “redo” surgery, and
stresses basic technical factors to improve
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patency rates, complete with numerous
pictures. It also states that cholecystectomy
or colon resection can be safely performed
after closure of the posterior peritoneum
in conjunction with artery surgery, a view
which is probably not acceptable to the
majority of vascular surgeons in North
America.
Vascular injuries, embolism of limbs
and aneurysms are succinctly described,
with emphasis both on the clinical and
technical aspects of their management.
Venous and cardiac gangrene, infective
gangrene and the role of anticoagulants
are also discussed.
The chapter on sympathectomy is of
interest for two reasons. First, the authors
believe there are sound indications for
sympathectomy in the management of
patients with rest pain and gangrene and
second, they describe their unequalled ex
perience with over 10 000 phenol sympa
thectomies since 1951, listing the indica
tions, precautions and complications.
Amputations are discussed in depth. The
authors describe the approach to selection
and rehabilitation in their unit. They
achieved 51% healed below-knee amputa
tions with a mortality of 2% compared
with 49% healed mid-thigh amputations
and a mortality of 22%. The authors
have not used immediate prosthetic fitting
or rigid dressings.
There is no discussion of the hemody
namics of arterial diseases or the role
of blood flow laboratories in the assess
ment of these patients. However, this has
been well covered in several recent text
books of vascular suurgery and does not
detract from the value of this book.
In their preface, the authors state that
the book is intended for the guidance
of the general surgeon and the postcontinued on page 204
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Long-Term Follow-Up of Patients Who Underwent
Single Valve Replacement with Bjork-Shiley
Prosthesis
B. B h ar a d w a j ,

R. W a l l ,

md|

and

at the time of late follow-up. In
patients who received an aortic
valve prosthesis, 73% had an excellent
result after operation (New York
Heart Association classes I or II) and
18% had some functional improvement.
In patients who received a mitral
valve prosthesis, 68% had an
excellent result and 18% were func
tionally improved after operation.
The incidence of thromboembolism was
8.3% and of anticoagulant-related
complications, 13.8%.

Single heart-valve replacement with
a Bjork-Shiley prosthesis was
undertaken in 118 patients between
Jan. 3, 1970 and Dec. 31, 1977.
The hospital mortality was 7% for
patients who had aortic valve replace
ment and 9% for those who had
mitral valve replacement. Recent im
provements in techniques for
myocardial preservation and cardio
pulmonary bypass resulted in a
notable reduction in hospital mortality
during the period 1974 to 1977
compared with that in the period 1970
to 1973; the rate was 5% for aortic
valve replacement and 4% for mitral
valve replacement between 1974
and 1977 compared with 9% and 18%,
respectively, during the period 1970
to 1973. There was an additional late
mortality of 8% in patients who
had an aortic valve replaced and
11% in those who had a mitral valve
replaced; the mean follow-up was 2.3
years (range 6 months to 7.5 years).
Seventy-one patients with an aortic
valve prosthesis and 38 patients
with a mitral valve prosthesis were alive

Entre le 3 janvier 1970 et le 31
decembre 1977, 118 patients ont eu le
remplacement d’une valvule cardiaque
par une prothese Bjork-Shiley. La
mortalite hospitaliere etait de 7% pour
les patients chez qui on a remplace
les valvules sigmoides de I'orifice
aortique, et de 9% pour ceux qui
ont eu un remplacement de la
valvule mitrale. Des ameliorations
recentes dans les techniques de
protection du myocarde et de cir
culation extra-corporelle ont resulte
en une diminution notable de la
mortalite hospitaliere durant la periode de 1974 a 1977 par rapport a la
periode de 1970 a 1973; entre 1974
et 1977 ce taux etait de 5% pour
le remplacement des valvules
sigmoides de I'aorte et de 4% pour
le remplacement des valvules mitrales, par comparaison avec 9%
et 18% respectivement, pour la
periode comprise entre 1970 et
1973. On a enregistre une mortalite
tardive additionnelle de 8% chez
les patients a qui on remplapa une
valvule sigmoide et de 11%
chez eux qui ont eu le rempla
cement d’une valvule mitrale; la
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postobservation moyenne fut de 2.3
ans (avec un ecart de 6 mois a
7.5 annees).
Soixante-et-onze patients porteurs
d'une prothese des valvules sig
moides de I’orifice aortique et 38
patients porteurs d'une prothese
de la valvule mitrale etaient encore
en vie lors du dernier examen
de controle. Parmi les patients qui
avaient recu une prothese aortique,
73% ont obtenu d'excellents resultats de I’intervention chirurgicale
(classes I ou II de la New York
Heart Association) et 18% eurent
une certaine amelioration fonctionnelie. Chez les patients qui avaient
repu une prothese de la valvule
mitrale, 68% ont beneficie d'excellents
resultats et 18% eurent amelioration
de la fonction cardiaque apres
I’intervention. La frequence des
thromboembolies etait de 8.3% et
celle des complications du traitement anticoagulant, de 13.8%.

Valve replacement is now well estab
lished treatment for valvular heart dis
ease. In 1969 Bjork1 introduced a new
type of tilting disc valve prosthesis
which had the advantages of low prof
ile, a lower gradient across the valve
orifice and central flow.2 The purpose
of this study is to report the long-term
follow-up (to IV 2 years) of patients
who had cardiac valve replacement
with a Bjork-Shiley prosthesis at Uni
versity Hospital, Saskatoon.
Patients and Methods

Between Jan. 3, 1970 and Dec. 31,
1977, 236 heart valves were replaced
at the University Hospital, Saskatoon.
The causes of the valvular lesions in
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these patients were: rheumatic heart
disease, subacute bacterial endocarditis,
myocardial infarction, dissecting aneu
rysm, myxomatous degeneration, con
genital bicuspid aortic valve and other
congenital anomalies. Bjork-Shiley val
ves were implanted in 142 patients.
There were 76 aortic and 42 mitral
valve replacements. Two patients with
tricuspid valve replacements, 12 who
received multiple Bjork-Shiley valves
and 10 patients who had a BjorkShiley valve as well as another
type of prosthesis (either Starr-Edwards
or porcine) implanted, were excluded,
leaving 118 patients available for
study. The patients were divided
into two groups: 50 patients who
underwent operation between 1970
and 1973 and 68 patients who were
operated upon between 1974 and 1977
(Table I). Hospital records provided
information on the age, sex, location
and type of valve, and early and late
complications. The operative procedure
was carried out through a median ster
notomy with standard techniques for
cardiopulmonary bypass using a bubble
or membrane oxygenator with a fluid
primer. The duration of bypass,
aortic cross-clamping and postoper
ative hospital stay for aortic valve re
placement averaged 70 minutes, 48 min
utes, and 17 days, respectively, com
pared with 64 minutes, 35 minutes and
19 days for mitral valve replacement.
The number of units of blood used dur
ing the hospital stay for aortic valve
replacement averaged 3.1 and for mi
tral valve replacement 2.3. Hemolysis
was assessed by serial determinations
of hemoglobin concentration, reticulo
cyte count, total and direct serum bili
rubin, serum lactic dehydrogenase and
creatine phosphokinase concentrations.
All patients were given anticoagulants
and adequacy of therapy was followed
by measuring prothrombin times. Clini
cal follow-up of every patient was done
by cardiologists annually. Clinical im
provement was categorized into: ex
cellent (New York Heart Association
classes I or II); improved (a complica

tion of surgery prevented complete re
covery or cardiac status was improved
by one class compared with preopera
tive status); and no significant im
provement in cardiac status or severe
disability as a result of operation.
Late complications such as hemol
ysis, complications of anticoagulant
(warfarin) therapy, thromboembolism,
valvular leaks and mechanical malfunc
tions were assessed clinically. Patients
with a valvular leak were omitted from
the assessment of hemolysis complica
tions. Follow-up ranged from 6 months
to 71/2 years (mean 2.3 years).
Results

There was a male predominance of
3.8 to 1 in patients who had aortic
valve replacement, and a male predo
minance of 1.4 to 1 for patients with
mitral valve replacement. There were
five operative deaths (7%) in patients
who had aortic valve replacement and
four (9%) in the group of patients
having mitral valve replacement. In the
group of 68 patients operated upon
between 1974 and 1977, the hospital
mortality was substantially reduced; it
was 5% for aortic valve replacement
and 4% for mitral valve replacement,
compared with 9% and 18%, respec
tively, in the 50 patients operated on
between 1970 and 1973 (Table I).
Table II summarizes the late results.
Of the patients with aortic valve re
placement, two who were functionally
improved died, one of cerebral infarc
tion and one of subacute bacterial endo

carditis. Four patients with no func
tional improvement died, one of heart
failure secondary to failure of the valve
prosthesis, one of acute renal failure
secondary to hemolysis and one
of intracerebral hemorrhage. In one
patient the cause of death was undeter
mined. Of the patients who had mitral
valves replaced, three with no func
tional improvement died, one of subac
ute bacterial endocarditis, one of throm
boembolic complications and one died
suddenly (cause unknown). One patient
with functional improvement also died
of thromboembolism.
Four patients (3.7%) had hemolysis
in the presence of a normally func
tioning valve (Table III). Fifteen pa
tients (13.8%) had complications re
lated to the use of anticoagulants. Four
were serious complications, requiring
hospitalization. Nine patients (8.3%)
had thromboembolic complications; in
seven neurologic deficit resulted. Four
patients (3.7%) had hemodynamically
serious valvular or perivalvular leaks.
The survival rates of these 118 pa
tients according to the life-table meth
od is set forth in Table IV.
Discussion

The Bjork-Shiley prosthetic valve has
been used at the University Hospital
in Saskatoon since 1970. It was se
lected because it has a central flow, a
low pressure gradient across the valve
orifice, durability and a low profile
design decreasing the risk of damage
to surrounding tissues.1"3 An operative

Table II— Late Results
Result
Excellent

Improved

No. of
patients

No.

%

No.

%

No.

Aortic
1970-73
1974-77

71
30
41

51
20
31

73
67
76

13
5
8

18
17
20

1
0
1

Mitral
1970-73
1974-77

38
14
24

26
11
15

68
79
63

7
1
6

18
7
25

1
0
1

Valve

Same

Late deaths*
No.

%

1
0
2

6
5
1

8
17
2

3
0
4

4
2
2

11
14
8

%

* > 30 d, follow-up 6 mo to 7V& yr (mean 2.3 yr).
Table 1--Early Results
Early deaths*
Valve
Aortic
1970 73
1974-77
Mitral
1970-73
1974-77
* <30d.

184

No. of Average
patients age, yr
76
33
43
42
17
25

50.4
50.5
50.4
46.8
44.4
48.6

No.
5
3
2
4
3
1

Table III— Late Complications in 109 Surviving Patients

%
7
9
5
9
18
4

Valve
Aortic

Complication

2
11
6
2
3

Hemolysis
Anticoagulant
Thromboembolism
Leaks (valvular and perivalvular)
Infection
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Mitral
2
4
3
2
2

Total, no. (and %)
4
15
9
4
5

(3.7)
(13.8)
(8.3)
(3.7)
(4.6)
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mortality of 5%4 is generally accepted
for elective mitral or aortic valve re
placement in good-risk patients. The
operative mortality in this study was
7% for aortic valve replacement (5%
since 1974) and 9% for mitral valve
replacement (4% since 1974). It is
noteworthy that the study included
both good- and poor-risk patients. Late
mortality was 8% for aortic and 11%
for mitral valve replacement. Other
series reported an early mortality of
7.6% to 12% for aortic valve replace
ment5'8 and 2.6% to 4.7% for mitral
valve replacement6,7,9 for the same pa
tients. Late mortality is reported as
3.2% to 19% for patients with aortic
valve implants6’7 and 1.4% to 10.5%
for mitral valves.6,7,9 The lowest fig
ures for both valves were for a fol
low-up period of 6 months to
2Vi years,6 while the higher figures
were for follow-up periods of up to
6 V2 years.7,9 Turner and associates3 re
ported an early mortality of 17% and
a late mortality of 8% for aortic, mitral,
double and triple valve replacement.
It is encouraging to see that our mortal
ity figures are similar to those re
ported by others.
Studies on the Starr-Edwards pros
thesis reported a 9% to 14% early
mortality for aortic valve replace
ment8,10 and 10.8% for mital valve
replacement.7 Isom and associates10
reported 7-year survival rates of
64% and 64.5%, respectively, for
aortic and mitral valve replacements,
using the Starr-Edwards prosthesis.
MacManus and associates11 reported a
survival rate of 58% at 8.6 years for
mitral valve replacement. Combined
early mortality for aortic, mitral,
double and triple valve replacement is
reported as 2% to 8% and late mortal
ity rate as 3% to 7.6% ,13,13 using
porcine xenografts. Stinson and asso
ciates14 reported an early mortality of
6.0% and 7.8% and a 3-year survival
rate of 91% and 78%, respectively,
for aortic and mitral valve replace
ments. Angell, Angell and Sywak15
Table IV—Survival According to Life-Table
Method
Valve
Years after
operation

Total

Aortic

Mitral

1
2
3
4
5
6
7
8

89.6
86.4
81.7
80.1
77.0
77.0
77.0
77.0

87.1
87.1
85.0
85.0
81.8
81.8
81.8
81.8

90.0
81.2
75.4
64.6
64.6
64.6
64.6
64.6
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compared patient survival after im a substantially lower rate of thrombo
plantation of porcine and Starr- embolic complications with 0% to 1%
Edwards valves and found that porcine for aortic replacement and 4% to 8%
valves had a 30% advantage over for mitral replacement.12'14
Starr-Edwards prostheses at 3 years
Complications relating to the use of
(aortic position), but this was decreased anticoagulants (warfarin) occurred in
at 4 and 5 years. In the mitral position,
15 patients (13.8%) causing one death
they found a 10% advantage for the due to cerebral hemorrhage. This was
Starr-Edwards valve at 5 years.
the commonest complication in our ex
In our study the results of operation perience and slightly higher than that
for the survivors of aortic valve re reported in other studies of Bjorkplacement, as shown in Table II, are Shiley valves (6.4% incidence, 1%
comparable to those of Rubin and as mortality).7 The most common cause
sociates,8 using Bjork-Shiley and porcine of death was cerebral hemorrhage.
valves, who found that 80% to 83% of
In our study four patients (3.7%)
patients were asymptomatic or im had valves that leaked (including periproved; at 4.4 years 64% of those valvular leaks). In other similar se
with mitral valve replacement were ries3,3,7 this figure varied from 0.4% 7
greatly improved and at 4.0 years 67%
(average follow-up 3.67 years)7 to 5.8%
of those with aortic valve replacement (follow-up 6 to 24 months).5 Turner
were greatly improved.
and associates3 noted that all leaks de
Hemolysis after implantation of a veloped within 2 months after implan
prosthesis is often associated with leak tation. Rubin and associates,8 in their
age, but hemolysis may occur with a comparison of Bjork-Shiley and Starrnormally functioning, competent pros Edwards valves, found a higher number
thesis.3,16 Four of our 109 surviving of perivalvular leaks with the Starrpatients had the late complication of Edwards prosthesis. The mitral position
hemolysis, which contributed to the produced a higher number of leaks
death of 1 patient by causing acute renal with both prosthetic17 and porcine allo
failure. This rate compared with that of graft valves.12 Deterioration, particular
Rubin and associates,8 who had 2 pa ly stenosis with shortening, stretching
tients with hemolysis in a series of 61 and immobilization, or incompetence
(3.3%) who received Bjork-Shiley with thinning, stretching or fenestration
valves, and 22 patients in a series of of the valve leaflets, was the most
151 (14.6%) with various models of prominent complication of porcine
Starr-Edwards valves. Ahmad and valves within 5 years of operation.
associates16 also found a higher rate After 5 years, Stinson and associates14
and greater severity of hemolysis with found that only 40% of porcine allo
Starr-Edwards than with Bjork-Shiley grafts in the mitral position and 49%
prostheses. The homograft valve did in the aortic position failed to show
not show evidence of hemolysis.
degeneration.
Nine patients (8.3%) had thrombo
In conclusion, the results of valve
embolic complications which were replacement with a Bjork-Shiley pros
thought to have caused the death of thesis in our experience are good and
four of them (two had mural thrombi). are comparable to those of others.
These complications were the leading Thromboembolism remains the most
cause of late death in our series. Bjdrk serious late complication, but bleeding
and Henze9 reported that thromboem problems resulting from anticoagulation
bolism was the cause of late death in are the most common. Hemolysis and
40% to 45% of patients with mitral leaks are uncommon, but were present
valve replacement who died; there even in our small series; the physician
was a higher rate in the Delrin series must be aware of them as late compli
than in the pyrolytic carbon series of cations.
Bjork-Shiley valves. Lepley and asso
ciates7 found a 6.9% rate of thrombo
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Clinical Judgement versus Arthrography for
Diagnosing Knee Lesions
R. G r en ier , m d and P. du T rem blay , md

The authors carried out a retrospective,
randomized study of 200 patients
with a preoperative diagnosis of
meniscal tear of the knee. Of 208
knees operated on, more than one
lesion was found in 84 knees
(40.4%). Arthrographic diagnosis was
incomplete or incorrect in 103
(51.5%) of 200 knees.
Chondromalacia of the patella was
present in 55 knees (26.4%) and
tears of the anterior cruciate ligament
were present in 15 (20.8%) of
the 72 athletes who formed part of
the study population.
With regard to the medial meniscus,
arthrographic errors occurred in
19% while clinical errors occurred
in only 9%. For the lateral meniscus,
the rate of accuracy of the radio
logists’ reports was 67% compared
with 97% accuracy for clinical
assessment. This study points out
that clinical evaluation still remains
the best means of diagnosing
knee lesions.
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Les auteurs ont procede a une etude
retrospective de 200 patients choisis
au hasard, chez qui un diagnostic
preoperatoire etait une lesion meniscale
du genou. Plus d’une lesion furent
retrouvees chez 84 des 208 genoux
operes (40.4% ). Le diagnostic arthrographique etait incomplet ou incorrect
chez 103 (51.5%) des 200 genoux.
La chondromalacie de la rotule
etait presente dans 55 genoux (26.4%)
mais une dechirure du ligament croise
anterieur fut rencontree chez 15
(20.8%) des 72 athletes qui faisaient
partie du groupe de patients etudies.
Concernant le menisque interne, les
erreurs arthrographiques sont survenues dans 19% alors que les erreurs
cliniques furent rencontrees que chez
9% . Pour le menisque externe, le taux
de precision des rapports radiologiques
fut de 67% compare a 97% de
precision pour revaluation clinique.
Cette etude veut demontrer que
revaluation clinique demeure le
meilleur moyen de diagnostiquer les
lesions du genou.

The knee is probably more often sub
jected to operation than any other
joint but is not the most frequently
injured; however, this articulation is
the most disabled when it is traumat
ized. The success of knee surgery de
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pends upon precise diagnosis and pro
per treatment. Precise diagnosis of
internal derangement of the knee can
be made by thorough clinical assess
ment. Technical aids should be used
only to complement the clinical eval
uation. Adequate treatment must take
into consideration all lesions that can
be found at arthrotomy.
With the advent of improved tech
niques of arthrography and arthros
copy 1 for assessing knee joint
symptoms, the clinical evaluation of
these problems has been neglected.
Arthroscopy is becoming more pop
ular, but is expensive, time con
suming, requires expertise and is not
available everywhere. Therefore it is
appropriate to remind ourselves that
good clinical evaluation is still the
best and cheapest means of diagnosing
knee problems.

4

Patients and Methods
In this retrospective study, we re
viewed the charts of 200 patients
picked at random from appro
ximately 600 patients who were
operated on with a preoperative
diagnosis of a meniscal lesion. We
checked all clinical preoperative diag
noses as well as the arthrographic
reports and compared them with the
operative findings.
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Arthrographic Diagnosis

There were 155 males (77.5%) and
45 females (22.5%). Operations were
performed on 208 knees. The age of
the patients ranged from 11 to 70
years (mean 32 years). Fig. 1 illustrates
the distribution of patients by sex
and age, and also indicates the
number of athletes in each age
group. For the male group there was
a higher proportion of injuries in
young adults and middle-aged patients
compared with the female group in
which internal derangement of the
knee seemed to be evenly distributed.
Men participated more than women
in physical activities and for a longer
time.
There were 72 athletes in the study
(36% of the total), 58 were men and
14 were women.

Arthrography was performed in
200 (96%) of the 208 knees.
Arthrographic diagnosis was in
complete or incorrect in 103 knees
(51.5%); in 97 knees (49.5%) the
diagnosis was complete and correct.
Findings

In 124 of the 208 knees (59.6%)
only one lesion was diagnosed preoperatively and confirmed by surgical
exploration; in the remaining 84 knees
(40.4%) more than one lesion was
found at operation.
The Medial Meniscus
Clinical examination indicated a
tear of the medial meniscus in 158
of the 208 knees, but a medial meniscal tear was found in only 144 in
dicating an error of clinical judgement
in 14 knees (8.8%), In 158 knees sub
jected to arthrography, a torn medial
meniscus was demonstrated in 132
knees but this was confirmed at oper
ation in only 123 knees, giving an
arthrographic false-positive rate of
6.8% (9 knees). (Two knees had a torn
lateral meniscus, three were normal
and four had other lesions.) Of the
other 26 knees in which arthrography
indicated no abnormality of the
medial meniscus, a tear was found at
operation in 21— an arthrographic
false-negative rate of 80.7%. (Two
knees had a torn lateral meniscus and
three were normal. Five knees had a
torn medial meniscus, but in addition
to a torn lateral meniscus.) Therefore
with respect to the medial meniscus
there were 30 arthrographic errors in
158 knees (18.9%) which is compar
able to that reported in the literature.1’2

The Side
Fig. 2 illustrates the distribution
of the knee lesion in patients by sex
and side. The right knee was operated
on 118 times (57%) and the left knee
90 times (43%). In eight patients
(seven men, one woman), both knees
were operated on.

The Lateral Meniscus
With respect to the lateral meniscus,
clinical examination pointed to a tear
in 34 (16.3%) of the 208 knees.
Arthrography showed the lesion in
only 22 knees, but a tear of the
lateral meniscus was found at oper
ation in 33 knees. Therefore, there

FIG. 1—Age and sex distribution.
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FIG. 3—Diagram illustrating oblique
views of patellofemoral joint advocated
by Maldague and Malghem.4 E = me
dial, I = lateral.

FIG. 2—Sex and side distribution.
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was only one clinical error (2.9%)
compared with 11 arthrographic er
rors (32.3%) which again corresponds
to what is reported in the litera
ture.2,3 There were also seven discoid
lateral menisci (3.4%).
Negative Exploration
In only seven instances was arthrotomy performed on knees that were
found to be anatomically normal.
Thus, clinical judgement together
with arthroscopy gave a 97% rate
of diagnostic accuracy.
Associated Lesions
Thorough, systematic exploration of
the knee joint at arthrotomy enabled
us to discover associated lesions in
84 knees (40.4%).
Chondromalacia of the patella was
the most common associated lesion
being encountered in 55 of the 208
knees (26.4%). Arthrosis was present
in 16 knees (7.7%) either in the
tibiofemoral compartments or the
patellofemoral joint. A tear of the
anterior cruciate ligament was dis
covered in 15 (20.8%) knees of the
72 athletes, 7.2% of the total series.
A pathologic suprapatellar plica was
found in eight knees (3.8%). There
were six meniscal cysts (2.8%), five
of the lateral and one of the medial
meniscus. A Baker’s cyst had to be
excised from five knees (2.4%).
Osteochondritis dissecans was found
in two knees (0.96%). There were
two knees with associated discoid
lateral menisci in addition to the five
isolated ones (3.4% of the total).
Discussion

A thorough meticulous clinical
evaluation of the knee by an ex
perienced orthopedist is still the best
way to diagnose internal derangement
of the knee. If the diagnosis is still
uncertain, arthrography and arthros
copy are useful aids. A normal ra
diologic result will avoid unnecessary
surgery. A positive examination, on
the other hand, will minimize de
lays.
A proper techique for arthro
graphy, using single or double con
trast material, is important,2 but
even more important is personal re
view of the films and inspection of
all internal structures, not only of
the menisci. It is quite easy to obtain
patellar views to assess the patello
femoral joint for vertical lesions in
the articular cartilage and oblique
views to assess each of the patellar
facets as advocated by Maldague and
Malghem4 (Fig. 3). Thus, arthro-
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graphy permits assessment not only
of the tibiofemoral compartments but
also of the patellofemoral joint, the
capsule and cruciate ligaments. Roent
genograms can also be taken with
valgus and varus stress or with an
terior and posterior stress, to assess
the stability of the knee. When oper
ation is undertaken, we agree with
Hughston,5 that arthrotomy must al
ways be performed with adequate
exposure to allow thorough explor
ation of the joint. This can be done
through a straight medial parapatellar
incision, which can be extended proximally or distally if necessary. It is
the only approach that allows ex
ploration of both sides of the joint.
Each compartment of the knee must
be inspected before meniscectomy.
When the surgeon performs an arth
rotomy, he must do it with an ade
quate and rational exposure to be
able to explore the joint com
pletely;6 each structure not only must
be visualized but also manipulated
with special instruments such as a
meniscus hook.
In view of incomplete findings of
arthrographic reports in 51.5% of
cases, the surgeon should personally
review the films to evaluate each
structure and to correlate the oper
ative findings with the radiologists’
reports. Discussions with radiologists
are often beneficial to both parties.
Once all diagnoses have been made
adequate treatment can be undertaken
and a valid prognosis determined.
Finally the surgeon will be in a better
position to manage rehabilitation
which will enable the patient to re
sume his normal activities more
quickly.
In a prospective study of 100
problem knees, Korn, Spitzer and
Olsson3 reported a high rate of ac
curacy with arthrography. Such good
results could have been obtained
because their study was a prospective
one. Under the same circumstances,
a retrospective study such as ours
better reflects the actual situation.
Conclusions
The surgeon who must operate on
the knee must avoid the common
error of planning his treatment in
accordance with the radiologists’s
report without reviewing the films
himself. Arthrography or arthroscopy
of the knee should not preclude a
thorough systematic exploration of
the structures of all compartments of
the knee. It is only by gathering all
information provided by clinical
evaluation,
arthrographic
studies,
188

arthroscopic and operative findings
that the surgeon can get a complete
picture of the knee, give the patient
the appropriate treatment and es
tablish a valid prognosis.
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by helping to prevent
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Neosporin Irrigating
Solution has a broad,
overlapping spectrum of
activity against susceptible
strains of gram-negative and gram-positive
uropathogens (including most strains of
Proteus and Pseudomonas). Resistance has
not been a problem with this agent.
Neosporin can be used with three-way
catheters or other catheter systems. Because
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there is no need to interrupt continuous
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Bile Reflux Gastritis and Esophagitis
G a e t a n o D e R o se ,

The authors reviewed 39 patients
in whom bile reflux gastritis and
esophagitis were diagnosed and
treated. All had epigastric pain not
relieved by antacids, 26 had heartburn,
13 dysphagia and 7 hematemesis.
On endoscopic examination, all had
reflux of bile into the stomach with
gastritis, 14 had bile in the esophagus
and 21 had esophagitis. Results of biopsy
in 15 patients were consistent with
gastritis or esophagitis. All but one
patient had a history of peptic
ulcer disease— gastric or duodenal— and
35 had undergone 48 gastric opera
tions. Treatment was medical but
those refractory to medical management
underwent operation.
A Roux-en-Y diversion of bile was
the most successful operative
treatment, benefiting 9 of 12 patients.
An adequate length of the efferent
limb was found to be important
as two patients were not improved
until this length was increased to
45 cm. Successful treatment depends
on the ability to distinguish this
syndrome from recurrent acid peptic
disease and esophageal reflux due
to sphincteric incompetence.
Les auteurs ont etudie 39 patients
chez qui une gastrite et une
oesophagite avec reflux biliaire ont
ete diagnostiquees et traitees.
Tous souffraient de douleurs
epigastriques qui n’etaient pas soulagees par les anti-acides, 26 avaient
des brulures d’estomac, 13 de la
dysphagie et 7 une hematemese.
L'examen endoscopique revela un
reflux biliaire e t une gastrite chez
tous les patients, la presence de
bile dans I'oesophage chez 14
d'entre eux, et 21 avaient une
oesophagite. Chez 15 patients, la
biopsie etait compatible avec une
gastrite ou une oesophagite. Tous, a
I'exception d'un patient, avaient des
antecedents d'ulcere— gastrique ou

From the department of surgery,
The University of Western Ontario,
University and Victoria hospitals,
London, Ont.
Accepted for publication May 15, 1979
Reprint requests to: Dr. J.H. Duff,
Department of surgery, University
Hospital, 339 Windermere Rd„ London,
Ont. N6G 2K3
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m d and

J o h n H. D u f f ,

duodenal— et 35 avaient subi 48 inter
ventions a I'estomac. On entreprit
un traitement medical mais les
cas resistants subirent une inter
vention chirurgicale.
Un detournement de la bile par
une operation de Roux-en-Y fut
I'intervention la plus efficace avec 9
bons resultats sur 12. Une longueur
adequate de la partie efferente a
ete jugee importante lorsque deux
patients ne purent etre ameliores
jusqu'a ce que la longueur soit
portee a 45 cm. Le succes du
traitement depend de I’habilete de
distinguer ce syndrome d'un ulcere
gastroduodenal recidivant ou d'un
reflux oesophagien du a une
insuffisance sphincterienne.

m d , f r c s [c ]

diagnosed and treated at Victoria and
University hospitals in London, Ontario,
during the years 1971 to 1976. Of these
39 patients, 17 were women and 22 were
men. The age range was 22 to 80 years
(average 52.6 years). All had endo
scopic examination. The endoscopist
judged all patients to have gastritis and
all had reflux of bile into the stomach
or lower esophagus, or into both. Signs
and symptoms were severe enough to
warrant medical or surgical treatment
of all patients.
Findings

Symptoms
Epigastric pain, unrelieved by anta
cids, was a presenting symptom in all
39 patients. The pain was usually made
worse by food, restricting the oral
intake and resulting in weight loss in
19 patients. All patients experienced
nausea and vomiting. The emesis was
reported as bile stained in 28. Twentysix patients complained of heartburn,
20 described symptoms of regurgitation
and 13 had dysphagia. Seven had one
or more episodes of hematemesis.

During the past two decades, the symp
tom complex alkaline or bile reflux gas
tritis has been increasingly recognized.
The clinical features are upper abdo
minal pain, nausea, bilious vomiting,
hypo- or achlorhydria and, in some pa
tients, gastrointestinal bleeding. Gastro
scopy reveals reflux of bile and gas
tritis with and without esophagitis. Most
patients have had gastric operations.
Investigative Procedures
Thus, other postgastrectomy syndromes
On endoscopic examination bile was
must be excluded.
Bilious vomiting has long been re seen refluxing into the stomach in all
cognized as a complication of gastric 39 patients, with 14 demonstrating bile
operations. In 1965, Toye and Williams1 reflux into the esophagus. Gastritis was
described a syndrome that was due to observed in all 39 patients and 21 had
bile reflux but different from the af esophagitis. Two patients were found
ferent loop syndrome. In 1968, Daven to have esophageal stricture and one a
port2 showed that bile salts could dis stomal ulcer. Biopsy specimens of
rupt the gastric mucosal barrier and gastric or esophageal mucosa, or both,
cause gastritis by allowing back diffu from 15 patients always showed a
picture consistent with gastritis or eso
sion of hydrogen ion.
It is well established that gastritis phagitis. Roentgenography after a bar
occurs after stomach operations in ium meal was carried out in all patients.
some patients. Gastritis is most com This was helpful in diagnosing hiatal
monly found following gastric resec hernia in four patients and esophageal
tion with gastrojejunostomy. It is reflux in six.
less common following Billroth I
Past Illness and Operation
gastrectomy, gastrojejunostomy with
Before the onset of the symptoms,
out resection, and vagotomy and
38
patients had a documented history
pyloroplasty. Whether bile regurgitation
and gastritis are concomitant findings of previous gastrointestinal disease. The
or have a cause and effect relationship majority had peptic ulcer disease—duo
is not yet established. It seems true that denal ulcer in 27 and gastric ulcer in
a number of patients have bile reflux 7. Only 4 of the 39 patients had not
previously undergone surgery. In the
and some gastritis without symptoms.
other 35 patients, 48 gastric procedures
Patients and Methods
had been carried out. Some patients
The records were reviewed of 39 had two or three operations before the
patients in whom this condition was start of their symptoms.
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Since 30% of patients had had sev
eral gastric procedures, it was impossible to tell which procedure, if any,
was the cause of biliary reflux gastritis.
Therefore, it was assumed that the ana
tomical status of the patient’s upper gas
trointestinal tract, at the time of diag
nosis, was most relevant. In this regard,
14 of the patients with bile gastritis or
esophagitis had had vagotomy and Bill
roth II gastrectomy, 11 had had vago
tomy and pyloroplasty and 3 had had
vagotomy and Billroth I gastrectomy.
The average interval from the date of
previous surgery to the onset of symp
toms of bile gastritis was 3.5 years.
Although 14 patients had symptoms
within the first year following opera
tion, the symptoms in two patients did
not develop until 21 years after vago
tomy and Billroth I gastrectomy in one
patient and following vagotomy and
Billroth II gastrectomy in the other.
The average duration of symptoms
from time of onset to initiation of
therapy, surgical or medical, was 2.6
years.
Three complications of bile gastritis
or esophagitis were observed. Nineteen
patients had weight loss, 15 had anemia
and 2 had esophageal stricture.
Treatment

The efferent limb of the Roux-en-Y
anastomosis was made 40 to 45 cm
long. All 19 patients had previously
had bilateral truncal vagotomy.
The follow-up of the surgically
treated patients ranged from 1 to 26
months (average 9 months). Of the 12
patients with a Roux-en-Y revision,
9 were asymptomatic. Three patients
had poor results following Roux-en-Y
gastrojejunostomy. Analysis of the poor
results showed that one had no further
bilious vomiting but was found to have
an esophageal motility abnormality and
continuing symptoms due to this dis
order. One patient had no relief of
symptoms despite normal findings at
endoscopy 24 months after operation.
This patient had a personality disorder
and required psychiatric therapy. One
patient returned 15 months after oper
ation with gastric outlet obstruction and
a stomal ulcer. Thus, 9 of 12 patients
who had a Roux-en-Y procedure of
adequate length did well. In contrast,
none of the seven patients treated by a
variety of other surgical procedures had
any improvement on follow-up (Table
I). In particular, none of three pa
tients improved following hiatal hernia
repair, which consisted of Nissen fundoplication in two and suture of crura
in one.

relieving esophageal symptoms. After
Roux-en-Y diversion, 9 of 12 patients
were cured of all such symptoms and 2
patients with esophageal stricture re
quired no more dilatation. Thus, it ap
pears that gastroesophageal reflux is
not symptomatic when bile is absent
and acid is minimized by gastric opera
tion. Several factors are important in
the pathogenesis of bile gastritis, eso
phagitis and associated bilious vomiting.
The gastroesophageal sphincter pressure
is lowered by gastrectomy.3 Since most
or all of the antrum is removed with gas
tric resection, serum gastrin levels are
decreased by up to 75%.4 Gastrin con
tracts the gastroesophageal sphincter.5
Thus, the effects of a lowered serum
gastrin on a weakened sphincter would
favour incompetence and regurgitation.
There is good evidence to support the
contention that the gastritis and eso
phagitis associated with bilious vomiting
are due to the effect of bile on gastric
and esophageal mucosa. Eastwood6 has
demonstrated disruption of gastric cells
in mice following instillation of bile
salts. Davenport2 showed disruption of
the gastric barrier due to bile salts in
denervated fundic pouches in dogs. In
man, there is evidence that duodenogastric reflux is a factor in causing gas
tric ulcer and acute gastric erosion.7,8
But the combination of bile reflux and
gastric acid is necessary. Ulcers do not
occur without acid. They may occur
without bile when there is hypersecre
tion of acid. In this and most other
series of patients with bile gastritis,
ulceration is rare. Most patients have
had gastric operations that profoundly
lower acid secretion. In this situation,
the result of bile reflux appears to be
gastritis which does not progress to
ulceration. The success of bile diver
sion by Roux-en-Y anastomosis in this
and other series9" of patients with bile
gastritis is further support for the con
cept that bile is an irritant to stomach
and esophageal mucosa. The rarity of

Medical.—Twenty patients had med
Discussion
ical treatment only and 19 had both
medical and surgical treatment. Medical
In the syndrome of bile reflux gas
therapy consisted of antacids, diet, tritis as described in this and other
metoclopramide and cholestyramine. series, symptoms and signs suggesting
Fifteen patients were treated with an esophageal involvement are common.
tacids alone and 11 of them were sub Twenty-six of our patients had heart
sequently operated upon; 19 were burn, 13 had dysphagia, 14 had eso
treated with antacids and metoclopra phageal reflux, 4 had hiatal hernia and
mide and 7 of them were later operated 2 had stricture. There is clinical evid
upon; 2 had antacids and cholestyra ence at least of an incompetent lower
mine and 1 required operation; 2 were esophageal sphincter and it is not sur
treated with a combination of antacids prising that antireflux procedures have
and both drugs and neither had un been advocated. Our experience sug
dergone operation at the time of follow gests that antireflux procedures are not
up. Long-term follow-up is incomplete. successful and, moreover, that diversion
Surgical.—In this series, the indica of bile is the most effective means of
tions for surgery were severe symp
toms, demonstration of gastritis and
bile reflux by gastroscopic examination,
Table I—Follow-Up of Surgical T re a tm e n t*
microscopic evidence of diffuse gastritis
and failure of medical management.
No. of
Im Eight of the 19 patients who were
O riginal procedure
Current procedure
patients proved
treated surgically had a previous Bill
B illroth II gastrectomy
Roux-en-Y gastrojejunostom y
roth II gastrectomy converted to a
B illroth I gastrectomy
Roux-en-Y gastrojejunostom y
Roux-en-Y gastrojejunostomy; 1 had a
Roux-en-Y diversion
Efferent limb of R oux-en-Y
Billroth I gastrectomy converted to a
lengthened to 45 cm
Gastropexy
Hemigastrectomy and R oux-en-Y
Roux-en-Y; 2 had Roux-en-Y diver
gastrojejunostomy
sions revised to lengthen the efferent
B illroth II gastrectomy
B illroth I gastrectomy
1
limb to 45 cm; 1 patient, having previ
B illroth I gastrectomy
B illroth II gastrectomy
1
Vagotomy and pyloroplasty B illroth II gastrectomy
ously had a gastropexy, underwent hem1
Gastrojejunostom y
Heineke-IVlikulicz pyloroplasty
1
igastrectomy and Roux-en-Y gastroje
H iatal hernia repair
3
junostomy; 3 patients had hiatal hernia
•Average follow -up, 9 mo.
repair; and the remaining patients had
a variety of other gastric procedures.
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ments of the blood. Diffusion
of oxygen from the alveoli is
greatly decreased, commonly
resulting in arteri^v^njoiis r
shunting t- d ph^npmenqn anT
which blood passes through
the lung without oxygenation,
i f th6 shock state jcdntiflu^
lysosomal enzymes in the
anoxic pancreas trigger the
release of myocardial depres
sant factor (MDF), a vaso' ^ctivepeptide whicKiaih
pattern of interstitial oedema. 1cause
of
j^ lih g lo t blood in the stag- the microcirculatiom4
nant microcirculation and
aggregatiorr ofl^jfdrriied ele^ ~

As th e treatmenfof the ij)aj
| tient in shndk has progressed
in recent years, various organ
systems have, in turn, been
The*‘Weaklink’’ Bbruting"

Although cerebral blood flow
is maintained early in shock
at the expense of the other
organs, this state of adequate!
perfusion does not persist for,
long. Relatively soon, avail
able oxygen becomes critically low, and the brain, too,
turns to anaerobic metabo- <
lism. Lactate aaff levels rise j
testitial spaces. Continued
oxygen deprivation threatens
both the cellular integrity of
the braih aridthe central ner
vous system function.
Once shock has progressed
bevond its early stage, fluid
administration alone is usu-

severe shock threatens each link
body’s chain of organ systems
Solu-Medrol exerts a protective
to preserve tissue function and i

m

S§ y.
1

LUNGS
[R A IN J g S B
r

K
it

-- J 1

ally not sufficient to reverse
j f i e haem odynam ic and cel
lular disruptions.

The actions of Solu-Medrol
affect all of the body’s systems:
In the kidney, increased per
fusion reverses the anoxic state
and improves organ function
as evidenced clinically by an
increase in urine output.1
irrr
.
1-..!.......h
Improvement m the pulmonary
vasculature is demonstrated by a
reduction in shunting and an
increase in oxygen consumption.
The affinity of haemoglobin for
oxygen is reduced permitting
increased delivery of oxygen by
the blood to the tissues.3

Solu-M edrol, administered in
^pharmacologic doses as part
r o f a comprehensive treatment
^regimen, can reduce vasocon
striction and increase tissue
perfusion. The multiphasic
^activity o f Solu-M edrol helps
■ restore haem odynam ic bal
a n c e , preserve lysosom e and
r cell membranes, and protect
Pplllllor*
o n rl intracellular
Cellular and
♦structures and function.

Pancreatic Iysosi
stabilized halting |lie[ productioi
of MDF.5
Capillary membram
the brain
are stabilized.
permeability reduced.*
Through its network of protectr
actions, Solu-Medrol strengthen
the chain of organ systems and
increases the shock patient’s
chances of survival.

A positive inotropic effect is
____4.1____
exerted on the heart ffurther
increasing the flow
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Solu-Medrol
(methylprednisolone sodium succinate)
Action:

Solu-Medrol, like other corticosteroids, exerts its action
by its anti-inflammatory effect.
Indications and Clinical Uses:

Intravenous administration of Solu-Medrol is indicated
in situations in which a rapid and intense hormonal
effect is required.
Shock:

In severe shock adjunctive use of intravenous methyl
prednisolone sodium succinate (Solu-Medrol) may aid
in achieving hemodynamic restoration. Corticoid
1 therapy should not replace standard methods of
l combating shock, but present evidence indicates that
concurrent use of large doses of corticoids with other
measures may improve survival rates. In particular,
large pharmacological doses of Solu-Medrol have been
proven useful in bacteremic or endotoxin shock,
hemorrhagic shock, traumatic shock, and cardiogenic
shock.
Contraindications:

Except when used for short-term or emergency therapy
as in acute sensitivity reactions, Solu-Medrol is
contraindicated in patients with arrested tuberculosis,
herpes simplex keratitis, acute psychoses, Cushing’s
syndrome, peptic ulcer, vaccinia and varicella.
Precautions:

Existence of diabetes, osteoporosis, chronic psychoses,
active tuberculosis, renal insufficiency or predisposition
to thrombophlebitis requires that Solu-Medrol be
administered with extreme caution. In the presence of
i infection, the causative organism must be brought
under control with appropriate anti-bacterials, or
therapy with Solu-Medrol should be discontinued.
While therapy with corticoids does not appear to be
contraindicated in pregnancy, caution is recommended,
particularly during the first trimester. Also, newborn
infants of mothers who received such therapy during
pregnancy should be observed for signs of hypoadrenalism and appropriate measures instituted if such
signs are present. Since Medrol, like prednisolone, sup
presses endogenous adrenocortical activity, it is highly
important that the patient receiving Solu-Medrol be
under careful observation, not only during the course
of treatment but for some time after treatment is
terminated. Adequate adrenocortical supportive
therapy including ACTH, must be employed promptly
if the patient is subjected to any unusual stress such as
surgery, trauma, or severe infection. Patients should be
advised to inform subsequent physicians of the prior
use of Solu-Medrol.
There have been a few reports of cardiovascular
collapse associated with the rapid intravenous admini
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause
and relation to other medications (i.e., diuretics) is not
known at this time, but physicians should be alert to
this possibility.
Adverse Reactions:

Adverse reactions are not likely to result from short
term intravenous administration of Solu-Medrol, but
may be anticipated if continued therapy with oral or
intra-muscular corticosteroid preparations is to follow.
Medrol has less tendency than prednisolone to induce
retention of sodium and water, and in some cases has
been observed to produce diuresis and an increased
excretion of sodium. Likewise, therapy with Medrol
appears to produce less nervousness and psychic
stimulation than that produced by prednisolone. While
epigastric distress has not been totally lacking in
patients receiving Medrol, the incidence and severity of
this side reaction to date suggest that although Medrol
has an enhanced anti-inflammatory potency when com
pared with prednisolone on a weight basis, the socalled ulcerogenic potential jf this corticosteroid is no
greater, and may even be less, than that of
prednisolone.
With the exception of the differences noted in the
preceding paragraph, Medrol is similar to hydro

cortisone and prednisolone in regard to the kinds of
adverse reactions and metabolic alterations to be
anticipated when treatment is intensive or prolonged.
Negative nitrogen balance is usually counteracted by a
high protein intake. In patients with diabetes mellitus,
Solu-Medrol may increase insulin requirements during
the period of administration. Ecchymotic manifesta
tions, while noted only rarely during the clinical
evaluation of Medrol, may occur. Excessive loss of
potassium is not likely to be induced by effective
maintenance doses of Medrol. If such reactions are
serious or distressing to the patient, reduction in
dosage or discontinuance of corticoid therapy may be
indicated. While a retardant effect on wound healing is
seldom encountered, except in high doses, it should be
a matter of consideration when Solu-Medrol is admin
istered in conjunction with surgery.
Symptoms and Treatment of Overdosage:

Single large doses of Solu-Medrol do not have any
apparent toxic effect and require no specific therapy.
Continuous overdosage would require careful gradual
reduction of dosage in order to prevent the occurrence
of acute adrenal insufficiency.
Dosage and Administration:

In treating severe shock there is a tendency in current
medical practice to use massive (pharmacological)
doses of corticosteroids. The following are Solu-Medrol
doses suggested by various authors:
Repeat
Author
Dose
Every 2-6 hours
100 mg
Oaks
100 mg. every 4-6 hours
200 mg
Weil
Every 4-6 hours
250 mg
Melby
15 mg/kg Every 24 hours
Cavanagh
30 mg/kg In 4 hours if needed
Dietzman
Therapy is initiated by administering Solu-Medrol
intravenously over a period of at least 10 minutes. In
general high dose corticosteroid therapy should be
continued only until the patient’s condition has
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose
short term corticoid therapy are uncommon, peptic
ulceration may occur.
In other indications initial dosage will vary from 10 to
500 mg depending on the clinical problem being
treated. The larger doses may be required for short
term management of severe, acute conditions. The
initial dose usually should be given intravenously over
a period of at least 10 minutes. Subsequent doses may
be given intravenously or intramuscularly at intervals
dictated by the patient’s response and clinical
condition.
Availability:

As Solu-Medrol (methylprednisolone sodium succinate)
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials
with water for injection.
Product monograph is available on request.
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1. Lillehei RC, et al (August 1972) Geriatrics, p 81
2. Lillehei RC, et al (1974) In Principles o f Surgery.
2nd Ed. Schwartz SI (Ed), p 133
3. McConn R (1972) Shock in Low- and High-Flow
States. Exerpta Medica, p 28
4. Webb WR (1977) The Organ in Shock. A Scope
Publication, p 16
5. Lefer AM (1974) Circ Shock, /: 165
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the symptom complex in the face of the
rather frequent endoscopic observation
of bile reflux is paradoxical and unex
plained.
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Correction
On page 11 of the January 1980 issue
in the article “Hyperalimentation and
cancer” by M. Deitel, M. Alexander
and L.R. Hew, an error was made in
the penultimate line (“had a total leuko
cyte count of less than”). It should
read “had a total lymphocyte count of
less than”. Also, in the English abstract
on the same page, the fourth and fifth
lines from the end are transposed. They
should read “and improvement in the
quality of life can be obtained. With
careful IVH”.

Further Manifestations of Behget’s Syndrome
D. W o o ster ,

m d , f r c s [ c ],*
m d , f r c p [ c]

E.S. L ilker ,

Behcet originally described a
syndrome of iritis and anal and vaginal
ulcerations. Many other manifestations
of this disease have since been
added, including rarely esophageal
and bronchial ulceration.
The authors report the case of
a 65-year-old woman who had a
40-year history of oral and genital
ulcers associated with arthritis,
thrombosis of the left subclavian
artery, asthma and esophageal
ulceration. Her esophageal and respi
ratory symptoms were dominant.
In the esophagus, despite effective
control of reflux, she continues
to have ulceration and secondary
stricture requiring intermittent
dilatation. When the stricture is tight,
aspiration of food occurs, aggravating
her asthma. The radiologic,
endoscopic and manometric features
of her esophageal disorder are
described.
Behcet, en premier lieu, decrit un
syndrome constitue d'iritis et
d’ulcerations anales et vaginales.
Plusieurs autres manifestations ont
depuis ete ajoutees, dont de
rares ulcerations oesophagiennes et
bronchiques.
Les auteurs signalent le cas d’une
femme de 65 ans qui presentait
une histoire de 40 annees d’ulceres
buccaux et genitaux, accompagnes
d’arthrite, de thrombose de I’artere
sous-claviere gauche, d’asthme et
d'ulceration oesophagienne. Les
symptomes oesophagiens et
respiratoires predominaient. En depit
d’un controle efficace du reflux,
elle continue a souffrir d'ulceration
et de retrecissement de I’oesophage
necessitant une dilatation periodique.
Ouand le retrecissement devient
important, il y a aspiration de
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nourriture, ce qui aggrave, I'asthme.
La radiographie, I’endoscopie et les
caracteristiques manometriques
de son probleme oesophagien sont
decides.

Behcet1 originally described a “triple
syndrome complex” of iritis and oral
and vaginal ulceration. Since that de
scription many other manifestations of
Beh§et’s syndrome have been re
ported . 2"15 These include arthritis, 5
thrombophlebitis, 6 myocarditis, aneu
rysms, 7 skin lesions, 4 and central nerv
ous system and renal involvement. 8
Gastrointestinal manifestations9 such
as esophageal disease, gastric, duode
nal, jejunal and colonic ulcers10,11 and
malabsorption have also been de
scribed. 7 Pulmonary manifestations12
consist of diffuse bilateral infiltra
tion , 13 recurrent pneumonia14 and
hemoptysis. 15
We report the case of a patient
with shallow bronchial and discrete
esophageal ulceration, who had asso
ciated esophageal stricture. These
findings, with the exception of eso
phageal ulceration, have not been
reported previously.

2). On endoscopy a mid-esophageal
stricture was seen and a biopsy specimen
revealed nonspecific ulceration. The
distal esophagus appeared normal.
In 1977 she again presented complain
ing of food sticking in her throat and of
increasing dyspnea. She denied having
any symptoms of reflux or hemoptysis.
Physical examination revealed shallow,
3 to 5-mm discrete ulcerations of
the oral and genital mucosa. Diffuse
rhonchi were heard in the chest. Roentgenographically there was no evidence
of reflux. The results of routine labor
atory investigations and chest roentgeno
grams were normal. Pulmonary function
tests indicated mild obstruction and air
trapping. Arterial blood gas values
showed minimal hypoxemia.
Contrast roentgenography and mano
metry confirmed that the hiatal hernia
repair was competent and an aspiration
scan
using
technetium-sulfur-colloid
showed no reflux or aspiration; how
ever, the technetium was noted to adhere
to the ulcerated mid-esophagus. On

Case Report
A 65-year-old white woman was seen
in 1972 with reflux associated with a
hiatal hernia. She had a 40-year history
of oral and genital ulcers associated with
arthritis in her hands, knees and ankles,
thrombosis of the left subclavian artery,
asthma and recurrent migrating pul
monary infiltrations. She had night as
piration with choking on refluxed gas
tric content and an esophageal stricture
(Fig. 1).
The patient’s esophageal stricture was
dilated to 60 French and a transthoracic
partial fundoplication gastroplasty was
performed; this gave good control of
reflux.
Postoperatively the patient did well
for 1 year. Then progressive dysphagia
developed and she required dilatation.
She had no symptomatic or roentgenographic evidence of reflux.
Esophageal motility studies performed
in 1975 demonstrated a normal length
of esophagus at the gastroesophageal
FIG. 1— Roentgenogram obtained in
junction but low tone, a functioning
1972 shows small hiatal hernia with re
gastroplasty tube and moderately severe flux. Mid-body of esophagus is diffusely
disordered motor activity of low ampli narrowed for 5 cm (arrows) by ulceration
tude in the body of the esophagus (Fig. and scarring.
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bronchoscopy discrete shallow ulcera
tions were seen in the trachea and left
main bronchus. Esophagoscopy revealed
multiple punctate superficial ulcers in
the mid- and upper esophagus and a
stricture in the middle third. The lower
esophagus was normal.
In view of the patient’s poor respir
atory status and possible bowel involve
ment, colon transposition was not re
commended. She is maintained with
symptomatic management for recurring
infection and bronchospasm. Her esopha
geal stricture requires intermittent di
latation.

Discussion

Behcet’s syndrome presents clini
cally in the third decade of life
with an incidence of 1:10 000.
According to Lehner,2 men are af
fected twice as frequently as women.
Two major features (iritis and oral or
genital lesions) and two minor fea
tures (any other including family his
tory)2'11 are necessary for the diag
nosis of Beh?et’s syndrome.
The cause is unknown, but viral,
bacterial and autoimmune mechan
isms have been thought to account
for the vasculitis underlying these
lesions.2,16 Increased amounts of C9,
c-reactive protein,
autoantibodies
a 2-globulin, y-globulin and salivary
IgA immunoglobulin have been de
monstrated.2 There is no specific
treatment.17
Pulmonary complications occur in
5% of patients,15 are associated with
thrombophlebitis and obstruction of
the superior vena cava12 and parallel
the general activity of the disease.
Pulmonary embolism is unusual and
does not account for the findings.7'12
Other pulmonary manifestations in
clude pleurisy, recurrent pneumonia
and massive, occasionally fatal, hemo
ptysis. Roentgenograms show recur

rent lung opacities and pulmonary
function tests indicate mild restric
tion.12
The findings on bronchoscopic
examination are seldom reported, but
have shown normal mucosa.15 One
report of bronchial aphthae has been
cited from the Russian literature.15
Lung biopsy specimens and autopsy
studies demonstrate diffuse fibrosis,
lymphocytic infiltration, medial de
generation of pulmonary arteries with
intimal thickening and angiomatoid
lesions.13,15 The short-lived opacities
seen in roentgenograms have been re
lated to pneumonitis,14 thrombosis
and aneurysms15 and fibrosis and
vasculitis.13
Nonspecific gastrointestinal com
plaints and malabsorption have been
reported in 44% to 55% of patients.7
Gastric, duodenal, jejunal and colonic
ulceration with hemorrhage or per
foration have occurred.911 Four pre
vious cases of esophageal involvement
with Behcet’s syndrome have been
reported.16-20 One case, however, was
questionable because steroids were ad
ministered in high dosage and the
presentation was atypical18 and a
second case19 was more likely one of
achalasia. Discrete esophageal ulcers
were not reported in either of these
patients.
One well documented case20 de
scribed a 21-year-old woman who had
oral and anal ulcers and a family
history of odynophagia. Esophagos
copy demonstrated three discrete,
8-mm shallow ulcerations in the
lower esophagus. Examination of a
biopsy specimen showed acute and
chronic inflammation. The findings
of motility studies and roentgeno
graphy were normal. The patient was
asymptomatic 8 weeks after treatment
with transfer factor and antacids.

A second reported case17 was of a
man with gastrointestinal bleeding
and oral, genital and skin lesions as
well as thrombophlebitis. Esophagograms obtained after a barium
swallow were reported as normal
and esophagoscopy showed multiple
discrete ulcerations in the distal eso
phagus.
Shallow discrete ulcerations appear
commonly with many manifestations
of Behcet’s syndrome and are related
to the associated vasculitis. Common
antigens have been shown for oral
mucosa, pharynx, esophagus, colon,
conjunctiva, skin and vagina and
autoantibodies to oral mucosa are
found in some patients.2 The vasculitis
common to these lesions is character
ized by perivascular infiltration re
sembling a delayed hypersensitivity
response.7
Summary

A patient with a long history of
oral and genital ulcers, arthritis,
thrombosis, esophageal and lung le
sions consistent with Behqet’s syn
drome is presented. This represents
the third report of discrete esophageal
ulcerations and the first report of
bronchial ulcers and esophageal stric
ture associated with this syndrome.
Diligent endoscopic studies in pa
tients with Behcet’s syndrome may
reveal additional examples of these
findings.
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Emergency Portacaval Shunting in Jehovah’s Witnesses
J am es S. D orsey , md and R .M . S to n e , m d , fr c s [c ], facs

Major surgical procedures in
Jehovah's Witnesses are complicated
by their refusal to accept blood
transfusion. This problem is ac
centuated in Jehovah's Witnesses
with major gastrointestinal
bleeding. The authors present two
cases of successful surgical man
agement of upper gastrointestinal
bleeding in Jehovah’s Witnesses
who had bleeding esophageal varices.
A short “skin to skin” time and
minimal blood loss were important
factors in the successful outcome.
Treatment of these patients without
blood transfusion suggests that
less blood might be needed in
more routine surgical procedures.

ment avec succes. Un temps
operatoire court et une perte de
sang minimale furent des facteurs
importants pour le succes des
resultats. Le traitem ent de ces
patients sans recours aux transfu
sions sanguines indique que moins
de sang est necessaire lors d'interventions chirurgicales plus
courantes.

who, for medical or religious reasons
are opposed to transfusion.
Case R ep o rts

Case 1
A 52-year-old Jehovah’s Witness had
a 15-year history of alcoholic cirrhosis
and chronic pancreatitis. He had ex
perienced three episodes of upper gas
trointestinal hemorrhage (15 years, 6
years and 9 months before admission).
On
the morning of admission he noticed
Refusal by the patient to accept melena
and reported to his local hospital.
blood or blood products complicates Esophagogastroscopy
demonstrated eso
the treatment of Jehovah’s Witnesses. phageal varices; at the time of endoscopy
This refusal is derived from their the varices were not bleeding. The patient
interpretation of the following script was transferred to the Mount Sinai Hos
ure: “For it is the life of all flesh; pital in Toronto for further manage
the blood of it is for the life thereof: ment.
The patient was a thin man; he was
therefore I said unto the children of
acute distress. His blood pressure
Les interventions chirurgicales maIsrael, Ye shall eat the blood of no inwasno130/70
Hg, without postural
jeures chez les temoins de Jehovah
manner of flesh: for the life of all changes; his mm
pulse
was 92 beats/min
sont compliquees par leur refus
flesh is the blood thereof: whosoever and regular. Cardiorespiratory examin
des transfusions sanguines. Ce proeateth it shall be cut off.” (Leviticus ation showed a grade 2/6 systolic
bleme s'accentue quand un temoin
17 : 14) .
ejection murmur along the left sternal
de Jehovah souffre d'hemorragie
In spite of this difficulty, major border but no other abnormality. The
gastro-intestinale grave. Les auteurs
operative procedures are being per findings on examination of the abdo
men were normal; tarry stool was pre
decrivent deux cas ou le saignement
formed on Jehovah’s Witnesses with sent
on rectal examination. There was
des voies digestives superieures
out blood transfusion.1 Although there
encephalopathy.
chez des temoins de Jehovah soufare several reports of cardiac opera noLaboratory
investigations showed a
frant de varices oesophagiennes
tions performed on Jehovah’s Wit hemoglobin value
of 8.9 g/dl; pro
hemorragiques fut traite chirurgicalenesses,2,3 we found only one reported thrombin time 18 seconds
(control 12
portacaval shunt.3 We report two Jeho seconds), normal electrolyte values; total
From the faculty of medicine, University vah’s Witnesses with alcoholic cir serum protein value 5.3 mg/dl; al
of Toronto and the department of
rhosis who underwent emergency bumin 3.2 mg/dl; total bilirubin 0.5
surgery, Mount Sinai Hospital,
portacaval shunting for management mg/dl, direct 0.2 mg/dl.
Toronto, Ont.
The nature of his disease was dis
of bleeding esophageal varices. This cussed
the patient and his wife.
report raises questions concerning Because with
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esophagogastric varices in patients, to be high, a portal decompression
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Workshops
Available
The Royal College of Physicians
and Surgeons of Canada is pleased
to announce a series of workshops
which will be held in conjunction
with the Annual Meeting. These
have been structured and are being
presented in response to requests
to provide more practical clinical
application sessions at the meeting.
The majority of workshops will be
held on Tuesday, June 3 with others
on Wednesday and Thursday, June 4
and 5.
Topics of workshops and registra
tion fees are as follows:
Workshop on How to W rite and
Publish a Medical Paper —

Tuesday, June 3
Registration fee:

$75

Postgraduate Course on
Anorectal Diseases —

Tuesday, June 3
Registration fee:

$75

Systems of In-Training Evaluation —

Tuesday, June 3
Registration fee:

$75

Cardiovascular Pathology —

Tuesday, June 3
Registration fee:

$40

Advances in Diagnostic
Clinical Enzymology —

Tuesday, June 3
Registration fee:

$40

Practice and Investment
Management Workshops —

(A special series of half-day
workshops)
a) Building a Successful Practice —
a.m., Wednesday, June 4
Registration fee: $40
b) Direct Billing —
p.m., Wednesday, June 4
Registration fee: $40
c) Taking the Wrinkles Out
of Group Practice —

Case 2
A 53-year-old Jehovah’s Witness was
admitted to hospital for investigation of
splenomegaly and thrombocytopenia.
Liver function tests gave normal results;
however, a liver biopsy specimen showed
macronodular cirrhosis. Endoscopy re
vealed esophageal varices. A prophylac
tic portal decompression procedure was
suggested but the patient refused. He
had experienced one life-threatening
hemorrhage before admission.
Fourteen months after discharge he
was readmitted to hospital with massive
hematemesis. On examination he had
tachycardia but was normotensive. His
hemoglobin concentration on admission
was 7.1 g/dl. Because of profuse bleed
ing a Blakemore tube was inserted. The
patient refused blood transfusion because
of his religious beliefs. Considering the
circumstances, an emergency portal de
compression procedure was suggested.
The patient agreed; the risks of surgical
treatment without blood transfusion were
explained to the patient and his family.
An end-to-side portacaval shunt was
carried out. Estimated blood loss was
50 ml. Postoperatively his hemoglobin
level fell as low as 4.2 g/dl, but his
course was uncomplicated. He was
treated with iron supplements. Five and
a half years after operation, the patient
is alive and well. There have been no
further episodes of bleeding.
Discussion

a.m., Thursday, June 5
Registration fee: $40
d) Specialty Investments —

p.m., Thursday, June 5
Registration fee: $40
For more information write:
Secretary
Annual Meeting
Program Committee
The Royal College of Physicians
and Surgeons of Canada
74 Stanley Avenue
Ottawa, Ontario K IM 1P4
— D032
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procedure was elected. The problems of
a surgical procedure without blood
support were explained to the patient
and his wife. They again refused blood
transfusion, but requested operation.
Within 24 hours of admission, the
patient underwent a portacaval shunt.
Operating time was 59 minutes. Except
for a postoperative septicemia from a
central venous catheter, his course was
smooth. Postoperatively, his hemoglobin
concentration fell to 5.4 g/dl on the
11th postoperative day but had risen to
8.9 g/dl by the time of discharge on
the 23rd hospital day. Iron supplement
was prescribed upon his discharge from
hospital. Three months postoperatively
his hemoglobin level was 11.1 g/dl.
He has had no further episodes of
bleeding.

Major surgical procedures in Jeho
vah’s Witnesses are complicated by
the refusal of these patients to ac
cept blood transfusion.1 In some
instances this problem can be cir
cumvented by the use of auto
transfusion, but some Jehovah’s Wit
nesses refuse autotranfusion also.
Gordon and associates4 reported the
successful management of a hemor
rhage due to peptic ulcer in a Jeho
vah’s Witness by using selective
arterial infusion of vasopressin. The
Jehovah’s Witness with a severe

VOLUME 23, NO. 2, MARCH 1980 /

hemorrhage
from
esophagogastric
varices secondary to portal hyper
tension presents a problem in man
agement. Patients with serious hemor
rhage from varices are at a high
risk of rebleeding with an increased
risk of death. With these factors in
mind, we suggest that Jehovah’s
Witnesses who have such a condition
should undergo either prophylactic or
emergency portal decompression de
pending upon the clinical situation.
Orloff and associates5 have advo
cated emergency portacaval shunting
in selected patients. They reported a
50% operative mortality. This high
mortality may be related not only to
a long operative procedure in their
series (average “skin to skin” time 4.2
hours), but also to the extensive pre
operative studies (7 hours of radiographic investigations). A shorter
“skin to skin” time and minimal
blood loss were important in the
management of our two patients, and
preoperative investigations were min
imal.
The management of these two
patients without blood transfusion
suggests that less blood need be used
in more routine surgical procedures.
Minimal blood requirements have
been demonstrated in cardiac oper
ations.6,7 We do not advocate that
many patients be made anemic post
operatively, but in view of the
limited blood supply and the asso
ciated risks, blood transfusion should
be used conservatively.
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Determinants of Mortality following
Coronary Bypass Surgery
Conrad P elletier , md, frcs[c ],* R obert Cossette, md, frcs[c], L eon D ontigny, md, frcs[c ],
Claude M ercier , md, A rthur P age, md, frcs[c] and A lain V erdant, md, frcs[c]

Factors related to early and late
mortality were studied in 663
consecutive patients who had coronary
bypass operations. There were 18
operative deaths (2.7% ) and 15 late
deaths (2.3% ). Patients who died
were slightly older than surviving
patients. Operative mortality was
higher (5.3% ) in those with congestive
heart failure; this correlated directly
with the degree of abnormal wall
motion shown on left ventriculograms.
Preoperative end-diastolic pressure of
the left ventricle was not a good
predictor of death. While operative
mortality was 1.5% in those with
stable angina, it increased to 4.2%
in patients with unstable angina and
to 25% in patients with evolving
myocardial infarction. In those with
stenosis of the left main coronary
artery, early mortality was 12.3%.
Although early mortality was un
affected by the extent of coronary
disease or by the degree of correction,
it increased significantly (P < 0.05)
with the number of grafts inserted
and when other cardiac procedures
were also performed. Perioperative
myocardial infarction was associated
with a 28% mortality, but was
unrelated to graft failure in 60% of
the cases. Late mortality was related
only to the number of diseased
coronary arteries. Thus, left ventricular
function, severity of angina and
extent of coronary obstruction appear
to be the main determinants of
survival following coronary artery
operation.

mortality precoce et tardive. II y a
eu 18 deces operatoires (2.7%) et
15 deces tardifs (2.3% ). L’age
des patients decedes etait
legerement superieur a celui des
survivants. L'insuffisance cardiaque
a augmente la mortality operatoire
(5.3% ) et nous avons retrouve une
correlation directe avec le degre
d'atteinte de la dynamique ventriculaire
gauche a la ventriculographie. La
pression tele-diastolique ventriculaire
gauche pre-operatoire ne s'est pas
averee un bon facteur de prediction
de la mortality. La mortality operatoire
fut de 1.5% dans I'angine stable,
4.2% dans I'angine instable et 25%
dans I'infarctus en evolution. Une
stenose du tronc commun gauche
augmentait la mortality precoce a
12.3%. Si I’etendue de la maladie
coronarienne et le degre de correction
n'ont eu aucun effet sur la mortality
operatoire, par contre celle-ci
augmentait avec le nombre de pontages
ainsi qu'avec ('association d’autres
procedures cardiaques. L’infarctus
operatoire entrainait une mortality de
28% , mais dans 60% il ne pouvait
etre attribue a une occlusion du
greffon. Seule I'etendue de la maladie
coronarienne a influence la survie
a long terme. En conclusion, la
fonction ventriculaire gauche, le
tableau angineux et I'etendue des
lesions coronariennes sont les
principaux facteurs de survie apres
la chirurgie coronarienne.

The value of coronary bypass opera
tion for relieving angina pectoris has
been well demonstrated,1,2 but whether
or not operation prolongs the life of
patients with ischemic heart disease
is still controversial. There are indica
From the cardiovascular and thoracic
surgery service, Hopital du Sacre-Coeur tions that survival may be improved
de Montreal, and the department
by surgical treatment in specific
of surgery, Universite de Montreal,
groups of patients.3"5 To improve pa
Montreal, PQ
tient selection for operation and to
*Scholar, Medical Research Council
assess more accurately the prognosis
of Canada
for individual patients, factors that in
Accepted for publication July 5, 1979
fluence survival following direct myo
Reprint requests to: Dr. Conrad
cardial revascularization must be bet
Pelletier, Chirurgie cardiovasculaire
ter defined. Preoperative function of
et thoracique, Hopital du Sacre-Coeur
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to be the most important determinant
Chez 663 patients consecutifs soumis
a la chirurgie coronarienne, nous avons
etudie les facteurs qui influencent la
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of survival. Other factors that may
affect survival have been found to do
so inconsistently.
The purpose of this study was to
determine the factors that were of
prognostic value in patients treated
surgically for coronary artery disease.
Data from 33 patients who died (18
early, 15 late) were compared with
those of survivors in a consecutive
series.

Patients

From May 1, 1971 to Apr. 30,
1977, 689 consecutive patients under
went aortocoronary bypass grafting at
the Hopital du Sacre-Coeur in Mont
real. Twenty-six patients who also had
valve replacement were excluded.
The remaining 663 patients with iso
lated ischemic heart disease formed
the basis of the study. There were
523 men (79%) and 140 women
(21%), aged 23 to 69 years. Preoperatively, 479 patients (72%) pre
sented with stable angina and 184
(28%) with unstable angina, includ
ing 16 patients with electrical or
enzymatic evidence, or both, of an
evolving myocardial infarction just
before operation. In addition to by
pass grafting, resection of a left ven
tricular aneurysm in eight patients
and closure of a postinfarction septal
rupture in one patient were carried
out. The clinical, angiographic and
operative data for each patient were
entered prospectively into a com
puter analysis program. Survivors were
followed regularly at the out-patient
clinic and follow-up forms were com
pleted for each visit.
Of the 18 operative and early deaths
(2.7%), that is, death within 30 days
of operation, 11 patients died of myo
cardial infarction; 3 others died of
congestive heart failure and the re
maining 4 patients died of various
noncardiac causes.
The patients who died early were
compared with the 645 early survivors
(those who survived at least 1 month).
Seventy-nine patients with a follow
up of less than 5 months were ex
cluded from the late survivor group.
All but six (1%) of the remaining
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group were followed up from 6
to 72 months. There were 15 late
deaths (2.3% ) which occurred from
2 to 40 months (average 14 months)
after operation. Eight of these pa
tients (53% ) died of cardiac causes,
five patients (33% ) died of noncar
diac causes, and in two the cause
of death was unknown. These 15
patients were compared with the re
maining 545 long-term survivors in
whom the mean follow-up was 21
months.
A nalysis o f D ata

Patients who died early and those
who died late were compared with
the early and late survivors separa
tely. The yf test and unpaired Stu
dent’s /-test were used for analysis of
the data and the 5% significance
level was adopted.
R esults

Early Death
Age.— The average age of the
patients
who
died
early
was
57.1 ± 1.8 (mean ± standard error
of the mean) at the time of operation
compared with 50.9 ± 0.3 years for
the 645 survivors, a difference that
is significant (P = 0.001); 78% of
the operative deaths occurred among
patients aged 50 years or more.
Risk factors.— In this study, the
incidence of previous myocardial in
farction, demonstrated by electro
cardiography, and of diabetes mellitus
were higher in patients who died at
operation, but this difference was
not significant (Fig. 1).
Left ventricular function.— Thirty-

eight patients (5.7% ) had clinical with the severity of angina preoevidence of left ventricular failure pre- peratively. None of the 59 patients
operatively, and all suffered anginal with class I or II (NYHA) angina
pain. There were two operative deaths died, but there were six deaths
in this group (5.3% ) compared with (1.7%) among the 346 patients with
16 deaths (2.6% ) among the 625 class III angina and 12 deaths (4.7% )
patients free of clinical signs of heart among the 258 patients with class IV
failure. However, this difference was angina.
Distribution and extent of coronary
not statistically significant. None of
the 19 patients with a class II in artery disease.—While lesions of the
capacity (New York Heart Association left main coronary artery were signifi
classification) died, but there were cantly (P < 0.0001) more frequent
two deaths (10.5%) among the 19 in patients who died early compared
with surviving patients, the distribu
patients in class III or IV.
Resting left ventricular end-dias tion of lesions in other coronary ar
tolic pressures, measured at the time teries was similar in both groups
(Fig. 2 ). Operative mortality was
of coronary angiography in 15 patients
who died early and 98 consecutive 12.3% in the 65 patients with signi
survivors, were compared (Table I). ficant stenosis of the left main coro
The average pressure was similar in nary artery (greater than 50% nar
both groups and the same percentage rowing). The number of diseased
of patients (27%) had a pressure above arteries in both groups was not si
20 mm Hg before operation. On the gnificantly different, although triple
other hand, wall motion assessed from vessel disease occurred more often
a single plane left ventriculogram in in those who died (Table III).
the right anterior oblique projection Operative mortality was 1.5% (three
correlated directly with operative mor patients) in single-vessel disease, 2.8%
tality, which increased from 1.4% (six patients) in double-vessel disease
when contractility was normal, to and 3.7% (nine patients) in triple
2.6% when a localized contraction vessel disease.
Number of bypass grafts.— The
defect was present, and to 6% when
more diffuse abnormal motion was number of bypass grafts inserted per
patient averaged 1.8 ± 0.03 for sur
present (P < 0.05, Table II).
Severity of angina.— Among the vivors and 2.2 ± 0.2 for those who
479 patients with stable angina 7 died early (not significant). However,
a breakdown of the mortality in this
(1.5%) died at operation. Of the 168
patients with unstable angina 7
(4.2%) died and of the 16 patients
with an evolving myocardial infarc
tion 4 (25%) died. These differences
in operative mortality are significant
(P = 0.0001). Operative mortality
also increased significantly (P < 0.05)

A

4

Table I— Preoperative Left Ventricular End-Diastolic Pressure (LVEDP) in 98 Consecutive
Long-Term Survivors, and in Those Who Died Early and Late
Preoperative LVEDP

FIG. 1— Risk factors among survivors
and those who died early.

> 2 0 mm Hg
O perative
result

Mean,
mm Hg

No. of
patients

16.0
16.3
12.0

98
15
14

Survived
Died early
Died late

No.

%

26
4
2

27
27
14

Table I I — O perative M ortality According to Preoperative Im pairm ent of Left V en tricu lar
Contraction Assessed from Ventriculogram s
Total patients

Early deaths

Wall motion
abnorm ality

No.

%

No.

%

None
1 w all
> 1 w all

296
233
134

45
35
20

4
6
8

1.4
2.6
6.0
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FIG. 2— Anatomical distribution of
coronary artery lesions among survivors
and patients who died early. Only sten
osis of left main coronary artery shows
significant difference.
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regard showed a significant relation
ship (P < 0.05). While the mortality
was 1.7% in the 286 patients who
received only one graft, it increased
to 2.1% in the 235 patients with two
grafts and to 5.6% in the 142 patients
who had three or more grafts placed.
Degree of revascularization.—Com
plete myocardial revascularization was
achieved in 435 patients (66% ). In
the remaining patients, revasculariza
tion was incomplete and accounted
for a similar proportion of surviving
patients (34%) and those who died
(39% ). There was no significant dif

Table I I I — Number of Diseased Coronary
A rteries among Survivors and Those
Who Died Early*
Early
deaths
(n = 18)

Survivors
(n = 645)

No. of
vessels
involved

No.

%

No.

%

1
2
3

198
211
236

31
33
37

3
6
9

17
33
50

♦Differences are not significant (P > 0.05).

ference in operative mortality between
the groups with complete and with
incomplete operative correction (2.5%
and 3.1%, respectively).
Associated operative procedures.—
Isolated myocardial revascularization
resulted in an early mortality of 2.3%
(15 of 654 cases). In the small group
of nine patients who underwent re
section of an aneurysm or septal re
pair in addition to bypass grafting,
there were three operative deaths, all
due to irreversible cardiogenic shock.
Perioperative myocardial infarc
tion.—The diagnosis of a new infarc
tion related to operation was estab
lished on the basis of any one of the
following criteria: increased levels of
serum glutamic oxaloacetic transami
nase and creatine phosphokinase
above 100 and 1000 IU/1, respect
ively, electrocardiographic evidence of
new Q waves, loss of R wave potential,
the usual vectorial changes and ana
tomical evidence of recent necrosis at
autopsy. Forty-three patients (6.5%)
had perioperative myocardial infarc
tion and this was the main cause of
operative death; 12 (28%) of these
43 patients ultimately died. In 90%
of the cases, the newly infarcted ter

ritory was that of a bypassed coronary
artery. Most often (73%) the inferoposterior wall was involved. In 20
of these patients, graft patency was
verified either by angiography (18
patients) or at autopsy (2 patients).
The bypass grafts in the territory of
the new infarction were found to be
patent in 12 instances (60% ) and
thrombosed in 8 (40% ).
Late Death
The 15 patients who died late were
significantly older (P = 0.001) than
the 545 long-term survivors, their age
at the time of operation averaging
58.7 ± 1.8 and 50.8 ± 0.3 years,
respectively; 93% of those who died
late were aged 50 years or more.
There were no significant differ
ences between the long-term survivors
and patients who died late in regard
to risk factors, clinical signs of con
gestive heart failure, angiographic
evidence of decreased motion of
the left ventricular wall and clinical
type of angina preoperatively (Table
IV). Among the risk factors, only
hypertension was notably more fre
quent in those who died late, al-

v

v-

v
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While the ejection fraction has im Emergency operation is now resorted
portant predictive value for late car to only for the occasional patient who
diac death, it is not discriminating does not respond to medical man
for early death.12,13 This index of agement. In such patients, mechanical
cardiac function could not be eval support preoperatively by intra-aortic
uated adequately in our patients be balloon pumping may contribute to
cause the complete contour of dilated decreased mortality.20
Although half the operative deaths
left ventricles often could not be
traced on a single frame of the ven occurred in patients with triple-vessel
triculogram, thus resulting in over disease, the mortality was not sub
stantially greater than in patients with
estimation of the ejection fraction.
Operative mortality was influenced less extensive disease. Overall late sur
by the clinical status of the patients vival was lower in these patients than
preoperatively. Evolving myocardial in those with single- and double-vessel
infarction carries a high surgical risk involvement. On the other hand, ana
and bypass grafting is now rarely con tomic distribution of the coronary
templated when there are no mech
anical complications of infarction.14
In our experience the surgical mortal
ity in patients with unstable angina
is almost three times higher than in
patients with stable angina. Similar
results have been reported by
others.1546 The increased surgical risk
may be partly imputed to the timing
of operation. During the period of this
study, emergency operation without
medical stabilization was performed in
Discussion
FIG. 3— Actuarial rate of survival fol
most cases of unstable angina. Recent
coronary bypass grafting accord
In the present study, three groups studies indicate that angina can usually lowing
ing to number of vessels involved. There
of factors were found to influence be controlled by medical therapy and is no significant difference in survival
mortality in patients who underwent elective operation can then be per between three groups for each interval
coronary bypass operation: left ventri formed with a lower mortality.17'19 (P > 0.05).
cular performance, severity of the
coronary artery disease and factors
T a b l e I V — P r e v a le n c e o f V a r i o u s C li n i c a l F e a t u r e s in L o n g - T e r m S u r v i v o r s a n d
related to the operation. In addition,
T h o s e W h o D ie d L a t e *
patients who died were slightly older
than those who survived. However,
L a te
L o n g -te rm
good functional improvement and a
d e ath s, %
s u r v iv o r s , %
(n = 15)
(n = 545)
F e a tu re
low operative mortality can be ex
pected in elderly incapacitated pa
33
37
P r e v i o u s m y o c a r d ia l in f a r c t io n
25
29
tients, so that age alone should not
H y p e r lip e m ia
25
10
H y p e r t e n s io n
be considered a contraindication to
0
9
D ia b e t e s
surgery.11
8
6
C o n g e s t iv e h e a rt fa ilu re
The risk of operation is markedly
58
54
V e n t r i c u l a r h y p o k in e s i a
83
72
increased in patients with clinical
S t a b le a n g i n a
17
28
U n s t a b l e a n g in a
evidence of disabling congestive heart
failure preoperatively,7,9 but because
‘ D i f f e r e n c e s a r e n o t s i g n i f i c a n t ( P > 0 .0 5 ).
of the small number of our patients
with such a condition the difference;
was not statistically significant. The
decrease in left ventricular function
T a b le V — E x t e n t o f C o r o n a r y D i s e a s e a n d O p e r a t i v e C o r r e c t io n in L o n g - T e r m S u r v i v o r s a n d
T h o s e W h o D ie d L a t e *
was assessed objectively by measure
ment of the end-diastolic pressure and
L a te
L o n g -te rm
by visual evaluation of the segmental
d e ath s, %
s u r v iv o r s , %
E x t e n t o f d is e a s e a n d
wall contractility on the left ventri
(n = 1 5 )
(n = 545)
o p e r a t iv e c o r r e c t io n
culograms. In our experience, pre
C o r o n a r y a r te ry le s io n s
operative end-diastolic pressure did
17
8
L e f t m a in
not prove to be a good predictor of
83
89
A n t e r i o r d e s c e n d in g
mortality. On the contrary, a direct
67
48
C ir c u m f l e x
75
63
relationship was found between abnor
R ig h t
No. o f g ra fts
mality of segmental wall motion and
42
45
1
operative mortality which was four
33
37
2
times higher in patients with marked
25
18
>3
33
35
impairment than in those with normal
S u r g e r y in c o m p le t e
contraction. Ejection fraction has also
‘ D i f f e r e n c e s n o t s i g n i f i c a n t ( P > 0 .0 5 ).
been used to quantitate left ventri
cular performance preoperatively.

though the difference was not signifi
cant. Preoperative left ventricular enddiastolic pressure averaged 12 mm
Hg in 14 of the patients who died
and was greater than 20 mm Hg in
only 2 of them (14%). These figures
are lower than those of the long-term
survivors (Table 1).
The anatomical distribution of coro
nary artery lesions, number of grafts
implanted and completeness of opera
tive correction were also similar in
those who survived and those who
died (Table V). Although stenosis of
the left main coronary artery was
found twice as often in the latter
group, the difference was not signifi
cant.
The overall rate of survival com
puted by the actuarial method, showed
a slightly better survival in singleand double-vessel disease than in
triple-vessel disease (Fig. 3). The dif
ference between the three groups for
each interval was not statistically
significant.
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lesions had no significant effect on
survival, except for left main coronary
artery stenosis in which a higher oper
ative mortality has been reported; re
cent reports, however, indicate an im
provement in prognosis with careful
hemodynamic management at the time
of operation . 21"23
No correlation was found between
completeness of coronary revasculari
zation and survival. This contrasts
with the findings of others15,24 who
reported a decrease in mortality when
more grafts were implanted. However,
in those studies the improvement in
results may be attributed to increased
experience rather than the number of
bypassed arteries, since groups of pa
tients operated upon early in the
surgical experience were used as the
basis of comparison. 15,25 Our overall
surgical mortality compares favourably
with these studies in which more nu
merous grafts were placed. While cor
relation between the number of bypass
grafts and operative risk is still con
troversial, it is generally recognized that
coronary artery surgery combined with
other cardiac procedures carries an
increased mortality. 12,15,26,27 This may
be partly related to a poorer preoper
ative left ventricular function.
Perioperative myocardial infarction
was the main cause of operative death.
Most often the newly infarcted ter
ritory was that of a bypassed coronary
artery. However, in less than half of
the cases, the infarction could be
ascribed to graft failure. This raises
the question of the cause of necrosis
in the remaining group; the necrosis
could be due either to suboptimal
myocardial protection during opera
tion or to reperfusion necrosis. There
are experimental data supporting both
hypotheses. 28,29

infarction. Better definition o f those
factors with a predictive value leads
to improved patient selection and as
sessment of risk before operation. The
fact that, in most cases, perioperative
myocardial infarction occurs in the
territory of a grafted artery but is not
related to graft failure suggests that
protection of the ischemic myocardium
is not always optimal. This stresses
the need for improved patient man
agement before bypass is carried out
as well as for better techniques of
myocardial preservation during oper
ation.

Preoperative left ventricular func
tion, severity of clinical disability and
extent of involvement of the coronary
arteries were all found to be impor
tant determinants of early death fol
lowing coronary artery surgery. Others
have also reported a marked increase
in operative risk in patients with poor
ventricular
contraction associated
with extensive coronary artery dis
ease. 30 Late survival in our patients
correlated only with the number of
diseased coronary arteries. On the
other hand, no relationship was found
between early or late death and the
degree of operative correction of the
lesions or the presence of such risk
factors as diabetes, hyperlipemia, hy
pertension and previous myocardial

in patients 70 years of age and older.
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SYMPOSIUM ON AESTHETIC SUR
GERY OF THE BREAST. Y ol. 18.
Edited by John Q. Owsley, Jr. and Rex
A. Peterson. 363 pp. Illust. The C.V.
Mosby Company, Saint Louis, 1978.
$65. ISBN 0-8016-3793-7.

In November 1975, the Educational
Foundation of the American Society of
Plastic and Reconstructive Surgeons and
The American Society for Aesthetic
Plastic Surgery held a symposium on
aesthetic surgery of the breast in Scotts
dale, Arizona. Forty well qualified and
experienced plastic surgeons contributed
papers to this 3-day symposium. The en
tire proceedings were taped and later
edited to produce this excellent book.
In the past decade there has been a
great increase in demand for aesthetic and
reconstructive procedures related to the
female breast, so the publication of this
book is timely.
The book is divided into five major
sections: reduction mammoplasty; correc
tion of ptosis, asymmetry and contour
defects; subcutaneous mastectomy and
repair; reconstruction after radical abla
tion; and prosthetic augmentation. Each
major subject comprises a historical re
view and an attempt to define aesthetic
goals for the various types of operations.
Black and white photographs and line
drawings are used to assist the reader’s
understanding of the text. Despite the
multiauthorship of the book it is co
hesive and easy to read. There are 50
chapters devoted to specific topics and
at the end of most chapters is a substan
tial bibliography.
I thought the chapters on subcutaneous
mastectomy were particularly well written
and sensible. The chapter on reconstruc
tion of the breast after mastectomy by
Cronin and Upton is excellent and clearly
demonstrates the use of regional flaps to
provide added tissue to facilitate staged
augmentation of the breast. Their method
of nipple reconstruction gives superior re
sults as judged by clinical photographs.
VOLUME 23, NO. 2, MARCH 1980
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Unfortunately, some new and important
procedures in breast surgery have been
reported since this book was conceived
in 1975. Use of the latissimus dorsi flap
to add soft tissue to the chest wall and
the inferior flap reduction mammoplasty
as described by Robbins and later by
Courtiss and Goldwyn are examples that
come to mind.
Undoubtedly this book will be of great
value to residents in plastic surgery and
also to more experienced surgeons who
are active in the field of breast recon
struction.
G.H. K nutson, md, frcs[c]
Department of surgery,
Toronto General Hospital,
Toronto, Ont.
THE YEAR BOOK OF SURGERY. 1978.
Edited by Seymour I. Schwartz, John
S. Najarian, Erie E. Peacock, Jr. and
others. 523 pp. Illust. Year Book Med
ical Publishers, Inc., Chicago, 1978.
Price not stated. ISBN 0-8151-7617-1.

This annual review of interesting articles
in the field of surgery is wide ranging.
Articles from the literature in the United
States, Canada and Britain, and a few
other countries, cover the period from
June 1976 to January 1978.
In each section a chosen article is re
viewed followed by an editorial comment
indicating the reason for the reviewer s
choice of that article. Most papers chosen
are of clinical value with some reviewers
being slightly more investigative in their
emphasis.
The annual overview at the beginning
of the book is worth reading first because
it highlights the areas of interest selected
by the panel of reviewers and notes
trends in the practice of surgery.
There is an obvious attempt by the
reviewers to make the article and editorial
comment useful to the reader and a learn
ing experience. For this the publication
can be commended. It is by no means an
exhaustive review of the literature but
draws attention to published information
considered important and timely by the
reviewers. Reading the book is an enjoy
able experience.
H.O.L.

M

urray

,

m d

,

f r c s [c

]

Irving Clinic,
Kamloops, BC

THE CANADIAN JOURNAL OF SURGERY

